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ABSTRACT 
 
HIV/AIDS remains a global pandemic that is affecting millions of people. The advent of 
antiretroviral medication in the late 1980s has led to major advances in clinical treatment 
that has turned the deadly disease into a chronic condition for those who are infected. 
However, adherence to antiretroviral medication remains problematic. Whilst extensive 
international research has been done to identify various variables that contribute to rates 
of non-adherence, there is not much research being done in South Africa that provides a 
reliable prediction of non-adherence or generates a theoretical understanding of the issue. 
The main aim of this study was to ascertain the barriers and facilitators that contribute to 
the level of adherence to antiretroviral treatment. This was done from a biopsychosocial 
perspective that takes into account not only the biomedical factors that may have an 
impact on antiretroviral treatment levels but also includes the various psychological and 
socio-political factors that contribute to non-adherence. The qualitative research 
methodology was used. Data was collected from 14 participants using semi-structured 
interviews. The participants included 3 medical practitioners, 1 nutritionist, 2 counsellors, 
2 treatment activist, 2 caregivers to PLWHA and 4 people on treatment. Interviews were 
audio-recorded and transcribed. Thematic content analysis was used to generate themes. 
Themes were categorised under individual, interpersonal level and systemic level barriers 
and facilitators to ARV treatment which included biomedical, psychological as well as 
social-political factors that facilitate non-adherence. The main findings in this study 
suggest that there is a complex web of interaction between the various biomedical, 
psychological and socio-political factors that impact on adherence levels. Additionally, 
the response by PLWHA to their illness and subsequently to ARV treatment is more 
complex than a mere conforming to a set of medical standards and instructions. As such 
intervention that looks to increase adherence levels cannot be a one-dimensional or one-
sided endeavour and requires a multifaceted approach.  
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CHAPTER ONE 
 
BACKGROUND TO THE STUDY 
 
1.1 INTRODUCTION 
 
The background to this study and adherence to the treatment of HIV/AIDS (Human 
Immunodeficiency Virus/Acquired Immune Deficiency Syndrome) is conceptualised and 
presented in this chapter. The epidemiology of the illness will be outlined first which will 
be followed by a brief discussion on antiretroviral treatment, and then a definition of the 
concept of adherence will be given. Thereafter the rationale for the study will be given, 
followed by the research questions and research aims. Finally, the layout of the report 
will be outlined. Throughout this report, reference to HIV/AIDS will be made as an 
illness rather than a disease (Radley, 1995), reflecting the position that the researcher has 
taken. According to the researcher, the treatment of HIV/AIDS cannot be limited to 
biomedical factors but has to be conceptualised within the broader psychological and 
socio-political contexts. The word “illness” in this study thus signifies a biopsychosocial 
stance to the virus whereas the word “disease” is mainly linked to the body. In keeping 
with this perspective, the word “patient” has been used sparingly. However, defining the 
patient cannot be totally avoided and has been limited to the biomedical discussions. 
Instead, a less medicalised discourse has been used around people who are on treatment. 
  
1.2 EPIDEMIOLOGY 
 
HIV/AIDS is a global pandemic that continues to escalate in a number of countries 
worldwide. According to the 2007 United Nations AIDS (UNAIDS) and World Health 
Organisation (WHO) (UNAIDS/WHO, 2007), the global number of people living with 
HIV/AIDS (PLWHA) ranges between 30.6 and 36.1 million.  In 2007, approximately 2.5 
million people were newly infected and AIDS-related deaths have been estimated to be 
around 2.1 million people. Of the 2.1 million estimated deaths, 1.7 million are adults and 
330 000 are children (UNAIDS/WHO 2007). 
 
Essential findings in this report indicate that although the overall global pandemic rate 
(those who have been newly infected) appears to have stabilised, the number of people 
living with the virus has increased because of ongoing accumulation of new infections 
(UNAIDS/WHO, 2007). However, despite a broad trend of some stabilisation in some 
countries, Sub-Saharan African countries remain the worst affected (UNAIDS/WHO, 
2007). Statistical estimations indicate that there are approximately 22 million people 
living with the virus in this region (UNAIDS/WHO, 2007). Newly infected figures are 
approximated at 1.7 million, and it is estimated that at least 1.6 million people have died 
in the past year due to HIV/AIDS-related causes (UNAIDS/WHO, 2007). 
 
South Africa is reported to be one of the countries with the largest population of people 
living with HIV/AIDS (Avert, 2008a; UNAIDS/WHO, 2007). According to the statistical 
estimation by the South African Department of Health, the country has an HIV 
prevalence rate of about 6.5 million people (29.1%) (Avert, 2008a). In addition, the South 
African National HIV Survey conducted in 2005 shows that the annual number of 
registered deaths in South Africa increased by 87% between 1997 and 2005, with a 
disproportionate rise in deaths among people between the ages of 25 to 49 years (Avert, 
2008a). This age group accounted for 42% of deaths in 2005 (Avert, 2008a). This places 
the number of people who died of HIV/Aids between 320 000 and 350 000, that is more 
than 800 deaths every day (Avert, 2008a). Notwithstanding statistical difficulties and 
contradictions, these results nonetheless provide substantial evidence of the continued 
seriousness and urgency of the situation in South Africa. 
 
1.3 ANTIRETROVIRAL TREATMENT 
 
For HIV infection to occur the virus needs to enter the body and attach itself to a 
particular set of host cells (CD4) in the immune system (Barnett & Whiteside, 2002). 
Once the virus has entered the cell, it copies and replicates the host DNA. This copying 
of the host DNA allows the virus to replicate rapidly as the human defence system is 
unable to recognise and therefore destroy the foreign body (Barnett & Whiteside, 2002). 
Despite enormous resources being mobilised to find a cure or a vaccination, neither has 
been developed yet.  
 
However, the advent of Antiretroviral Therapy (ART) in the late 1980s has led to major 
advances in clinical treatment that has the potential to suppress viral replication in those 
who are infected (Aids South Africa, 2006). Viral suppression in the body is primarily 
achieved by the course of medication interfering with the ability of the virus to replicate 
itself in the body, leading to minimum damage being caused to the immune system. As 
the immune functioning improves, PLWHA become less susceptible to other 
opportunistic illnesses. Antiretroviral medication (ARV) is not a cure, but has the 
potential of transforming the HIV infection into a chronic condition with a decline in 
morbidity and mortality rates (Webster & Barr, 1999).   
 
ART is a drug treatment that requires a single, dual or triple regimen (Barnett & 
Whiteside, 2002). Currently, there are five groups of ARV drugs that are available and 
each of these works differently to stop the replication of the virus in the body (Aids South 
Africa, 2006; Avert, 2008b). The term “Highly Active Antiretroviral Therapy” (HAART) 
is used to describe a combination of three or more anti-HIV drugs. Due to the complex 
replication process of the virus, once it enters the human host it is possible that a person 
may be carrying different strains of HIV. A new strain may be produced that can be 
resistant to the effects of ARVs, allowing the resistant strain to be able to replicate 
quickly thus nullifying the benefits of the treatment (Avert, 2008b). HAART reduces the 
rate at which the resistance develops. 
 
Treatment failure may lead to viral specified resistance. This may happen when PLWHA 
are rapidly put on mono-therapy which allows drug resistant mutation to take place 
(Mehta, Moore & Graham, 1997), or if the body fails to absorb treatment at an effective 
rate (Mehta et al., 1997). When there is a treatment failure, the entire drug combination 
has to be changed and a second-line regimen has to be started from a new class of drugs 
to minimise the risk of cross-resistance (Mehta et al, 1997).  However, a more crucial 
point that needs to be urgently considered is that many PLWHA have great difficulty in 
adhering to their treatment.  
 
1.4 DEFINING ADHERENCE 
 
Adherence refers to a complex concept that includes taking the medication as it is exactly 
prescribed. Studies have indicated that at least 95% adherence to ART regimen is optimal 
(Low-Beer, Yip, O’Shaughnessy, Hogg, Yip. O’Shaughnessy & Montana, 2000; Shuter, 
Sarlo, Kanmaz, Rhode, & Zingman , 2007). Adherence to treatment differs from 
compliance which only refers to a patient’s behaviour that conforms to medical orders.  
 
Non-adherence to ART refers to  not taking the medication correctly, taking it 
inconsistently or in missing doses which is another factor that leads to increases in the 
frequency of opportunistic infections, faster progression of the disease and a substantial 
decline in health for the PLWHA (Avert, 2008b). The lowered amount of chemicals in 
the body also reduces suppression and thus the viral load rebounds, causing an increase in 
the risk of the viral strain quickly becoming drug resistant. Studies have found a strong 
statistical relationship between the failure to obtain scheduled pharmacy refills and a 
more rapid progression to AIDS (Bansberg, Perry, Charlebois, Edwin, Clark, Robertson, 
Zolopa & Moss, 2001; Hogg et al., 2000). Treatment options in this case become less as 
resistance to one drug will sometimes lead to resistance to other similar drugs in the same 
group leading to cross-resistance (Avert, 2008b).  
 
1.5 RATIONALE 
 
Adherence to ART within the South African context is located in the complex early 
history of the illness and the socio-political response to the illness. The highest HIV 
prevalence rate in South Africa occurred between 1993 and 2000 when very critical and 
major political changes were occurring in the country (Kaiser, H.J. Family Foundation, 
2005). The South African government was slow to give the correct attention to the impact 
of the epidemic and was hesitant to address the demands and challenges that presented 
themselves (Snieder, 2002). The initial HIV/AIDS plan was poorly conceptualised and 
disorganised. The Department of Health finally set up a National AIDS Council to 
oversee the development of a five-year plan to combat HIV/AIDS (Department of Health, 
2000). However, the authorities remained hesitant about acknowledging the full impact 
and it was only in 2003 that the government approved of a plan to make ARVs available 
to the public, after the South African high court ordered that Neviripine be made 
available to pregnant women in an attempt to prevent mother-to-child transmission 
(Kaiser, H.J. Family Foundation, 2005). In March 2004 the government’s treatment plan 
finally took effect and by mid-2005 at least one service point for HIV-related care and 
treatment was set up in each of the 53 districts (Kaiser, H.J. Family Foundation, 2005).  
However, by the end of 2006 only 33% of those in need of ARVs received treatment 
(Avert, 2008a). Despite these critical issues, an early field exercise conducted by Abah et 
al., (2005) found that the initial response to ARV treatment was very hopeful.  
 
However, many problems relating to the adherence to treatment very quickly became a 
point of concern. It soon became evident that being on ARV treatment involved more 
than conforming to medical instructions and standards. Adherence to ARV medication 
involves an intricate interaction of emotional, cognitive, behavioural, social, cultural, 
political as well as medical factors (Frank, 2006). Affecting the success of ART include 
treatment variables like the medical regimen, pill burden, dosing frequency, nutrition 
requirements, convenience and toxicity.  In addition, drug interaction profiles need to be 
compared with other regimens before treatment can be started. Psychological and 
behavioural aspects include mental health status like depression, anxiety, stress or 
substance abuse in patients. Other variables include lifestyle patterns, financial support, 
trust between clinician and patient, educational level, stigma, and patients’ belief about 
the medication. These are all factors that act as predictors of adherence. 
 
Whilst extensive research efforts have served to identify the various variables that 
contribute to non-adherence, there has been a failure to provide a reliable prediction of 
non-adherence or to decrease the prevalence rates of non-adherence (Amassarri, Trotta, 
Murri, et al., 2002; Mehta et al., 1997; Mills, Nechega, Buchan, Orbisinki, Attaran, 
Singh, Rachlis & Wu, 2006). In addition, most of the research has been largely 
quantitative in nature and has failed to take into account the complex interaction of 
various biomedical, psychological, socio-cultural and political factors. Furthermore, the 
research has generally been carried out in developed countries, with some contribution 
from developing countries like China, Brazil and India. Studies from the African 
continent have been particularly lacking. South Africa has its own set of challenges and 
analyses have to take issues like poverty, lack of health care facilities and education into 
account in order to come up with a workable solution that will improve adherence levels.   
 
Furthermore, much of HIV-related behaviour, including non-adherence, is based on 
looking at health behaviour from the point of view of the individual who is on treatment. 
PLWHA are seen to be able to take responsibility for their illness and any deviation is 
seen as a failure on the part of the PLWHA.  Interventions therefore tend to look at the 
individuals’ gaps in knowledge. In addition, attitudes and behavioural intention and 
practices become the target for addressing change at an individual level. Focus on the 
individual level of change has presented many challenges and it is necessary to look at 
other more systemic ways of engaging with the question of non-adherence.  
 
This research represents a twofold endeavour. Firstly, on a practical level, there is an 
attempt to look at the various factors that impact on the adherence levels of those who are 
on ARV treatment, taking into account the multifarious interaction of various biomedical, 
psychological and socio-political factors. Secondly, as a result of the paucity of 
theoretical application, research also needs to examine the various theoretical 
underpinnings of health behaviour with regard to ARV adherence within the South 
African context. It therefore becomes imperative to make use of qualitative scientific 
research approaches to gather in-depth experiences in order to understand the behaviour 
patterns of PLWHA around ARV treatment adherence. The research questions that arise 
from this background are thus as follows. 
 
 
1.6 OBJECTIVES & AIMS OF THE STUDY 
 
The main objective of this study is to get a holistic understanding of the combined 
experiences of both the patients as well as the health-care providers that may guide 
towards bringing together the various biological, psychological as well as social factors 
that impact either positively or negatively on ARV adherence levels. This study will 
therefore examine two broad objectives within this aim: Firstly, to explore how health-
service providers may perceive the challenges and facilitative factors experienced by 
those on ARV medication. The second objective is to explore the patient’s perspective on 
the various challenges as well as factors that may contribute to the ease with which they 
may experience their ARV treatment regimen. It must, however, be noted that some 
health-care providers that were interviewed in this study are also on treatment and have 
therefore narrated their experiences across both roles 
 
The main aim of this research study is to explore and understand the potential barriers as 
well as facilitators to antiretroviral medication adherence. More specifically the aim was 
to uncover how these either impinge on or increase the efficacy of antiretroviral 
treatment. The aim was therefore, to elicit and uncover the various narratives from both 
the patients and the health-care provider’s perspectives pertaining to the experience of 
being HIV-positive and on ARV-treatment. These narratives are used to demonstrate and 
contest the biomedical discourse around the treatment of HIV/AIDS. Broader 
psychological, social-cultural and political discourses are used to demonstrate the wider 
contestations of power relations inherent in the treatment pf PLWHA. 
  
 
 
 
 
 
 
 
1.7 RESEARCH QUESTIONS 
 
The research questions that emanate from the objectives and aims of the study are: 
 
• What are the perceptions of health-care providers and patients of the potential 
biological factors that impact on adherence to ARV treatment? 
• What are the perceptions of health-care providers and patients of the potential 
psychological factors that impact on adherence to ARV treatment? 
• What are the perceptions of health-care providers and patients of the potential 
socio-cultural and political factors that impact on adherence to ARV treatment? 
 
1.8 LAYOUT OF THE REPORT OF THE PRESENT INVESTIGATION 
 
The following is an outline of the layout of this research report: 
 
Chapter 2 - This chapter presents the theoretical foundation of the research and the 
section is divided into two sections. A post-modernist argument on health, illness and 
disease as well as the biopsychosocial model of understanding of health and illness is 
presented first. The second section examines the relevance of the various health-related 
theories, models and concepts including individual health behaviour, models of 
interpersonal health behaviour and community and group models and concepts of health.  
 
Chapter 3 - This chapter reviews some of the salient literature relating to the various 
barriers as well as facilitators which PLWHA experience and how they come to have an 
impact on the levels of adherence to ARV treatment. This section is organised into three 
sections. The literature around biological factors of adherence to ARV medication is 
presented under issues relating to the treatment regimen, the patient/practitioner 
relationship and health system concerns. Secondly, psychological issues relating to stress, 
depression, anxiety and post-traumatic stress will be discussed. In addition, consequences 
of treatment, health-related quality of life, coping, managing the self and the role of 
counselling will be reviewed under psychological determinants with regard to ARV 
adherence. Lastly, the role of social factors relating to adherence in PLWHA is discussed. 
Under the social factors, a review of the literature regarding poverty-related issues, 
stigma and discrimination, social support, managing the environment, and knowledge and 
beliefs around the illness and treatment will be presented. 
 
Chapter 4 - The methodology used in the collection of data and analyses of data is 
discussed in this chapter. It begins with a brief discussion of the research paradigm and 
research questions. This is followed by a description of the setting in which the research 
took place and a discussion around the sample of the study. Then follows the procedure, 
the manner in which the data was collected and a short discussion on the data analyses. 
Finally, the ethical considerations and limitations of this study are outlined. 
 
Chapter 5 – In this chapter the findings, analysis and discussion of the data are 
presented. The themes of what biological, psychological and social factors may improve 
or impinge of ARV adherence levels are arranged into three broad categories. These are 
the individual level, interpersonal level and systemic level barriers and facilitators with 
regard to adherence. The findings also suggested that the levels of intervention are an 
important aspect that needs to be taken into account. This chapter further examines the 
different levels on which one can engage with PLWHA who are on treatment. This is also 
organised around individual level interventions and community level interventions  
 
Chapter 7 – This final chapter presents a summary of the study, the conclusion, 
limitations and recommendations in terms of the research study. 
 
 
 
 
 
 
 
 
CHAPTER TWO 
 
THEORETICAL FOUNDATION OF STUDY 
 
2.1 INTRODUCTION 
 
This chapter serves as the theoretical foundation on which the study is based and includes 
relevant theories. The chapter is presented in two main sections. The first section starts 
by outlining the postmodernist argument to health, illness and disease, and goes on to 
present and discuss the biopsychosocial model. This is done so that the reader may be 
orientated to the biopsychosocial position taken in this research. The second section 
serves to locate the research in relevant health behaviour theory. 
 
HIV-prevention efforts are traditionally based on an urgent need for risk education 
interventions based on the assumption that the greater the understanding of the 
behaviours associated with HIV transmission the more likely it will be for the adoption of 
HIV-prevention behaviour (DiClemente & Peterson, 1994). Consequently a rigorous 
attempt has been made at theoretical driven formulations that have relied on developing 
intervention methods based on the provision of risk information and behaviour change 
derived from behavioural science theory. This traditional use of engaging in individual 
level behavioural theory has been similarly used to engage with difficulties experienced 
with ARV adherence.  
 
The premise of this research is that the complexity of ARV adherence behaviour require a 
more integrative theoretical formulation since it has been argued that collaboration across 
disciplines (medical and social sciences) as well as across roles (involving medical 
practitioners, counsellors and other service providers and PLWHA) is imperative in 
understanding the level of adherence so that effective and sustainable health behaviour 
interventions may be developed (De Bruin, Hospers, Van der Bon, Kok & Prins, 2005; 
Fisher, Cornman, Wynne & Fisher, 2006; Friedland, 2006; Garcia, Schooley & Badar, 
2003). A number of theories have therefore been taken into account in this research in an 
attempt to provide a basis for a more holistic framework and to demonstrate a need for a 
more integrative theoretical understanding of HIV-related behaviours and indeed for that 
matter any health related behaviour within the complexity of the South African context.  
 
The theories that will be covered include the Health Belief Model which will serve as a 
model of individual health behaviour. This is one of the most popular and often used 
model in the study of health behaviour and it remains the most applied theory in 
HIV/AIDS intervention programs. However, there are many shortfalls to this approach 
and Social Constructionist and the Social Networks positions will be discussed as model 
of interpersonal health behaviour. Finally, the Community Organisation and Building 
Model will be covered to illustrate the position taken in this research in which it is argued 
that it is necessary to engage with a more integrative health conceptual frameworks. 
2.2 POST MODERNISM & THE BIOPSYCHOSOCIAL MODEL 
The field of medicine has traditionally been conceptualized through the positivistic 
scientific orientation and technological advancement based on facts and reality that an 
observer might know (Gilbert, Selikow & Walker, 2002; Puustinen, Leiman & Viljanen, 
2003; Tauber, 2005). From this point of view, clinical science views biological 
formulations through the effectiveness of the disease-orientated model of care. In this 
clinical perspective, disease is viewed as a distinct entity that is usually revealed through 
symptoms, and the individual being treated (i.e. the patient) is a passive object of disease 
manifestation. The understanding of disease and the treatment of that disease is located at 
the level of the body (Nettleton, 2002)  
More recently, advocates of postmodernist theory have argued against medicine’s 
attempts to explain human illness through biological concepts and have incorporated 
psychological and social experiences into medical theory (Gilbert et al., 2002; Nettleton, 
2002; Puustinen, et al., 2003; Richter, 1999; Tauber, 2005). Bury (1997) postulates that 
health, illness and medicine is a reflection of culture and society through a process of 
objectification, which is a separation of forms of knowledge that were once in the domain 
of the private setting into the public domain. Disease and illness became objectified 
through the twin processes of the development of modern science and the separation of 
disease from an individual’s experience to a scientific system of pathological anatomy. 
Secondly, through the acceptance of this objective view of disease, modern medicine 
became the “bounded profession we know today” (Bury, 1997, p6).  
According to Foucault (1994), the “clinical gaze” brings the patient under the control of 
the powerful experts and knowledge of the disease becomes the product of a very specific 
configuration of the patient and doctor relationship. Medicine remains a major source of 
knowledge and action (Foucault, 1994). This process of medical expert knowledge then 
gets fed back, enters the everyday world and gets infused with added and newer, more 
powerful dynamics (Foucault, 1994). This is a rationalization of medical practices thus 
becomes a part of society and gets taken on as social reality in a myriad of ways (Bury, 
1997). It is therefore, through this process of rationalization whereby people will absorb 
expert medical knowledge and reorganize their lives accordingly (Bury, 1997). Foucault 
(1998) argues, this medical power can be challenged. Foucault (1998) reasoned that there 
is no universal form of power but power is produced by quite specific social and cultural 
practices. This argument is pertinent as it allows for an analysis of medicine and medical 
practices to include the psychological and socio-political aspects that impact on medical 
behavior. ARV treatment can no longer remain within the confines of biomedicine but 
extends to include multilevel analyses.   
An influential attempt at bringing biologically-based medical theory in line with clinical 
reality is the biopsychosocial model (Sarafino, 2002; Sulls & Rothman, 2004). Although 
this model does not deconstruct the multiplicity of medical knowledge and power, it has 
been utilized in this research as a way of presenting and understanding the psychosocial 
realties that impact on the medical practice. The biopsychosocial model was initially 
conceptualized by George Engel, professor of psychiatry and medicine at the University 
of Rochester in 1977 and is based on the general systems theory. Engel (1978) (as cited 
in Puustinen et al., 2003) argued that medical practice is built on multiple levels that 
include the biological basis for medicine. However, in order to fully understand disease, 
health and illness, a number of other psychological and social variables need to be taken 
into account. These three processes are also interactively involved in physical wellbeing 
(Sulls & Rothman, 2004). Pellegrino and Thomasma (1981) (as cited in Puustinen et al., 
2003) contend that medicine is not what doctors do and what patients expect, but rather a 
human relationship that ties two people together and is therefore a human activity. This 
widens medical practice to humanistic as well as social issues (Puustinen et al., 2003). 
Such a multiple-level analysis may provide a more efficient way of understanding not 
only the illness aspect of HIV/AIDS but also the treatment of PLWHA in that it may 
recognize psychological and social settings in addition to the biomedical problems that 
PLWHA encounter. It has been found that by promoting the biopsychosocial model 
through an intensive training program amongst primary healthcare givers, there was a 
change in the physician’s behavior that benefited the patient (Margalit, Glick, Benbassat 
& Cohen, 2004). Margilit et al., (2004) found an increase in interaction time between the 
patient and the practitioner, more psychosocial interventions being discussed and fewer 
laboratory examinations being requested. Similarly, Cohen (2000) reported that a 
combined interdisciplinary care allowed for a better understanding of the different 
aspects of living with HIV/AIDS and this led to a better response to treatment in 
PLWHA. 
Building on the biopsychosocial model, the interactive biopsychosocial model provides a 
dynamic theoretical framework that understands disease, health and well-being through 
the concept of capital with regard to biophysical, psycho-cognitive and socio-economic 
inputs into health and comprises the health endowment of individuals (Lindau, Lauman, 
Levinson & Waite, 2003). Biophysical capital includes genetic composition, physiology, 
physique, nourishment, strength and appearance (Lindau et al., 2003). Psycho-cognitive 
capital includes intelligence, emotion, wellbeing, personal attributes, self-esteem, self-
efficacy, coping and resilience (Lindau et al., 2003). Social capital in the other hand 
refers to networks of dynamic relationships with others, social connectedness and social 
constrains (Lindau et al., 2003).    
 
Despite widespread recognition of the psychosocial factors that need to be addressed 
when dealing with disease and illness, many medical practitioners continue to show 
skeptism regarding the benefits of integrating these factors into medical diagnosis and 
treatment (Asten, 2008). In this it has been argued that the original biopsychosocial 
model holds true in describing the etiology of a disease but does not convert easily into 
therapeutic matters (Richter, 1999). Hence, it is argued that biological interventions seem 
more easily and successfully implemented rather than social or psychological 
interventions due to the internal condition of the medical system (Richter, 1999). 
However, integral to the argument of this proposal is the premise that the implementation 
and adherence to ART is inextricably and intimately linked to biological, psychological 
and social processes. Furthermore, the concept of biophysical, psycho-cognitive and 
social capital extends this argument to include the availability of these resources to 
protect against the adverse affects of the biopsychosocial processes. 
2.3 THEORIES OF HEALTH BEHAVIOUR 
 
2.3.1 Individual Health Behaviour 
 
2.3.1.1 Health Belief Model 
 
The Health Belief Model (HBM) has been one of the most widely used in the study of 
health behaviour (Janz, Champion & Strecher, 2002; Maiman & Becker, 1974). The 
HBM was developed around the theoretical understanding that suggests that beliefs form 
an important part of health-seeking behaviour. As a consequence, those individuals who 
know about and understand their health problems should perform better than those who 
are less knowledgeable (Rosenstock, Strecher & Becker, 1994). This model proposes four 
important components that will predict a health outcome.  These are the broad concepts 
of perceived susceptibility, perceived seriousness, perceived benefits and perceived 
barriers (Appendix 1). 
 
Perceived susceptibility is based on the idea that an individual will take the appropriate 
action to avoid ill health if they believe that they are personally susceptible to falling ill 
(Rosenstock, 1974). Susceptibility therefore refers to the subjective element around the 
risk being taken and individuals are believed to vary widely in their acceptance of 
personal susceptibility to a particular condition. These may range from an individual who 
on the one hand may completely deny any possibility of an illness occurring to the other 
extreme where an individual will believe that they are in real danger of harm 
(Rosenstock, 1974). Studies that have been conducted around perceived susceptibility 
and HIV/AIDS have shown a variation in the results, indicating that for individuals who 
exhibit high risk behaviour, the construct of perceived susceptibility is necessary in order 
to change high risk behaviour (Rosenstock et al., 1994). 
 
Perceived seriousness of a health outcome is argued to be related to the degree of 
emotional arousal that may be created in the individual. This emotional arousal is related 
to the thoughts around a particular disease and also the kinds of difficulties that the 
individual believes may be created (Rosenstock, 1974). Health issues are therefore 
perceived in relation to their clinical consequence. These may include fears around 
reduced physical or mental functioning. The fear may also be around the issue of dying 
and death. Perceived seriousness may also include the broader implications such as the 
effects of the illness on the work environment, family life or social relations (Rosenstock, 
1974). These health issues refer to social, psychological and economic components that 
are important in the understanding of health and illness. Studies conducted by Rosenstock 
et al. (1994) show that the perception of the severity of HIV/AIDS has to take into 
account the perceived cost of being HIV positive. This refers to a personal evaluation of 
problems, biomedical considerations, financial constrains as well as the social 
consequences of being infected with the virus. It has been argued that often this important 
measure is overlooked in the assessment of HIV-related health behaviour as it is assumed 
that all PLWHA would report that HIV/AIDS is an extremely severe disease (Rosenstock 
et al., 1994). 
 
According to Rosenstock (1974), perceived susceptibility and perceived seriousness are 
based on the cognitive component and are partly dependent on knowledge. It is argued 
that these two components together move the individual to take some kind of action. 
However, the course of action that is likely to be taken by the individual is related to the 
perceived benefits and barriers to taking the action (Rosenstock, 1974). 
 
Behaviour around the perceived benefits is thought to depend on the relative effectiveness 
of the known available alternatives that will reduce the disease threat (Rosenstock, 1974). 
Perceived benefits are more likely to be seen as beneficial to a person’s health outcome if 
the person subjectively reduces their susceptibility to or the seriousness of the illness. 
Rosenstock (1974) puts forward that it is the individual’s subjective beliefs about the 
availability and effectiveness of the various courses of action, and not the objective facts 
about the effectiveness of action, that will determine the course of action that an 
individual will take in relation to their health. 
 
These subjectively held beliefs are in turn influenced by the norms and pressures of the 
person’s social environment (Rosenstock, 1974). Hence, an individual may believe that a 
given action will be effective in reducing the threat of the disease, but at the same time 
they may see the action itself as being inconvenient, expensive, unpleasant, painful or 
upsetting (Rosenstock et al., 1994). These negative aspects serve as barriers of action and 
lead to conflicting motives of avoidance. According to the HBM several resolutions to 
this conflict may be possible. Hence, if readiness to act is high and negative aspects low, 
than action may be taken, whilst if readiness to act is low whilst the potential negative 
aspects are seen as strong then the negative aspects serve as barriers and prevent action. 
Finally where readiness to act as well as barriers to action is great, the conflict is more 
difficult to resolve (Rosenstock, et al., 1994). 
 
According to Rosenstock (1974), alternative actions of nearly equal efficacy may be used 
by individuals to manage their health outcomes. However, if such alternatives are not 
available to resolve conflict than it is argued that one of two reactions may occur. In the 
first instance, the individual may psychologically remove themselves from the conflict by 
engaging in activities that will not reduce the threat to their health. The second reaction 
may be an increase in the person’s fear or anxiety response (Rosenstock, 1974). If the 
fear and/or anxiety becomes elevated the individual may not be able to think rationally or 
in an objective manner in relation to their health. In this case it is postulated that even if 
the person was offered a more effective way of managing their health problem, they 
might not be able to accept it (Rosenstock, 1974). 
 
 However, an important factor to consider as a mediation of the action taken is one of 
cues or events that occur to set the process of health behaviour into motion (Rosenstock, 
1974). These cues can be internally driven, for example, by the individual’s perception of 
their bodily states. The cues that act as mediators can also be external events, for 
example, interpersonal interactions or the impact of media communication. The intensity 
of the cue that can be said to be sufficient enough to trigger a health behaviour response 
may vary with the difference in perceived susceptibility and severity that the individual 
experiences (Rosenstock, 1974). 
 
2.3.1.2 Evaluating Individual Health Behaviour Models 
 
The Health Belief Model is based on cognitive science research and tries to identify 
patterns and ways in which people can assess various health beliefs and how people 
might respond to these beliefs. It represents the individual as an information processing 
unit, human action as volitional and people are viewed as rational free agents restricted 
by their ignorance about their health and illness (Lupton, 1999).  The HBM proposes that 
if a number of perceptions are in place, individuals will then take steps to protect 
themselves. If the threat to oneself is perceived to have serious consequences but there is 
a belief that taking preventative action will be effective and that the benefits will 
outweigh the costs, then individuals will take the appropriate actions to protect 
themselves. 
 
 
In this way, health behaviour is reduced to a specific and discrete set of cognitions that 
become amenable to educational interventions. The individual and perception become 
limited by how humans see and understand their world through their senses and brain 
functioning without acknowledging social and cultural meaning systems (Lupton, 1999). 
However, beliefs are stable characteristics that are acquired or learnt through a process of 
socialisation, and the argument postulated by models like the HBM that beliefs can be 
differentiated between individuals of the same background requires a close and more 
critical examination. According to Rimmer (2002), these models may be more applicable 
to a homogeneous middle class population since they may be more orientated towards a 
specific common health goal. When looking at populations where health is impacted by 
large systemic-level barriers like poverty, lack of a good health system, traditional belief 
systems and different ideas around health, these models do not provide an adequate 
theoretical foundation for intervention (Rimmer, 2002) 
 
Apart from practical limitations, this model is further limited by its theoretical application 
(Rimmer, 2002). It is argued that some constructs in the HBM are not well understood 
and yet other constructs have low predictive value. In addition, in the application of the 
theory, researchers often choose some variables above others to focus on. This has an 
impact on the rigour of the theory itself.  Other individual health belief models are argued 
to be more rigorously codified and are systemically able to identify person behaviour 
around specific health practises more than the HBM. However, even these theories those 
remain located at the level of understanding health behaviour at the individual as it does 
not take into account emotional responses (Rimmer, 2002). Strong emotional responses 
as well as socio-cultural and political factors around aspects of health drive very powerful 
behaviour and it is often very difficult to anticipate such responses 
 
 
 
 
 
 
2.3.2 Interpersonal Health Behaviour 
 
2.3.2.1 The Social Constructionist Position 
 
As it has been argued in the previous section, a behaviour change model like the HBM, 
are based on looking at health behaviour from the point of view of ascertaining the 
knowledge, attitudes, behavioural intention and behavioural practices of individuals. 
Gaps in knowledge, attitudes and behaviours then become the target for addressing 
change at an individual level. However, focus on the individual level of change has 
presented many challenges (Shingal & Rogers, 2003). According to Shingals and Rogers 
(2003), these models fail to provide adequate explanations and change in attitude and 
behaviour for four reasons. 
 
Firstly, behaviour change communication strategies are based on the assumption that all 
individuals are capable of controlling their context (Shingal & Rogers, 2003). Yet there 
are many social, psychological and political factors which place the individual in a 
context where they may be able to exercise only limited control. Secondly, these 
strategies make the assumption that all individuals are on an equal footing. Subsequently 
these models fail to take disparate factors like gender, race or socio-economic factors into 
account (Shingal & Rogers, 2003). Thirdly, there is an assumption that all individuals 
make decisions based on their free will. Lastly, the assumption is that all individuals 
make preventative health care decisions in a rational and logical manner, and therefore 
people would not willingly put their lives in danger (Shingal & Rogers, 2003). 
 
According to Pavia (1995) (as cited in Shingal & Rogers, 2003), behaviour change 
communication strategies have constructed concerns around HIV/AIDS through the 
biomedical factors and interventions sometimes overlook the psychological, cultural and 
social concerns. Airhihenbuwa (1999) (as cited in Shingal & Rogers, 2003) believes that 
culture can be used as an ally with strengths and attributes that can be helpful in looking 
at issues around HIV/AIDS. Hence Airhihenbuwa (1999) (as cited in Shingal & Rogers, 
2003, p. 218) argues that the “metaphorical coupling of culture and barriers needs to be 
exposed, deconstructed and reconstructed so a new, positive cultural linkage can be 
forged”. Tapping into the strengths of certain cultural practises thus becomes important 
(Curtis & Tucket, 1996; Shingal & Rogers, 2003). This is not to take away from those 
studies that very strongly show the disastrous consequences of certain cultural practices 
that can undoubtedly become an detrimental to PLWHA. 
 
Furthermore, individual theories on health behaviour conceptualise health behaviour in 
relation to how well risk can be identified and calculated, the level  of seriousness of the 
risk, the possible effects and why people respond to risk behaviour in a certain way 
(Lupton, 1999). Risk is seen as pre-existing and in principle can be identified by using 
scientific measurements and can be controlled by using knowledge. (Lupton,1999). These 
theoretical formulations represent human action as logical, and categorise risk avoidance 
behaviour as “rational” whilst conceptualising risk-taking behaviour as “irrational”. 
Behavioural and cognitive models see a linear relationship between knowledge and risk, 
and individuals are seen as calculating and emotion-free actors (Lupton, 1999). 
 
The social constructionist position puts forward the argument that risk is never objective 
and never lies outside a belief system, and therefore health behaviour including risk-
taking behaviour should be identified and managed through pre-existing knowledge, 
reproduction of meaning and through social interactions (Gergen, 2001; Lupton, 1999). 
The way that the PLWHA manage their illness is therefore constantly constructed and 
reconstructed and negotiated through meaning-formation and social interaction. It is thus 
important to understand the perception of the various actors who are located in different 
contextual matrices and who therefore would have competing views on what it means to 
be on ARV treatment (Gergen, 2001; Lupton, 1999). Lupton (1999, p. 31) argues that for 
an activity or situation to become risky, the process of analysing harmful behaviour 
becomes a “rhetorical process, performed in specialised texts or in the public arena and 
often involves an intense struggle over meaning, particularly in relation to those actors 
who are deemed to be responsible for the risk object”. In the construction and 
understanding of risky behaviour it is rarely the layperson who plays a major role of 
constructing risk objects at public debates but rather the experts with scientific 
knowledge, particularly those emerging from science, medicine and psychology 
disciplines, that embed risk at an organisational level. Hence nothing is a risk in itself but 
needs to be deconstructed through the eyes of those who are living with the illness 
(Gergen, 2001; Lupton, 1999). 
 
2.3.2.2 Social Networks and Social Influence Model 
 
Social relationships have a very powerful influence on health behaviour and outcomes 
(Heaney & Isreal, 2002), and this has been a particularly favoured method of medical 
behaviour intervention with PLWHA. The social network refers to the social 
relationships that surround the individuals whilst social support defines an important 
function of the social relationship. Social networks may or may not provide social 
support. They may also provide for functions other than support (Heaney & Isreal, 2002).  
 
Structures of social networks can be dyadic between the individual and other individuals 
and these kinds of dyadic relationships are reciprocal in terms of give and take, intensity 
of emotional closeness, complexity and variedness of relationship (Heaney & Isreal, 
2002). However, social networks also imply entire networks of members limited only by 
the extent to which collective members know and interact with each other. These can be 
relatively homogeneous groups similar in characteristics like race, ethnicity, age, gender, 
geographic dispersion or socioeconomic status.  Social networks may also reflect 
heterogeneity based on diversity (Heaney & Isreal, 2002). Social networks may provide 
social support based on behaviours or acts that include emotional support (empathy, love, 
trust, care), instrumental support (provision of tangible aid and service that directly assist 
in needs), informational support (advice, suggestion, knowledge base) or appraisal 
support (constructive feedback, affirmation) (Heaney & Isreal, 2002). 
 
The mechanism through which social support and social networks may have a possible 
positive effect on health outcomes can be through utilising both individual coping 
resources as well as community resources (Appendix 2). By meeting the basic needs for 
companionship, intimacy, sense of belonging and reassurance of a person’s worth, 
supportive ties may enhance heath outcomes (e.g. adherence to medication) regardless of 
the stress levels that the PLWHA may experience. This will in turn increase the 
individual’s coping resources by providing for the accessing of new contacts, knowledge 
and helping PLWHA to identify and solve specific problems. Therefore, support systems 
may assist is reducing uncertainty and unpredictability, or they may help to produce the 
desired outcomes resulting in a sense of personal mastery and control for the PLWHA 
(Heaney & Isreal, 2002). Furthermore, the strengthening of social networks and social 
support in community networks bolsters the ability for that community to procure 
additional resources and to solve problems, enhancing community capacity and control. 
In this way adherence levels to ARV treatment regimens can be improved. 
 
The symbolic interactionist theory provides useful insight into the interaction between the 
individual and his or her social environment (Mead, 1934). It is argued that the manner in 
which one constructs the self and the meaning that one attaches to the environment is not 
limited to the personal but emerges out of social processes (Mead, 1934). Furthermore, 
social processes do not occur in isolation but interact on a symbolic level with the 
individual with consequences in the development of that person. People are therefore 
influenced by the attitude and behaviour of other people in their environment and are 
constantly readjusting their behaviour in an anticipated reaction to others (Mead, 1934).  
It has been found that PLWHA will often internalise the perception and behaviours of 
others. This internalisation will than be used as a frame of reference from which PLWHA 
would make meaning of their experiences (Patel, 2005). According to the study 
conducted by Patel (2005), PLWHA are likely to construct themselves through a negative 
self-concept, engage in devaluation of the self and many may withdraw from social 
interactions. Social networking and support is an important resource for PLWHA and 
these structures can assist in reducing fear, guilt, denial, anger and isolation thereby 
promoting their ability to adhere to treatment. 
 
Results from several studies strongly indicate that support-enhancing interventions 
should begin with assessments of the individual’s social networks (Heany & Israel, 
2002). Network mapping can assist in identifying the strengths and weaknesses of an 
individual. This can in turn lead to a reciprocal relationship of mutual trust and care, and 
foster a helping relationship based on interdependence and exchange between the various 
team members. The challenge of this type of assessment lies in identifying who or what 
can perform effective protective functions with regard to social networks (Heany & 
Israel, 2002).  
 
Studies also reflect that it is important to take into account a number of various options 
that may be available to the individual (Heany & Israel, 2002). Intervention type can be 
based on enhancing existing social networks or developing new social linkages. Although 
the former has untapped potential, the latter may provide challenges that include 
identifying such groups and members who are willing to commit to and sustain the group. 
The latter may provide to be more useful when the existing networks of those who are 
struggling with health-related issues have relative small or no social networks. If a 
support system is overburdened, then introducing new social linkages could prove to be 
useful in providing encouragement and support (Heany & Israel, 2002). 
 
2.3.4 Community Health Behaviour 
 
2.3.4.1. Community Organisation & Building 
 
Nguyen, Ako, Niamba, et al. (2007) put forward a compelling argument that PLWHA 
living with no social security and with minimal or no medical care are often faced with 
being ostracised, victimised, deserted, left destitute and face death alone. This is a 
response to what is a “moral economy” which can be understood as a cultural basis for 
evaluating value based on kinship and social relationships (Nguyen et al. 2007)). Hence, 
a person’s position in the kinship hierarchy can determine the person’s position in the 
social setting and therefore their vulnerability. Social triage on the other hand refers to 
the manner in which scarce treatment resources are applied to decide who will receive 
prioritised care (Nguyen et al., 2006). 
 
Since the advent of ARVs in the late 1990s, the demand for the medication still remains 
higher then what can be supplied by many developing countries and the question arises as 
to who should benefit from the limited resources. Those who are most likely to live are 
prioritised to receive care whilst those people whose prognosis is poor may be left to die. 
Ngunyen et al. (2006) argue that how ART becomes available largely depends on the 
social triage of moral economy. This is very strongly reflected by those who have 
become the strongest activists in South Africa and elsewhere on the continent.  Treatment 
activism has become based on a process of producing activism through the access of 
treatment and not shaped solely by social forces (Ngunyen et al., 2006).  
 
Therefore the argument put forward is that the social response to the epidemic should 
shift its focus to include the concept of empowerment that will allow PLWHA to 
negotiate and gain access to lifesaving treatment and the ongoing challenges of 
adherence. This can largely be understood as improving the conditions of those who are 
most vulnerable to HIV by emphasising their basic human rights to receiving the 
necessary medication. Van der Vliet (1996) makes a compelling argument that 
HIV/AIDS can be viewed as a product of both macro- as well as micro-political 
processes, and in order to turn this epidemic around one would have to take a careful look 
at power relationships and political processes that trap people into powerlessness 
stopping them from accessing the much needed treatment to stay alive for longer. 
 
In this regard, Foucault’s (1998) discussion on power has particular significance. 
According to Foucault (1998, p.89) “power must be analysed as something that 
circulates, or rather something which only functions in a form of a chain. It is never 
localised here or there, never in anybody’s hands, never appropriated as a commodity or a 
piece of wealth. Power is employed through a net like organisation and not only do 
individuals circulate between its threads; they are always in a position of simultaneously 
undergoing and exercising this power. In other words, individuals are the vehicles of 
power, not its point of application” This is a critical point as it may allow people through 
community engagement to reflect more openly about what it means to be HIV-positive in 
a move away from the various forms of “expert” knowledge that governs their health and 
health behaviour. Those who are HIV-positive may thus be able to move from being 
passive objects and bystanders in their medical experiences to having more agency. 
 
Empowering individuals and communities through civic associations may be useful when 
engaging with the question of the social triage and moral economy. Empowered 
citizenship where there is a high level of understanding of HIV/AIDS reinforced by 
community advocacy and the mobilisation process that promotes the rights of PLWHA 
(Robins, 2004) can be extended to include macro-political systems. 
 
Community organisation is a process in which community groups are assisted in 
identifying common problems and goals to mobilise resources and implement collective 
strategies (Appendix 3). Implicit in this definition is the concept of empowerment, 
critical consciousness as well as social action.  This model is thus viewed as a process in 
which both individuals and communities can take control of their lives and their 
environment to ensure better health outcomes for themselves (Rappaort 1981).  This 
fairly recent and more expanded view of and emphasis on community participation that 
leads to better health outcomes initially began in the 1970s (Minkler & Wallerstein, 
2002). The World Health Organisation adopted this view in 1986 whereby they focused 
on increasing people’s control over their determinants of their health with high level 
public participation. The aim of this model to health is to create a sustainable 
environment through both government as well as non-governmental sectors in partnership 
with the communities to can create public health policies, achieve high level participation 
in community-driven projects and to ultimately reduce inequities and disparities between 
groups (Minkler & Wallerstein, 2002). Alongside this is the idea of community building 
rather than just community organisation. This implies that the people in the community 
engage in the process themselves (Minkler & Wallerstein, 2002). 
 
This link between individual organisational and community level empowerment that calls 
for liberation is the process in transformation (Friere as cited in Hope & Timmel, 2003; 
Connolly 1980). This requires a critical look at what keeps and reinforces powerlessness 
in PLWHA. Through critical dialogue group participants can look and listen for issues 
contained in their own experiences, understand root problems and devise strategies to 
transform their reality (Friere as cited in Hope & Timmel, 2003 & Connolly, 1980). 
According to Rappaort (1981) empowerment is a dynamic construct that links the 
strengths of individuals and communities to bring about social change. One of the major 
goals of empowerment is to assist those people who are marginalised to develop a critical 
understanding of the socio-political environment through collective participation. In this 
manner, health can be seen through the extended lenses of wellness, competencies, 
strengths, capabilities and the impact of environmental influences of social problems and 
there is less focus on disease, deficits, weaknesses, blaming, categorising and risk factors 
(Rappaport 1981). 
 
Community empowerment is multi-layered and represents both the process and the 
outcome of change for the individual and the community social structures (Nelson & 
Prilleltensky, 2005). Empowerment can also challenge both perceived as well as real 
powerlessness (Nelson & Prilleltensky, 2005). At the level of the individual one can refer 
to psychological empowerment where there is an extension of intrapsychic abilities like 
self-esteem and self-confidence that will allow people to attain better control over their 
lives, make them more aware of their social context and of political efficacy (Nelson & 
Prilleltensky, 2005). Organisational empowerment, on the other hand, can look at 
resources and at greater participatory activities. This allows for better collective problem-
solving abilities and working towards collective empowerment (Nelson & Prilleltensky, 
2005). Hence it becomes important to understand health behaviours and outcomes from a 
place of empowerment, concientisation and community connectedness where there is a 
deep understanding and awareness of their lived situation and of the capacity for 
PLWHA to transform their lives 
 
The Social Action Model (SAM) takes on an active stance in understanding liberation 
through the act of transformation (Mann, 1978). In a bottom-up approach, the SAM 
challenges the notion of social inequality arguing that there is a link between inequality 
and psychosocial difficulties. In terms of the SAM, traditional models of understanding 
health therefore remain inadequate in explaining and understanding health behaviour. 
Analysis should not stop at the individual level. According to this model, it is also not 
enough to include aspects of the social environment without taking into account how the 
various socio-political structures impact on a person’s life (Mann, 1978). 
 
Closely related to the concept of empowerment is the notion of community capacity 
(Minkler & Wallerstein, 2002). Community capacity can be defined as the characteristics 
that a community has that affect their ability to identify, mobilise and address social and 
public health problems. Goodman et al. (1993) (as cited in Minkler & Wallerstein, 2002) 
postulates that community capacity has multiple dimensions of active participation, 
leadership, rich support networks, skills, resources, critical reflection, sense of 
community, understanding of their history, articulation of values and access to power. 
Community capacity includes the various components of the community members who 
are able to collaborate effectively in order to identify problems and any needs in the 
community, to achieve working consensus of goals and priorities, to agree on ways and 
means to implement the agreed-upon goals and to collaborate effectively in the required 
actions (Minkler & Wallerstein, 2002) 
 
2.4 CONCLUSION 
 
In this chapter the theoretical foundation for the study has been presented. A post-
modernist argument on health, illness and disease as well as the biopsychosocial model of 
understanding of health and illness were presented first. The relevance of the various 
health-related theories, models and concepts including individual health behaviour, 
models of interpersonal health behaviour and community and group models and concepts 
of health behaviour has been explained and examined. Thus the foundation has been laid 
on which this research study regarding adherence to HIV treatment is based. 
 
 
 
 
 
CHAPTER THREE 
 
LITERATURE REVIEW 
 
3.1 INTRODUCTION 
 
This chapter reviews some of the salient literature relating to the various barriers as well 
as facilitators which PLWHA experience and how they come to have an impact on the 
levels of adherence to ARV treatment. This section is organised into three subsections. 
The literature around biological factors of adherence to ARV medication is presented 
under issues relating to the treatment regimen, the patient/practitioner relationship and 
health system concerns. Secondly, psychological issues relating to stress, depression, 
anxiety and post-traumatic stress will be discussed. In addition, consequences of 
treatment, health-related quality of life, coping, managing the self and the role of 
counselling will be reviewed under psychological determinants with regard to ARV 
adherence. Lastly, the role of social factors relating to adherence in PLWHA is discussed. 
Under the social factors, a review of the literature regarding poverty-related issues, 
stigma and discrimination, social support, managing the environment, and knowledge and 
beliefs around the illness and treatment will be presented. 
3.2 BIOMEDICAL FACTORS CONTRIBUTING TO NON-ADHERENCE 
3.2.1 Treatment  
 
3.2.1.1 Complexity of treatment 
 
The clinical goal of ARV treatment has been defined as the suppression of HIV 
replication, immune reconstitution, a slowing of disease progression, increased survival, 
reduced morbidity and mortality, and a better quality of life (Hart, Curtis, Wilkins & 
Johnson, 2007). Yet ARV treatment is not an easy task since it is a life-time commitment 
in managing the durable suppression of the HIV viral replication to below the level of 
detection.  
 
Studies (Altice, Mostashari & Friedland, 2001; Hart et al., 2007; Lesho & Gey, 2003; 
Maneesriwongul, Tulathong, Fennie & Williams 2006; Seguy, Diaz, Pereira et al., 2007) 
have revealed that the duration of the treatment can determine the effectiveness of 
adherence to ARV.  According to Altice et al. (2001), with extended therapy there is an 
increased possibility of treatment interruptions, which will lead to virologic failure due to 
non-adherence. However, it has also been found that the longer people stayed on 
treatment, the more experienced they would become in the treatment and ultimately 
leading to better adherence (Maneesriwongul et al., 2006). Often this is because 
individuals who remain in the system for a long period of time receive on average a 
higher quality of care (Maneesriwongul et al., 2006). 
 
In addition, those who were put on nucleoside mono-therapy showed a better adherence 
level than those put on dual-nucleoside combination therapy, suggesting that the more 
complex the treatment regimen the higher the possibility of not taking the medication as 
it has been prescribed (Altice et al., 2001, Lesho et al., 2003). 
 
3.2.1.2 Side effects 
All classes of ARV drugs are associated with toxicities and adverse side effects that vary 
from being mild to severe and from acute to chronic. Some side effects can be lethal 
(Murphy, 2003). Specific toxicities that have been reported include coronary heart 
disease, lipodystrophy, bone disorders, lactic acidosis, glucose intolerance/diabetes, 
pancreatitis, liver disease, renal insufficiency, sensory neuropathy and neuropsychiatric 
conditions (Murphy, 2003). Full awareness of the potential toxicities, the individual’s 
tolerance to side effects and the management of these by medical practitioners is critical 
to ensure patient safety.  
 
Ammassari et al. (2001) found that symptoms of side effects of the medication were 
frequent in people treated with ARV. Amongst protease inhibitor–treated cohorts up to 
29% to 36% of subjects after 14 to 19 months of observation were found to be suffering 
from some type of side effect symptom (Ammassari et al., 2001). Similarly, Altice et al. 
(2001) reported that the most predictive factor associated with non-adherence was the 
side effect variable (92% of the sample population).  
Fear that results from powerful negative images of medication appears to have a 
substantial impact on adherence levels (Altice et al., 2001). Many respondents stopped 
taking or missed treatment because of a perception of what would happen if they had to 
take the medication (Altice et al., 2001; Ammassari et al., 2001. In addition, those 
individuals who stopped taking their medication immediately if they thought they might 
experience some kind of a side effect (i.e. perceived and not real experience of 
symptoms), had a much lower adherence level then those who would keep taking their 
medication until they could speak to someone about their actual symptoms (Altice et al., 
2001). Furthermore, it appears that trust in the medication’s efficaciousness to not cause 
harm is an essential factor in adherence (Stone, Hogan, Shuman, Rompalo, Howard, 
Korkonzelou & Smith, 2001). Providing reassurance over medication and timely 
management are components that increase the rate of adherence (Hardon, Akurut, 
Comoro, Ekezie, Irunde, Gerrits, Kglatwane, Kinsman, Kwasa, Maridadi, Moroka, 
Moyo, Makiyemba, Nsimba, Ogenyi, Oyabba, Temu & Laing, 2007; Nakiyamba, Kwasa 
& Akurut, 2006).  Often side effects will decrease or disappear over time but this 
valuable information is often not communicated to the PLWHA (Hardon et al., 2007; 
Nakiyamba, et al., 2006). Where side effects have been discussed extensively through 
counseling, adherence levels have had a more positive outcome (Hardon et al., 2007; 
Nakiyamba et al., 2006) 
Information regarding the potential long-term adverse consequences must be investigated 
as such new information may lead to doctors prescribing medication that has fewer side 
effects. This can assist in stopping the decrease or delay of the acceptance of ARVs in 
individuals who perceive the consequences of being on treatment as being worse than the 
progression of HIV itself (Altice et al., 2001).  
3.2.1.3 Nutrition 
 
Individuals with HIV have special nutritional needs due to the response of and the extra 
energy needs that are required of the immune system. This is irrespective of whether they 
are on ARV medication or not (Castleman & Seumo, 2003; Nakiyamba et al., 2006). 
Malabsorption and other digestive problems lead to protein loss which leads to a 
breakdown in muscle tissue (Castleman & Seumo, 2003; Nakiyamba et al., 2006). 
Furthermore, various complications related to repeated infections and fatigue may often 
result in poor appetite, leading to further loss of nutrients in the body (Castleman & 
Seumo, 2003; Nakiyamba et al., 2006). Proper nutrition helps to strengthen the immune 
system and to slow down the progression of the illness. 
 
ARV medication and food intake play an important role since they interact with each 
other and issues such as the following need to be taken into account: the effects of food 
medication efficacy, the effects of medication on the use of nutrition by the body, the 
effects of medication side effects on food consumption and the unhealthy side effects 
caused by medication and contraindicated foods (Castleman & Seumo, 2003). Certain 
foods can affect the medication absorption, metabolism, distribution and excretion of 
ARV medication.  In particular, foods that are high in fat and protein content may 
decrease the absorption of certain ARVs (Castleman & Seumo, 2003; Kotler, 2000; 
Sharpstone, Murray, Ross, Phelan, Crane, Cozi, Allessandrod, Nelson & Gazzard, 1999). 
Some ARVs need to be taken on an empty stomach. It has been found that that 
medication can impact on the absorption of nutrients into the body resulting in elevated 
blood cholesterol levels that may in turn lead to an increased risk in coronary diseases 
(Kotler 2000; Sharpstone et al., 1999). Another factor to consider are the toxicity levels 
produced by ARV medication which lead to side effects like nausea, diarrhoea, dryness 
of the mouth, vomiting and changes in taste or loss in appetite and nutritional loss 
(Kotler, 2000; Sharpstone et al., 1999). It should also be noted that PLWHA often have to 
take other medication to treat opportunistic infections and this may affect nutritional 
needs (Castleman & Seumo, 2003)   
 
Failure to manage these interactions between ARV medication and food intake often 
results in a failure to follow through on drug schedules or even in stopping the 
consumption of the drugs altogether (Castleman & Seumo). Although service provides, 
counsellors, home-based caregivers and communities are educated to understand the 
implications of a lack of nutrition, for many households the economic impact of HIV can 
be severe. Merely providing information on nutritional needs is clearly not enough (the 
social aspects of nutritional needs will be discussed later under the impact of poverty on 
adherence levels).  
 
3.2.1.4 Managing the regimen 
 
Other reasons cited by PLWHA for missing treatment included forgetting, being busy or 
being away from home (Conway, 2007). Surveys in developed countries have shown that 
there is a strong preference for a once-daily dosage and compact therapy which is more 
likely to yield better long-term adherence and virologic suppression (Conway, 2007). 
Conway (2007) also believes that some twice-daily dosages may be safely and effectively 
administered once daily. Allowing for the forgiveness of dosing that is delayed or missed 
is critical and it is important for health-care providers to emphasise that if a treatment 
dose is missed it is always better to take a dose late than not at all (Conway, 2007). 
  
As taking ARVs is a long-term commitment, tailoring the regiment where PLWHA are 
better able to pragmatically incorporate their medication regimen into their lifestyle using 
strategies which include habit development and choosing a regimen that fitted into a 
particular lifestyle, increased adherence levels  (Lewis, Colbert, Erlin & Meyers 2006). 
Secondly, those individuals who were better able to accept the trade-offs between the 
benefits of the medication in relation to the limitations (for example, keeping the side 
effects in perspective, understanding that treatment is beneficial to health of self and for 
survival, or understanding that there were limited treatment options) were able to 
recognise that adherence to the medication was important (Lewis et al., 2006).  Thirdly, 
acknowledging the role of medication in avoiding illness and death, the strong belief in 
the efficacy of their medication and acknowledging that adherence to treatment played a 
major role in avoiding illness and death seemed to contribute to the facilitation of high 
adherence (Lewis et al., 2006). 
 
3.2.2 Patient/Practitioner Relationship 
 
The relationship between the patient and practitioner is generally characterized by the 
provision of support, empathy, trust, communication and the practitioner’s knowledge of 
the patient (Leopold, Cooper & Clancy. 1996; Forest, Shi, Voon Schrader & Ng, 2002). 
In addition, the field of medicine has been increasingly analysed from a social control 
point of view (Hillier, 2002). Professional control over issues of health and illness remain 
under the control of the medical profession and it has been argued that medical doctors 
have come to exert an enormous amount of power and control over those whom they treat 
through their specialised knowledge and professional status. The opinion of the medical 
practitioner is seen as having greater value and insight than others (Hillier, 2002).  
 
The strength of the patient/practitioner relationship is therefore not always benign or 
existing in a vacuum and should not be overlooked when looking at the levels of 
adherence in PLWHA. A pertinent issue that relates to the patient/practitioner 
relationship is that often there is a concentration of the problem on the individual patient 
with a focus to change the patient’s behaviour patterns rather than on the wider 
psychosocial issues that may be impacting on such behaviour (Hillier, 2002). In addition, 
attention needs to be paid to the interaction process between patients and health care 
workers (Sixma, Spreeuwenberg & Van der Pasch, 1998,). The general practitioner’s role 
in the provision of health care should include responses to social issues and specific tasks 
should include the responsibility for the care of individuals; the role of gatekeeper; broad 
knowledge of curative, preventive, and rehabilitative medicine; teamwork; management; 
and development of population-based strategies (The Joint Working Party of the Welsh 
Council of the Royal College of General Practitioners and the Welsh General Medical 
Services Committee, 1994). Clinical work remains imperative and foremost in the 
treatment of HIV/AIDS, but studies indicate very strongly that this has to be done in 
combination with issues like better equity and access of care to benefit all patients, and 
these issues need to be actively engaged in (Sixma et al., 1998). 
 
According to Altice et al (2001), those individuals who have continuity in care from their 
physicians were overall more adherent, whereas those who were more socially isolated 
from their health care practitioners were less likely to keep to their medication regimen. 
This emphasises the importance of the relationship between the clinician, other health 
care professionals and the person receiving medical care. Furthermore, according to 
Kumarasamy et al. (2005) a major facilitator in the level of adherence remains the 
management of the illness in relation to controlling the virus, keeping one’s body in good 
healthy condition and strengthening the immune system. Where PLWHA felt lowered 
side effects, and managed to maintain their weight and had a healthier look, they were 
better able to engage with themes of general overall feelings of health and well-being 
(Kumarasamy et al., 2005). 
 
Trust in the physician and a high level of satisfaction with health care providers remain 
important factors for those on ARV medication. Those who have a higher level of trust in 
the medical providers show better adherence levels (Altice et al, 2001). Facilitating 
factors that emphasise a trusting relationship with medical caregivers include 
competence, comprehensiveness, consistency, continuity of care and compassion (Laince, 
& Davidhoff 1996; Lewis et al, 2006; Kaplan & Rogers, 1993). Conversely if there is a 
high level of social mistrust, especially from those who are marginalised and come from 
disadvantaged societies, this can affect adherence levels negatively. Such interactions in 
community health beliefs and medical outcomes play a prominent role in adherence to 
ARV. According to Gordillo, del Amo, Soriano and Gonzalez-Lahoz. (1999), satisfaction 
with the clinician does not necessarily translate to medication adherence. Therefore, 
although maintaining an honest, open and non-paternalistic relationship to those PLWHA 
remains crucial, in some cases well-intentioned interventions may paradoxically lead to 
the person’s disengagement with their medication intake (Conway, 2007). For example, 
admission to poor adherence may lead to the disapproval of the physician (Conway, 
2007) or the well-meaning intervention of medical alarms to remind the individual that it 
is time to take their medication may have a negative impact of experiencing stigma and 
discrimination by the PLWHA (Mannheimer, Morse, Mats, Andrews, Child, Schemetter 
& Friedland, 2006).  
 
The level of trust that the individual has in the medical system and the practitioners also 
intersects with the experience of side affects and the level of adherence. Those individual 
who had a higher trust in the medical system and the practitioners were better able to deal 
with the various side effects, and as a result managed to stay longer on the medication 
(Altice et al., 2001). Furthermore, it appeared that women in general were more likely to 
have longer visits with their medical practitioners and they were more likely to discuss 
emotional issues relating to their illness (Altice, 2001). Social desirability and the need to 
project a positive image seem to have impacted on the reported overestimation of 
adherence levels (Altice et al., 2001; Murri, Ammassari, Trotta, De Luca, Melzi, Minardi, 
Zaccarelli, Rellecati, 2004). PLWHA who are on ARV treatment have to be informed and 
reassured that their adherence response will not interfere with the care that they are 
receiving. 
 
3.2.3 Health Care System 
 
The health care system is found to have an impact on adherence levels. In some countries 
the waiting time to renew a prescription in public facilities can be on average five hours 
long (Hardon et al., 2007). The top end of this waiting time has been found to be 
approximately 12 hours. This translates into a loss of at least one working day per month 
and can present a host of issues for PLWHA (Hardon et al., 2007). Often those who have 
not disclosed their status or who do not have adequate support from those at work have 
the extra burden of explaining this time that they need (Hardon et al, 2007). In some 
situations these individuals may ask others to fetch the re-fills and requests are often 
made for three to four month refill time periods. However, paradoxically one month 
refills are used to monitor levels of adherence, and extended time periods may create 
added constraints (Hardon et al, 2007). Hardon et al. (2007) recommends that giving 
appointments may reduce waiting times. However, in the face of too little staff members, 
inadequate training and heavy workload at most public medical services, this may not be 
a workable solution in most developing countries where resources are scarce. 
 
3.3 PSYCHOLOGICAL FACTORS CONTRIBUTING TO NON-ADHERENCE 
 
There has been much research conducted on the difficulty PLWHA experience in relation 
to their physical, emotional and interpersonal wellbeing (Kalichman, Di Marco, Austin, 
Luke & Di Fonza, 2003; Simoni, Demas Mason, Drossman & Davis, 2000). PLWHA 
will very often experience a series of losses including fear around losing their future 
(Shisana & Simbayi, 2002), fear of becoming ill and dying (Van Dyk, 1993), fear of 
losing their identity and self-esteem (Van de Walt & McKay, 1991). The fear of being 
alone and loneliness also feature very strongly for PLWHA as many find themselves 
being ostracised and discriminated against (Siegal & Schrimshaw, 2006). Furthermore, 
feelings of guilt may be pervasive around the belief that certain behaviours or lifestyle 
choices resulted in them contracting the virus, or PLWHA may feel guilty about the 
shame that they may have brought on those around them (Deacon, Stephney & 
Prosalendis, 2005). Guilt may also be experienced around the extra expenses that the 
families have to endure in the face of already strained resources (Van de Walt & McKay, 
1991). 
 
3.3.1. Stressful life situations 
 
Considering the many psychological issues that PLWHA may have to face, much less 
research has been conducted on the psychological effects of being on ARVs. This area is 
poorly understood as the focus still appears to be primarily around the physical health and 
benefits of ARV treatment. However, findings indicate that the experience of 
psychological stressors on the PLWHA often result in poor health practices and thus lead 
to poor adherence levels (Bottonari, Roberts, Ciesla & Hewtitt, 2005). It was also found 
that that perception of stress was a greater predictor for poor adherence than acute 
stressful life situations (Bottonari et al., 2005). In addition, the number of stressors that 
the individual has to endure further complicates adherence levels (Mellins, Kang, Havens 
& Chesney, 2003; Murphy, Greenwell, & Hoffman, 2002). With regard to acute stress, 
adherence to ARV medication may drop after a major life stressor but will return to 
previous levels once the stress has subsided (Bottonari et al., 2005). Finally, stress is 
known to indirectly affect the immune system, causing those who are infected to become 
more vulnerable to other opportunistic illnesses (Van Dyk, 1993). It is therefore is 
imperative to understand how stress may further complicate ARV treatment outcomes. 
 
3.3.2 Depression, anxiety, PTSD symptoms 
 
It appears that individuals who have been diagnosed with HIV suffer from 
disproportionally high rates of post-traumatic stress disorder and depression with an 
increased likelihood of suicide (Boarts, Sledjeski, Bogart & Delahanty, 2006; Kalichman 
et al., 2003; Simoni et al., 2000; Sledjeski, Delahanty & Bogart, 2005). In addition, as 
symptoms related to the HIV infection increase, PLWHA become more vulnerable to 
experiencing symptoms of anxiety (Boarts et al., 2006; Sledjeski et al., 2005).  
 
Depression in PLWHA remains under-diagnosed, but it plays a significant role in non-
adherence to treatment. (Gordillo et al., 1999). Depression is also an indicator of a shorter 
survival period in HIV-positive men and appears to be mediated by poor health habits 
and reduced adherence to treatment (Gordillo et al., 1999). The causal effect between 
poor adherence and depression is difficult to ascertain as less than optimal adherence may 
lead to depression, yet depressed individuals may be less motivated to take their 
medication (Nakiyemba et al., 2006). However, according to Schonnesson, Ross and 
Williams (2004), given the chronic nature of the HIV infection and the complicated 
treatment regimen, it may be that the constant intrusive thoughts around the illness and 
treatment may increase stress in PLWHA and the accompanying depressive symptoms. 
Hence, medical concerns can become a substantial marker for depression for those on 
ARV treatment (Schonnesson et al., 2004). This indicates that there is a close relationship 
between the experience of treatment and psychological distress, and it is an indicator that 
symptoms like depression or anxiety must be acknowledged and worked with before 
treatment is changed because of the reported negative experiences. 
There also appears to be a high prevalence of PTSD in PLWHA, reflecting a high 
experience of traumatic events related to being diagnosed with HIV (Boarts et al., 2006). 
Studies (Gore-Felton, Butler & Koopman, 2001; Gore-Felton & Koopman, 2002; 
Kimerling, Armistad & Forehand, 1999a; Kimerling, Calhoun, Forehand, Armistad, 
Morse &  Morse, 1999b) indicate that PLWHA have experienced at least one traumatic 
event that has been severe enough to meet the DSM-IV criteria for PTSD. Significant 
amongst these is the experience of some act of violence perpetrated against PLWHA as a 
result of their HIV status (Delius & Glaser, 2005; Parker, Aggleton, Hawell, Pulerwitz & 
Brown, 2002; Strode & Grant, 2001). In addition, a diagnosis of a life-threatening illness 
like HIV infection may lead to the development of either acute stress or PTSD symptoms. 
However, some studies have found that PTSD in itself does not impact on the adherence 
rate to ARV treatment in PLWHA, however, the relationship between PTSD and non-
adherence may be driven by the presence of co-morbid depressive symptoms (Safren, 
Kumarasamy, James, et al., 2005; Sledjeski et al., 2005). 
 
3.3.3 Health-related quality of life 
 
Quality of life refers to the appraisal on one’s life which contains features that are 
satisfying and meaningful. Quality of life is important in medical decisions that enable 
the individual to survive (Sarafino, 2002). The quality of life that may be experienced by 
PLWHA who are on ARV can be influenced not only by the PLWHA but also by the 
clinician (Gordillo et al. 1999). This fact challenges medical doctors to collaborate with 
professionals in other areas like the social and behavioural sciences so that they may 
collectively explore the gap between the intention by the PLWHA of adhering to 
treatment and action outcome of such an intention (Gordillo et al., 1999). ART can 
prevent the progression of HIV, prolong life and improve the quality of life for those who 
are infected. The individual’s motivation around their illness and treatment as well as 
their lifestyles needs to be considered to understand levels of adherence (Gordillo et al., 
1999). 
 
Amongst the lifestyle variable, Holmes, Warren, Wang, Chapman and Gross (2007) 
argue that financial worries are a significant, strong and independent predictor to non-
adherence. PLWHA who worry that they are not going to be able to meet their financial 
needs often take limited care of themselves in order to minimise expenditure brought on 
by the illness (Holmes et al., 2007). Having this lifestyle attitude leads to self-rationing of 
medications and a lower level of adherence (Holmes et al., 2007). In addition, people 
competing with sustenance needs were found to have poorer access to medical care. 
Holmes et al. (2007) believe that asking people about how frequently they experience 
worries about financial needs, like meeting the payment of accounts and taking care of 
themselves, will often provide useful information for identifying higher-risk individuals. 
This information can also be useful when addressing behavioural interventions in relation 
to the level of adherence. 
 
A particularly vulnerable group of people are those who are homeless and who are at an 
increased risk of negative health outcomes (Kidder, Wolitski, Campsmith & Nakamura, 
2007; Webster & Barr, 1999). These individuals suffer from more chronic diseases, are at 
higher risk for infectious diseases, have more mental illnesses and suffer from more 
physical problems in comparison to the general population (Kidder et al., 2007; Webster 
& Barr, 1999). Drug and alcohol use further compound health outcomes for the homeless 
or those living in inadequate housing facilities. This group of people also are far less 
likely to get the quality of care that may be optimal for adherence to ARV treatment, and 
improving their quality of life is a potentially important mechanism (Altice et al., 2001). 
 
3.3.4 Coping and managing the self 
 
As has been discussed, PLWHA undergo great difficulty in relation to their physical, 
emotional and interpersonal wellbeing. The stress that they may experience involves a 
perceived discrepancy between the demands of a situation and the resources of that 
individual (Sarafino, 2002). Coping is the process by which PLWHA try to manage the 
perceived discrepancy between the various demands placed on them and the resources 
that are seen to be helpful in the stressful situation (Sarafino, 2002). 
The level of adherence to antiretroviral treatment by PLWHA may depend on their ability 
to adapt to the situation of living with HIV/AIDS (Cederfall, Langius, Lidman & 
Wredling, 2002; Siegel & Schrimshaw, 2007). According to Antonovsky (1987) (as cited 
in Cederfall et al., 2002), a good sense of coherence, with a focus on how the individual 
may comprehend, find meaning and manage his or her illness, may lead to better stress 
management and coping capacity. A patient who understands and finds meaning in the 
necessity of strict adherence often manages to take the ARV medication more 
successfully (Cederfall et al., 2002). In addition, cognitive coping strategies also have 
stress-buffering properties that can lead to improved coping. Cognitive coping models are 
based on the concept of finding benefits that can help PLWHA with the psychological 
adjustment to the chronic stressors, thereby increasing their rate of adherence to ARVs 
(Siegel & Schrimshaw, 2007). However, it must also be noted that finding cognitive 
benefits to a stressor like HIV/AIDS may not to have much of an impact on individuals 
who are experiencing multiple HIV/AIDS-related stressors. Other stressors like social 
conflict or poverty may impose an added burden that may decrease psychological 
adjustment through cognitive processes and these needs must be taken into account as 
well (Siegel & Schrimshaw, 2007).  
 
In managing the self in the face of severe multiple stressors, PLWHA who managed to 
overcome self-blame and who found meaning in the suffering that they had to endure 
tend to have better levels of treatment adherence (Lewis et al., 2006). These individuals 
also recognised the need for personal accountability, to regain control over their lives and 
their health and to confront the disease. Investing in themselves and taking  pride in their 
accomplishments of managing their illness and medication allowed them to adhere to the 
medical regimen.  According to Lewis et al. (2006), individuals who described an 
experience of personal development through self-reflection and education, learning from 
life experience, adopting a realistic future outlook and making themselves a priority had a 
better chance of staying on course. In addition, PLWHA who were optimistic about their 
future and experienced health within the illness despite living with a disease were better 
able to make plans for a future that might have been previously impossible (Lewis et al., 
2006). 
3.3.5. Counselling needs 
 
HIV/AIDS counselling is a vital part in the dissemination of information. HIV/AIDS 
education is generally aimed at informing PLWHA about the disease in order to alleviate 
fear as well as ignorance so that they may better manage their illness (Van Dyk, 2001; 
Van Dyk & Van Dyk, 2003) Counselling in relation to its educative purpose is also 
beneficial in prompting people to change their behaviour around HIV/AIDS in order to 
prevent further spread of the disease and to stop the individual from being infected by 
different strains of the virus (Van Dyk, 2001; Van Dyk & Van Dyk, 2003). In addition, 
counselling serves a vital purpose in providing much needed emotional and social care 
and support to PLWHA (Van Dyk, 2001; Van Dyk & Van Dyk, 2003).  The 
dissemination of information and provision of care and support that the PLWHA receives 
through counselling should be extended to include the facilitation for better treatment 
adherence. 
 
Therefore, whilst the physician may provide the preliminary explanation of treatment and 
the biomedical reason for adherence, the HIV/AIDS counsellor spends a greater time 
covering ART adherence and other HIV-related issues in much more detail (Safren et al., 
2005). Additionally, even though medical doctors are revered due to their status in 
culture, counsellors may be perceived to be more approachable and easier to speak to 
(Safren et al., 2005). 
 
In settings with poor resources, lay counsellors serve a more important function. 
According to Hardon et al. (2007), the quality of counselling given to PLWHA differed  
greatly between countries and also between different facilities within a country. In 
resource-strapped countries and situations only a small proportion of ARV users see a 
counsellor at each visit. Most PLWHA come into more frequent contact with a 
pharmacist, nurse or doctor (Hardon et al., 2007). In public care facilities health care 
workers are generally overworked and struggle with the large volume of work. Low 
motivation and work fatigue can have a severe impact on how PLWHA are managed. 
Non-adherence to ARV treatment places an additional burden on the medical 
practitioners, creating a cycle of burn-out and lowered attention (Hardon et al., 2007). In 
resource-strapped situations the training and use of lay counsellors regarding ARV 
adherence may take the burden off the medical system and allow the PLWHA to gain 
access to the much needed support they need in order to keep to the treatment regimen.   
 
3.4 SOCIAL FACTORS CONTRIBUTING TO NON-ADHERENCE 
 
3.4.1. Poverty  
 
The chance of being exposed to the HI virus is equal between those who are wealthy and 
those who are living in poverty and there is no single formulation that can be used in the 
examination of the interplay between poverty and HIV/AIDS (Mosley, 2004). However, 
research indicates that HIV has come to be known as the disease of poverty (Jackson, 
2002; Barnett & Whiteside, 2002; Mosley, 2004; Van Der Vliet, 1996; Whiteside & 
Shunter, 2000). An indirect association remains between poverty and the rate of HIV 
infection and this can be described by several factors like poor nutrition, lack of access to 
health care and having limited resources in meeting basic needs (Barnett & Whiteside, 
2002; Kalichman, Simbayi, Jooste, Cherry & Cain, 2005). Whilst poverty relief will not 
stop HIV/AIDS, Crothers (2001) postulates that raising individuals and communities out 
of poverty will enhance their capacity to resist HIV/AIDS once infected. Furthermore, the 
literature reveals that people who have a higher income have less difficulty when 
adhering to their treatment than those who are poverty stricken (Nakiyamba et al., 2006). 
This is especially relevant in underdeveloped countries where many thousands of people 
are living in poverty, and HIV adherence is increasingly becoming an issue 
(Nakiyambaet al., 2006). 
 
3.4.1.1 Hunger and food needs  
 
Not only does the PLWHA need extra nutrition (Kotler, 2000; Sharpstone et al., 1999), 
but there is an additional nutritional need during the initial stages of treatment as the body 
regains strength and weight (Au, Kayitenkore, Shutes, et al., 2006; Jimenez, Garcia-
Lorda, Allonso-Villaverda, de Virginia Sola, et al., 1998). In addition,  PLWHA who are 
on treatment have reported that treatment increases their appetite (Au et al., 2006). 
Addressing poverty and nutritional needs as a social issue is critical to those who are on 
ARVs (Hardon et al., 2006; Kumarasamy et al., 2005; Nachega, Lehman, Hlatshwayo et 
al., 2005; Weiser, Wolfe, Bangsberg et al., 2003). Nachega et al. (2005) argue that on the 
surface, treatment to adherence sounds simple, but it is difficult for people to take their 
medication when they are hungry. One respondent in a survey commented that “the 
challenge is how do you link that person to a support mechanism that would ensure that 
there is some food on that person’s table at least once a day” (Hardon et al., 2006, p.661). 
Often employed family members provide the necessary financial support for adherence 
including the provision of food. Some PLWHA  have to resort to the extent of begging 
for the old age pension from their grandparents so that they can buy some food (Hardon 
et al., 2006; Kumarasamy et al., 2005; Nachega et al., 2005). Some PLWHA stop 
treatment because of a lack of food. In other cases it has been found that patients will not 
adhere strictly to the treatment often reducing the intake of medication from a twice-a-
day regimen to once a day because they have only one meal (Hardon et al., 2006; 
Kumarasamy et al., 2005; Nachega et al., 2005). Government social grants are often a 
major concern for those who are unemployed and on treatment (Hardon et al., 2006; 
Kumarasamy et al., 2005); Nachega et al., 2005). Free treatment is clearly not enough 
and ARV programmes in resource-poor settings will also have to find ways to address 
hunger constraints with regard to treatment. 
 
3.4.1.2 Transport and other costs 
 
Even though PLWHA may receive free treatment, transport costs may be a reason why 
some individuals are not able to come to the health facility for refills of the medication 
(Hardon et al., 2006). This may be particularly of concern to those individuals who live in 
rural areas where HIV treatment points may be difficult to access. Kumarasamy et al. 
(2005) found this to be the most frequently and profoundly discussed theme. Even when 
facilitating factors like family help in getting patients to their treatment points are 
available, the cost of transport is a powerful barrier (Kumarasamy et al., 2005). In some 
instances, individuals reported taking drastic measures, like sacrificing irrigation systems 
for their farming needs or getting into further debt, to ensure they could pay for transport 
and other costs (Kumarasamy et al, 2005). Such a situation thus leads to further poverty 
for the families who are than unable to manage the illness. In other cases the cost of the  
treatment led to self-imposed drug holidays where the patient would only resume taking 
medication when they could afford to do so again (Laniece, Ciss, Desclaux, Diop, 
Mbodji, Ndiaye, Sylla, Delaporte & Ndoye, 2003; Safren et al., 2005). 
 
The increasingly high cost of ARVs, even with generic competition, is an important 
barrier to access, more especially in developing countries (Seone-Vazquez & Rodriguez, 
2007). Several multi-national efforts by the Accelerated Access Initiative (AAI), which 
was set up in May 2000 and consists of several international organisations involved in the 
fight against HIV/AIDS, and various pharmaceutical companies have been negotiating 
price ceilings through shared expertise and technical resources on ARVs. However, there 
have been several problems related to drug regulations and policies (Seone-Vazquez & 
Rodriguez, 2007) and the high cost of ARV thus still remains a significant barrier. 
 
3.4.2. Stigma and Discrimination  
 
HIV/AIDS-related stigma is a social as well as psychological reaction to the epidemic 
that is rooted in denial, fear and distrust of those who are infected but also includes those 
who are affected by the disease by virtue of their association with the infected individual 
(Aggleton, Parker & Maluwa, 2003; Deacon et al., 2005). Many studies show the very 
deep and embedded nature of stigma-related discrimination (Aggleton et al., 2003; Kelly, 
Ntlabati, Oyosi, Van Der Riet & Parker, 2002; Niyonzima, 2003; Parker et al., 2002,). 
Discriminating attitudes include religious, moral and ethical positions that are taken 
around the perception that PLWHA are to be blamed, punished, that they bring on shame 
on the family and community or that they are deviant in some way.  
 
 
Stigma and discrimination form a large part of the isolatory nature of PLWHA due to a 
lack of support from others around then (Hardon et al., 2007). People who hide their 
status also have to keep the treatment that they are receiving hidden and this has 
consequences for adherence, and taking medication in secret often leads to irregularity 
(Hardon et al. 2007; Kumarasamy et al. 2005, Nachega, Knowlton, Deluca, Schoeman, 
Watkinson, Efron, Chaisson & Maartens, 2006). In addition, these individuals are also 
not able to get adequate encouragement and support from others to take medication 
(Hardon et al., 2007; Kumarasamy et al., 2005). In some instances, individuals did not 
view the community members as people who could assist them with their medication at 
all and often feared being ostracised and mistreated (Kumarasamy et al., 2005). 
 
Often individuals on ARVs expressed fear of a lack of confidentiality regarding treatment 
delivery (Laniece et al., 2003, Nachega et al., 2006). PLWHA feared that their status 
would be divulged to others in their communities and many participants wished to get 
treatment for two months or more to reduce contact with the medical staff. In a study 
conducted by Patel (2005), a participant reported that she would sometimes miss her 
treatment refills as a neighbour worked at the local hospital and she would wait for the 
days when he was on leave from the hospital before she refilled her scripts rather than 
risk being recognised. This participant feared that her HIV status would be discovered 
and revealed to the community and as a result she might be victimised. Using public 
pharmacy set-ups also led to ARV users to not adhere strictly to the regimen as they 
feared their HIV status would be exposed (Rief, Whetten, Lowe & Osterman, 2006). 
Some individuals would also travel longer distances so that they could access treatment 
further away from home in an attempt to hide their status for fear of some kind of 
repercussion from others (Rief et al., 2006). This often further complicated cost and put 
an extra financial burden on them.  
 
 
 
 
 
3.4.3 Social Support Needs 
 
An HIV diagnosis can place a substantial amount of stress and burden on those who are 
infected as well as those who are affected, and there are many psychosocial consequences 
following an HIV diagnosis. Social isolation is often a painful reality for many (Batohi, 
2004). Support networks can be a powerful force that can prove to be a rich source of 
empowerment for those living with HIV/AIDS. These networks can supply information  
around issues such as challenging discrimination, promoting counselling needs, seeking 
legal protection for basic human rights and advocating for treatment in relation to ARV 
treatment, and some members may even become very useful in assisting others as they 
become experts in the latest treatment options or treatment combinations (Jackson, 2002, 
Nachega et al., 2006). Hence, PLWHA can become partners in their own treatment, 
shifting the patient/practitioner relationship to a point that ensures balance (Jackson, 
2002). 
 
3.4.3.1. Support groups 
 
One of the key psychosocial consequences to being diagnosed with HIV is social 
isolation. PLWHA have been found to spend increasingly longer amounts of time being 
alone and engaging in socially solitary activities (Kalichman et al., 2003; Simoni et al., 
2000). Others often avoid contact with PLWHA, leaving the individual with 
overwhelming emotional responses which require social support to help them cope 
(Kalichman et al., 2003; Simoni et al., 2000).  
 
Unmet mental health needs related to counselling, substance abuse, loss, grief, depression 
and anxiety have been found to be significantly associated with low adherence levels in 
PLWHA (Rief et al., 2006). In addition, participants who experienced three or more 
different types of unmet needs were less likely to take HIV medication, indicating that 
multiple unaddressed needs may influence medication use. Rief et al. (2006) also argue 
that adherence levels are influenced more by a specific unmet need of mental health 
related issues rather than multiple unmet social support needs. Gordillo et al. (1999) 
believe that depressed individuals who do not have adequate social support also have a 
problem in staying on their medication. However, perceived social support did not seem 
to increase improved adherence in the case of depression (Gordillo et al., 1999). Hence, 
depressed individuals may renegade on their treatment irrespective of whether they 
receive social support or not (Gordillo et al., 1999). On the other hand, PLWHA who did 
not show depressive symptoms were more likely to be assisted in adhering to their 
medication through a social support network (Gordillo et al., 1999). Social support 
groups continue to be among the most widely available psychosocial intervention for 
PLWHA (Walch, Roetzer & Minnett, 2006), and present an area that requires further 
research in relation to adherence to ARVs. 
 
Furthermore, those individuals who are pessimistic about the effectiveness of the 
treatment that they are receiving and who do not have adequate social support remain 
highly vulnerable to becoming non-adherent in their treatment regimen (Diabate, Alary 
Koffi, 2007). There also appears to be an intimate relationship between stigma and social 
support (Kumarasamy et al., 2005). Although social support is very often needed, 
PLWHA are scared to disclose their status for fear of discrimination. However, the most 
frequent social facilitator to adherence includes help from others. Family members have 
been more frequently referred to in this context, but the benefits of the community as a 
social facilitator in this regard still remain poorly understood (Nayikamba et al., 2006; 
Wagner, 2002). Visnegarwala, Rodrigeuz-Barradass, Graviss et al., (2006) propose that 
de-institutionalising the approach to ARV adherence and using community outreach 
programmes may be a more cost-effective and acceptable way to deliver ARV therapy. 
Support groups incorporating those peers who can provide both the delivery of the ARVs 
as well as constant cognitive reinforcement and social support may be an area for further 
investigation (Visnegarwala et al., 2006) 
 
 
 
 
 
3.4.3.2. Home-based care-giving 
 
Home-based care-giving provides improved assistance to the PLWHA and also reduces 
the burden on overcrowded and under resourced health systems (Gupta, da Silva & 
Neves, 2006; Jackson, 2002). Integrated home-based care promotes an extended 
relationship between the healthcare team and the PLWHA, as well as increased attention 
for the family and community. This allows for more social and psychological support 
(Gupta et al., 2006). Concentrating therapy at home establishes primary caretakers within 
the home or community, fortifying social support networks and thereby increasing daily 
adherence. Research by The Brazilian Ministry of Health indicated that the cost of 
extended resources of integrated home care would be a justified and more cost effective 
measure to supporting PLWHA and also assisting in an increase in adherence levels 
(Gupta, 2006). 
 
In addition, Hardon et al. (2007) found that children can be useful as facilitators to ARV 
adherence. They can be an important source of support when it comes to collecting 
medication for their parents or in contributing towards their food needs, as indicated by 
this comment made by a respondent in a survey, “My children, after seeing the state I was 
in and getting my ARVs, I called them and told them my state. They got encouraged and 
as a result they buy me passion fruits and sugar because they know that the drugs that I 
am taking is so strong” (Hardon et al, 2007, p. 662). 
 
However, it has also been found that home- and community-based care-giving can 
actually lead to neglect for many PLWHA as they are kept out of the health system 
(Gupta et al., 2006; Hardon et al., 2007). The burden of home care on women and 
children also places those who are most vulnerable in the community at further risk as 
their work load increases (Gupta et al., 2006; Hardon et al., 2007) As such, home-based 
and community care have to be critically evaluated as an activity of social action. 
 
 
 
3.4.3.3. Managing the environment 
 
Participants who were able to manage the environment by recognising positive and 
negative sources of support are better able to adhere to their treatment (Lewis et al., 
2006). Individuals who were better able to assess their support system as appropriate, 
gauged their level of disclosure, and avoided stressful people and situations were in a 
much stronger position. Secondly, if the participants could identify external cues, creative 
solutions and lifestyle habits like finding a convenient hour to take the medication, 
linking taking medication to a favourite time of the day, using partners and other 
supportive networks or establishing an active partnership with their health care team 
assisted them in adhering to their medication, i.e. their problem-solving attitudes helped 
in adherence (Lewis et al., 2006). 
 
Mannheimer et al. (2006) used the initiatives of the Community Program for Clinical 
Research on Aids (CPCRA), a community-based HIV clinical trials network, evaluated 
two different approaches to promoting ARV therapy initiation and continuing support 
throughout follow-up. The first intervention, the Medication Manager (MM), was an 
initiative that involved trained research staff members who worked individually with 
participants to provide tailored adherence support. This was done in a guided manner 
identifying and addressing each participant’s background information, motivation levels 
and skills base (Mannheimer et al., 2006). The second intervention was an electronic 
medication reminder system – A Little Reminder (ALR) device - that was devised to 
sound and flash at certain times to remind the person to take their ARVs (Mannheimer et 
al., 2006).   
 
The MM intervention programme worked better on individuals who were on less 
complex medication regimen but showed less favourable results for those on more 
complex treatment plans (Mannheimer et al., 2006). This may have been due to increased 
toxicity for the more complex regimen group of individuals, but nonetheless the MM was 
a community initiative that appears to show some favourable results because of repetitive 
adherence support  that may have been as a result of frequent contact and social support. 
In comparison, the ARL programme showed much less success as direct support was not 
available (Mannheimer et al., 2006). The ARL also brought up other issues around 
confidentiality as well as practical issues of battery malfunctions, thereby limiting its 
effectiveness (Mannheimer et al., 2006). A technical reminder device falls short of 
addressing barriers that are likely to be dealt with in a more comprehensive manner 
through face-to-face contact. 
 
3.4.4. Knowledge of illness/Belief about the treatment 
 
Stemson et al. (2005) have put forward the argument that the first step in empowering 
patients to care for their health is by equipping them with information in the belief that 
high levels of basic knowledge will promote desirable behaviour. A better perception of 
at least one negative consequence of non-adherence, like side effects, lowered quality of 
health, weight loss, hastening death and increasing cost for treatment, allowed PLWHA 
to improve their adherence levels (Stenson et al., 2005). In addition, there is some 
indication that individuals who have a better education show a propensity towards better 
adherence levels to ARVs (Gordillo et al.1999; Kleeberger, Phair, Strathdee et al., 2001; 
Wong, Lawrence, Struthers, McIntrye & Friedland, 2006).  
 
Using alternate treatment has proven to have become a significant barrier to ARV 
adherence (Owen-Smith, Diclemente & Wingwood, 2007; Wong et al., 2006). In a study  
by Owen-Smith et al. (2007), it was fond that women who use natural immunity boosters 
or vitamins are significantly more likely to miss doses of ARV, suggesting that they were 
using these as an alternative to ARV treatment rather then complementing treatment. 
Two possible explanations may explain this; firstly, patients may experience difficulty 
incorporating the immunity boosters into their day-to-day life. As a result those who use 
them may feel both logistically and psychologically overburdened and may find it 
necessary to sacrifice the prescribed treatment (Owen-Smith et al., 2006). Secondly, 
ARV treatment may be significantly disliked due its unpleasant side effects and therefore 
PLWHA may be relying increasingly on alternative treatment options. However, despite 
these findings, Wagner (2002) argued that attitude and beliefs around traditional healing 
systems and alternative treatment options were largely unrelated to the level of adherence 
to ARVs by PLWHA.  
 
3.5 CONCLUSION 
 
This chapter has reviewed pertinent issues in this field of research and examined the 
various biomedical, psychological and social barriers and facilitators that impact on the 
levels of ARV adherence. It should be noted that this literature review has mostly 
presented the barriers as these are predominantly discussed in the literature. However, 
facilitators to ARV adherence are imperative as these may help to understand the full 
scope of ARV treatment and thus provide a more holistic understanding of the topic.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER FOUR 
METHODOLOGY 
4.1 INTRODUCTION 
 
In this chapter the methodology used in the collection and analysis of the data is 
discussed. This includes information regarding the research paradigm that has been 
utilised, setting, the sample, the procedure, data collection and analysis of data. This is 
followed by a reflection as part of a personal exercise on the part of the researcher. 
Finally, a discussion of the ethical considerations is presented. 
 
4.2 RESEARCH PARADIGM 
 
A qualitative research paradigm underpins this study. The decision to use qualitative data 
is based on the need to understand matters from the participant’s perspective. (Babbie & 
Mouton, 2004; Neuman, 1994). The aim of this study is to describe and explain events as 
close as possible to the lived experiences of the participants. Consequently, every attempt 
has been made by the researcher to understand the worldview and belief systems of the 
participants (Babbie & Mouton, 2004; Neuman, 1994). In addition, the researcher hoped 
to uncover deep and meaningful interpretations of the related research questions through 
in-depth descriptions to capture the understanding of the participants (Babbie & Mouton, 
2004; Neuman, 1994). 
 
The qualitative methodology of phenomenology has been utilised in this research to 
develop insight into the dynamic experiences of PLWHA who are on ARV treatment. 
According to Babbie & Mouton (2004), phenomenology goes beyond the positivistic 
paradigm and aspects of causal factors to include reflexivity and the various ways of 
being in the world. The focus of phenomenology is the rigorous emphasis of the 
PLWHAs subjective experiences of being HIV-positive and on ARV treatment and the 
manner in which the experiences are constructed, co-constructed and de-constructed in 
socially contrasted contexts 
 
4.3 RESEARCH QUESTIONS 
 
This research sought to explore the various biopsychosocial barriers and facilitators 
regarding ARV adherence from the perspectives of the health-care providers and the 
patients. As the themes unfolded four major themes emerged in relation to the main 
research questions, aims and objectives. The first three themes revealed, individual level 
barriers and facilitators, secondly interpersonal level barriers and facilitators and thirdly 
systemic level barriers and facilitators. The fourth theme has been organised around 
intervention level barriers and facilitators to ARV adherence. 
 
4.4 SETTING 
 
The sample of the present study was primarily drawn from the Themba Lethu Clinic 
which is based at the Helen Joseph Hospital in Johannesburg. The Themba Lethu Clinic, 
which means “Our Hope” in isiZulu, is one of the biggest HIV sites in Southern Africa. 
There are approximately 6200 patients on ARV treatment at the clinic. The clinic has a 
staff compliment of about 65 and sees approximately 200 patients a day (Health-e, 2008).  
 
The patients who use this facility are mainly from the inner city “townships” that 
surrounds the Johannesburg area. Many of the patients come from as far as Alexandra 
and Diepsloot even though there may be ARV treatment points close to their place of 
living. Majority of the patients face profound difficulties related to poor socioeconomic 
standards facing unemployment, low education levels and poverty.  
 
In addition to this, a further sample was drawn from the Treatment Action Campaign 
(TAC). The TAC is a non-governmental organisation which was started in 1998. Its main 
purpose is to procure treatment for those infected with the virus. Part of the TAC’s initial 
mission was to put pressure on the African National Congress (ANC) to start a free ARV 
programme in state hospitals, and to get pharmaceuticals to drop their ARV drug prices. 
The TAC is an activist group that grew out of the political belief that PLWHA should be 
afforded the same dignity, access to healthcare and equality as all other South Africans 
(Treatment Action Campaign, 2008).  
 
4.5 PARTICIPANTS  
 
In keeping with qualitative principles, the intention of this study has not been to yield 
generalisable data (Babbie & Mouton, 2004; Neuman, 1994) but rather to gain an in-
depth understanding of the participants’ perspectives. A non-probability sample was thus 
used.  Due to the nature of non-probability sampling, the criteria for sampling was based 
on the availability and willingness of people to participate in the study, and participation 
was completely voluntary (Rosenthall & Rosnow, 1991).  
 
Furthermore, a combination of purposive as well as convenience sampling was used in 
this study. The purposive sample included those individuals who were able to provide 
specialist opinion regarding the facilitators and barriers to ARV adherence. The use of 
purposive sampling did not allow for random sampling, therefore all persons in a given 
category were not given an equal chance of being sampled. This sample included medical 
practitioners. The medical doctor heads the HIV-clinical unit at the hospital. Two nursing 
sisters were interviewed. Both the nursing sisters have a number of years of experience 
with PLWHA. One of the nursing sisters has also been instrumental in HIV/AIDS 
activism for a number of years. Two HIV-adherence counsellors were interviewed. The 
counsellors who do adherence counselling are specifically trained in this area and see 
patients individually and also run adherence and re-adherence groups for those patients 
who default on treatment. A nutritionist was interviewed. Initially this was not intended 
but it became evident during the data collection that valuable information in relation to 
nutritional and food needs was of crucial importance. Finally, two ARV treatment 
activists were interviewed. Both of the participants have a number of years of experience 
as project managers at the TAC. The reason for including these participants in the study 
was so that a more holistic understanding of the issue at hand could be gained not so 
much for an expert point of view but rather from a multidisciplinary perspective. 
 
The sample group also included individuals on ARV treatment as well as caregivers to 
individuals who are on ARV treatment. This sample group is reflective of convenience 
sampling and the criterion for participation was based on the availability and willingness 
to participate. Four patients were included in the study. Two of the patients had defaulted 
on treatment and had come back to the clinic for treatment. In addition 2 caregivers to 
HIV-positive patients were interviewed so as to include some of the challenges that they 
may be facing. 
 
The sample was thus chosen to reflect those who were the most likely to provide the most 
meaningful information in relation to the aims and objectives specific to this research 
based on the judgment of the researcher and in consultation with the supervisor (Rosnow 
& Rosenthal, 1991). By including this range of participants it was hoped that a more 
holistic and in-depth understanding of the research aims and objectives would be 
achieved. It should be noted that some of the professional participants were also HIV-
positive and on ARV treatment. Their experiences intersect with both having the 
experience of working with people who are on treatment as well as having a personal 
experience with treatment. The following is a breakdown of the participants: 
 
Medical doctor    1 
Nursing sisters   2 
Nutritionist    1 
ARV adherence counsellors   2 
Treatment activists   2 
PLWHA on treatment   4 
Caregivers of PLWHA on treatment 2   
 
 
 
4.6 PROCEDURE 
 
The Themba Lethu Clinic at the Helen Joseph Hospital was the main site used in this 
research. All the participants except the two treatment activists were interviewed through 
this clinic. Ethical clearance was first sought from the University of Witwatersrand -
Medical Research Ethics Committee. Once this was obtained (Appendix 10), permission 
to conduct this study was obtained from the Clinical HIV Research Unit, Department of 
Medicine (Appendix 4). After the regulatory manager of this unit had granted permission 
for the research to be conducted at the clinic (Appendix 10), the researcher was put in 
touch with the senior social worker.   
 
The purposive sample (doctor, nurses, counsellors, nutritionist) was identified with the 
assistance of the senior social worker at the clinic. Interviews were set up with these 
participants by the social worker. Since Themba Lethu is a very busy clinic and the work 
schedule and work load of these participants is very heavy, the researcher had to often 
wait for the participants to have a break in their work routine before proceeding with the 
interviews. 
 
The convenience sample (participants on treatment and caregivers) were identified with 
the assistance of one of the adherence counsellors as there was already an established 
relationship of trust with the patients who were receiving their treatment at the hospital.  
All the participants were informed verbally about the study by the counsellor on the day 
that they were attending the clinic and a choice was given to the participants to meet with 
the researcher.  The researcher then arranged for a convenient time to meet with the 
participants whilst they were waiting for their treatment. As this sample was drawn from 
a hospital in a specific area, it was envisaged that there would be some common 
characteristics in terms of racial and socio-economic background. It is hoped that this 
may have assisted in the facilitation of the sharing of common experiences.  
 
Letters explaining the nature of the study were handed out to all the participants 
(Appendix 5). Consent forms requesting permission to conduct the interviews as well as 
permission to audiotape the interviews were handed out at the same time (Appendix 6). 
Once the letter of consent had been returned, appropriate arrangements were made for the 
interviews to be conducted.  
 
Treatment activists were accessed through the Treatment Action Campaign organisation. 
Information letters explaining the nature of the study were given to potential participants 
(Appendix 7). An appropriate time and place of meeting was arranged with each 
participant. Before the interviews took place the full nature of the study was explained to 
the participants and the necessary consent (Appendix 6) was obtained.  
 
4.7 DATA COLLECTION 
 
Data was collected using semi-structured, in-depth interviews. All the interviews were 
audio-recorded. Interview times ranged between 30 minutes and one hour.  
 
According to Marshall and Rossman (1995), an in-depth interview is more like an 
ordinary conversation than a question-and-answer session. However, unlike a 
conversation, there was a clear purpose in the interview session (Marshall & Rossman, 
1995). This was done by using a semi-structured interview schedule that allowed for a set 
amount of information to be gained without limiting the sequence and flow of the 
discussion (Appendix 8). Thus the semi-structured, in-depth interviews allowed for 
greater flexibility in the questioning process. As a result the researcher was able to probe 
for greater detail and depth, or clarification of opinions, attitudes and beliefs regarding 
the subject matter (Marshall & Rossman, 1995). This method also allowed the researcher 
the opportunity to observe non-verbal behaviour.  
 
As a personal interaction is necessary in semi-structured, in-depth interviews, the 
participant’s willingness and co-operation was imperative (Marshall & Rossman, 1995). 
A weakness of this interviewing method may have been that participants may have at 
times been unwilling or uncomfortable to share sensitive information. One participant 
had substantial difficulty in engaging with the researcher. It appeared that some of the 
participants feared that they might be disregarded for further treatment based on their 
responses. In addition, the interviews were in English and it was difficult for some of the 
participants to understand particular questions posed to them. Finally, this type of 
interviewing required a certain degree of expertise on the part of the interviewer 
(Marshall & Rossman, 1995). This can be particularly challenging when working with a 
highly vulnerable population. The researcher’s background in community psychology 
was helpful in trying to manage and negotiate some of these difficulties. 
 
One of the reasons for choosing to audio-record the interviews was that the key 
advantage of this method over taking field notes is that it is less prone to the interpretive 
filtering effect which is more evident in taking field notes (Speer & Hutchby, 2003). In 
addition, Hammersley and Atkinson (2003) (as cited in Speer & Hutchby, p.316) argue 
that recording enables the researcher to capture the social process and context in their 
entirety and that it provides for a more accurate and detailed account of what was said. A 
distinct disadvantage of audio-taping may include reactivity or reactive affects (Speer & 
Hutchby, 2003). It is thus possible that the recording device may have made the 
participants nervous or anxious, affecting their responses. The non-verbal interaction of 
at least two participants suggested a discomfort with the recording device. The option of 
conducting the interview by making field notes was given to all participants but they all 
preferred the interviews to be audio-recorded. 
 
Finally, even though every effort was made to find a private and quiet environment in 
which to conduct the interviews, this was not always possible. The rooms where 
counselling takes place at the hospital are very small and the walls are not soundproof. 
This made it very difficult for the participants to talk in complete privacy. In addition, the 
interviews were interrupted from time to time as counsellors looked for a free space from 
which to work from. This may have impacted on the information that was provided by 
those who were on treatment. A further difficulty was that the data from four of the 
interviews was lost due to a combination of very loud background noise and some 
participants talking very softly. However, despite this the semi-structured nature of the 
interviews ensured that a large amount of data was generated for analysis.    
4.8 DATA ANALYSIS 
 
The analysis of data was done by means of the qualitative analytical technique. All the 
audiotapes were transcribed verbatim. Once the data was transcribed, thematic content 
analysis was used to analyse the barriers and facilitating factors impacting on the 
adherence levels of PLWHA on ARV treatment.  Thematic content analysis involves 
thematic coding which is a process of developing initial categories of concepts and 
themes through in-depth analyses of the data (Marshall & Rossman, 1995). General 
themes were thus extracted and carefully scrutinised to accurately capture the 
understanding and perspective provided by the participants. This involved examining the 
text for the occurrences of selected words, phrases, concepts, themes or sentences in 
order to draw out meaning of a descriptive nature (Marshall & Rossman, 1995). A 
thematic content analysis can therefore be defined to be a systematic technique for 
compressing huge amounts of information into fewer categories (Boyatzis, 1998). 
 
This procedure involved the evaluation of information through five key steps (Marshall & 
Rossman, 1995). Firstly, the data was organised into key ideas and theories arising from 
the literature review (Marshall & Rossman, 1995). For the purpose of this research, 
questions asked during the interview (Appendix 8) provided the framework and 
cornerstone for the organisation of the themes. This assisted in reducing the raw data into 
a more manageable size. It also allowed for an internalisation of as much data as possible 
by the researcher (Boyatzis, 1998). 
 
Secondly, key themes were identified through a process of induction (Marshall & 
Rossman, 1998). During this process the precise description of the themes was not as 
important as looking for and finding broad patterns across the responses (Boyatzis, 1998). 
Themes were then developed and categorised deductively (Boyatzis, 1998).  Prior 
research and theory was applied to replicate, extend or refute what was already presented 
in the literature review (Boyatzis, 1998). 
 
Thirdly, coding of the emerging themes took place by using different colour markers. The 
aim of this type of clustering was to further break down thematic information (Marshall 
& Rossman, 1995). Fourthly, the themes were then explored. This was done via 
elaboration that allowed for a comparison between themes and sub-themes (Marshall & 
Rossman, 1995). Finally, the data was written up as an interpretation (Marshall & 
Rossman, 1995). This process involved the process of deciding on the level of analysis 
that sufficiently captured the views of the participant as well as deciding on the number 
of concepts to code for the accurate representation of the collected data.  
 
Thematic analysis is a logical way of organising data in relation to the research questions 
as well as in the interest of the participants. It should be noted that while coding captures 
the descriptive nature of the data, the process undertaken in this research also provided 
for latent content. This latent content was examined and the underlying meaning of the 
data was then discussed (Ritchie, Spencer & O’Connor, 2003). 
 
4.9 VALIDITY OF RESEARCH    
 
A common concern with qualitative research is the way in which the researcher’s bias 
may influence the findings and discussions (Greenstien, 2003).  It is thus important that 
some form of systemic check or cross-check be carried out by the researcher to ensure 
that the data is plausible. Greenstein (2003) argues that trustworthiness is an important 
factor for good qualitative research. Furthermore, the four aspects of credibility, 
transferability, dependability and confirmability were also taken into account 
 
Credibility is the accuracy of the description of the data (Greenstein, 2003). In this the 
researcher worked closely with her supervisor to ensure that the reconstruction and 
representation of the respondents’ views on the barriers and facilitators to ARV 
medication were thematically coded and depicted accurately. In addition, although it was 
not possible to carry out member checks with all the respondents, the researcher cross-
checked her understanding of what was reported with some of the participants. The 
second aspect of transferability ensures that the findings can be applied to other contexts 
and to other respondents (Greenstein, 2003). This was done by establishing the degree of 
similarity in the respondent’s views with other research material on the same subject 
matter. Additionally, differences were explored and alternative explanations were also 
sought. The third aspect of dependability concerns the stability of qualitative data over 
time (Greenstein, 2003). This research collaborated with other similar research and even 
though people’s reality changes over time, much of the findings concur with similar 
themes and observations found in the literature survey. Where the arguments in this 
research report differ, the researcher has made the data available so that the findings, 
discussions, conclusions and recommendations can be traced for verification and ensure 
comparability.   
 
Despite the above checks to control for researcher impartiality, the personal as well as 
intellectual biases and values of the researcher have to be taken into consideration as this 
will impact on the nature of the interaction and the quality of the information gained.  
Seedat (2001) suggests that research cannot be a neutral exercise and that the researcher 
cannot be independent from the participants. Personal and epistemological reflexivity 
become necessary as ways to explore the manner in which the researcher engaged with 
the study and how further meaning is created out of this exercise (Seedat, 2001) 
 
The researcher’s personal view in undertaking this research is that the analysis of 
treatment adherence in PLWHA cannot be limited to the biomedical/positivistic position 
or the interpretive epistemological perspective. A thorough study of this topic has to 
include a critical evaluation that extends beyond just understanding phenomena in order 
to bring about real change through active participation and activism. The researcher’s 
own interest in HIV began almost a decade ago when she first came into contact with 
HIV-positive babies at the Chris Baragwaneth Hospital. The researcher found it was a 
travesty that these babies were allowed to suffer and die whilst the government would 
engage in one debate after another that stopped pregnant mothers and babies from 
receiving the much needed treatment.  
 
Furthermore, the researcher’s interest in medical sociology and her background in 
community psychology added to her standpoint that whilst biomedicine and traditional 
psychology may view health behaviour from a micro point of view, this was a further 
injustice that PLWHA have to endure. The assumption that all people are in control of 
and responsible for their health and health behaviour fails to take into account the impact 
of the greater social order.   
 
It is, therefore the opinion of the researcher that to “cut of the hand of those who steal” is 
an injustice of enormous magnitude if one does not take into account those aspects of 
society that creates conditions in which harmful activities can flourish. This is not to take 
away from personal responsibility but it is rather a reflection on how we all contribute to 
human-rights violations and create human suffering. This is particularly pertinent for 
those who are HIV-positive. The researcher thus believes that there is  collective and 
universal responsibility that we all share in fighting inequalities in society. 
 
A further aspect that requires some thought is it became clear to the researcher during the 
interviews that she was constructed as a professional with specialist knowledge. Whilst 
the researcher made every attempt to establish rapport and to engage in an emphatic 
manner, the process of this research did not allow for participatory research where time 
could have been devoted to building relationships and becoming part of the community in 
order to gain the information. Hence it was felt that a certain distance between the 
participants and researcher remained, and it may be that as a result some participants 
would have been hesitant to speak freely. In addition, all the health professionals who 
were interviewed reported that there was a tendency on the part of those who came to the 
clinic for treatment to respond to the staff in a pleasing manner. This may have created a 
false sense of security between the researcher and participant. 
 
Lastly, the research aim and objectives was aimed at exploring the topic of barriers and 
facilitators of HIV-adherence and participants were chosen to provide the information in 
keeping with this. Data was collected in a wide range to include as many biological, 
psychological and social factors that impact on PLWHA who are on treatment and an 
analytical trial was not followed until a saturation point was reached. However, for the 
purpose of this research saturation of data collection was not seen as a possibility from 
the onset and the data was collected within the limitation of a project of this nature   
 
4.10 ETHICAL CONSIDERATIONS  
 
The aim and objectives of this research involved engaging with an extremely vulnerable 
part of the population on highly complex issues about themselves. Therefore, discretion 
was applied on the part of the researcher to ensure that the interviews were conducted in a 
manner that did not endanger the participants in any physical or psychological way. The 
following principles of ethics were followed.  
 
Ethical clearance was first sought from the Medical Research Ethics Committee. Once 
this was obtained (Appendix 9), permission to conduct this study was obtained from the 
Clinical HIV Research Unit, Department of Medicine (Appendix 10). The researcher 
was put in touch with the social worker as well as the counsellor who runs re-adherence 
counselling groups at the hospital. This ensured that participants were able to decide 
whether they wanted to take part in the study from an already established relationship of 
trust. 
   
Informed consent was gained from all the participants and they were assured of their 
confidentiality and privacy. Their participation was completely voluntary and they were 
made aware that they were free to withdraw from the study at any point if they wished to 
do so.  They were also informed that they were not obliged to answer any questions if 
they felt that some of the questions were too personal, and if they felt uncomfortable they 
had a right not to respond. Participants who had been struggling to adhere to their 
treatment were informed that the information that they would provide would not affect 
their relationship with the medical practitioners or the future course of their treatment.  
 
In addition, permission to audio-tape the sessions was gained beforehand. The option of 
conducting the interview with a reliance on field notes was extended to all participants. 
All the participants signed an informed consent for the audio-taping of the interviews. 
Participants were informed that the tapes would be transcribed verbatim and that at no 
time would any mark in the transcripts or research report be able to identify the 
participant. A guarantee was undertaken to destroy all the audiotapes once they had been 
transcribed. The researcher assured all the participants that no information of a personal 
or sensitive nature would be used in the report. Lastly, professional counselling was 
arranged through the counsellors at the unit for those who may have needed it in the 
event of stress occurring as a result of the interviews.  
 
4.11 CONCLUSION 
 
In this chapter the methodology used in the collection and analysis of data was discussed 
with special reference to the research paradigm, setting, sample, procedure, data 
collection, data analysis, validity of the research and ethical considerations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER FIVE 
 
RESULTS AND DISCUSSION 
 
5.1 INTRODUCTION 
 
This chapter outlines the findings of the study and presents a discussion of these findings. 
Quotes from the transcribed data are presented under primary and secondary headings. 
Primary themes have been organised under four main sections. The biological, 
psychological and social factors that impact on adherence levels are organised under 
individual, interpersonal and systemic level barriers and facilitators to ARV medication. 
The fourth main theme is organised under the topic of intervention to ARV adherence. 
Furthermore, secondary themes are organised under the four main topics. The themes that 
are covered under individual level factors include treatment factors (complexity of 
treatment and side effects), psychological factors (stress, depression and anxiety, other 
psychological symptoms and substance abuse/other medical conditions) and personal 
factors. Interpersonal themes are covered under topics of the patient/practitioner 
relationship, disclosure, stigma and discrimination and traditional/other belief systems. 
Systemic themes are organised under the sub-heading of poverty (unemployment, food 
needs, transport and social grants), the health care system and political contributors. 
Finally, the section on intervention level barriers and facilitators to ARV adherence 
includes the themes of counselling, support networks and community organisation. The 
presentation of the primary and secondary themes has been done in accordance with the 
research questions and research aims.  The themes are considered to be representative of 
the biological, psychological and social factors that have emerged from the data analyses. 
As there is considerable overlap between the biopsycosocial factors it was deemed more 
appropriate to organise the findings in a manner that demonstrated the multiplicity of 
issues that impact on adherence levels without getting lost in the content but nevertheless 
remained in keeping with the thematic content analysis. 
 
5.2 INDIVIDUAL LEVEL BARRIERS AND FACILITATORS TO ARV     
ADHERENCE 
 
5.2.1 Treatment 
 
5.2.1.1 Complexity of Treatment 
 
ARV treatment is a lifelong commitment to a combination of drugs. The regimen is given 
as a dual or triple therapy and there is often a large amount of medication that the 
PLWHA has to take (Hart et al. 2006).  Health-care providers and patients indicated that 
ARV treatment is a complex regimen for individuals to follow and complete adherence 
was not always an easy task due to this complex nature of treatment:  
 
Resp 1: Adherence is about taking your medication properly as you have been instructed by 
the doctors, at the right time, not taking it late, not skipping doses. It’s fairly complex and 
not easy to do. Well just think about it, the last time you took antibiotics, did you take every 
single dose? It [is] just so difficult. [nurse] 
 
Resp 6:  ARVs is a lifelong commitment. Having to pop pills every single day of your life is 
quite frustrating. I have been on treatment since 2005, it is my third year. Sometimes I do 
ask myself, “Why am I still taking this thing?”. You know, is [there] not another 
alternative? Something I can do to suppress the virus? It [is] difficult you know. [treatment 
activist] 
 
These responses indicate that due to the chronic nature of ARV treatment there is always 
a possibility that treatment may be interrupted from time to time (Altice et al., 2001; Hart 
et al., 2007; Lesho & Gey, 2003, Maneesriwongal et al, 2006 & Seguy et al., 2007). 
Taking ARV treatment is a lifelong commitment that can be an arduous and difficult task 
even for those PLWHA who know about and understand their health problems indicating 
that despite having adequate knowledge and support, those who are on ARV treatment 
are often left feeling frustrated as was indicated by respondent 6. Even though individual 
level health models like the HBM put forward that those individuals who are more 
knowledgeable will have a higher adherence level (Rosensock et al., 1994), the 
complexity of the treatment may interact with other psychological factors, for example 
treatment fatigue (as was indicated by respondent 6), to impact on adherence levels. 
Treatment complexity in therefore not limited to the quantity of medication, number of 
doses or the precise times that the medication needs to be taken but must be extended to 
the manner in which this interacts at an emotional level for the PLWHA. This is pertinent 
as emotional aspects (like treatment fatigue) can be combated by a higher quality of 
medical as well as psychological and support (Maneesriwongel et al, 2006).  
 
In addition, due to the PLWHA’s compromised immune system they often suffer from 
many other co-morbid opportunistic illnesses. The complexity of ARV treatment is 
complicated even further by a combination of other medical treatment that the PLWHA 
may have to take to treat these ailments (Altice et al., 2001; Lesho & Gey, 2003). The 
following response indicates the difficulty in managing multiple treatments 
simultaneously and how this may serve as a barrier to complete adherence levels: 
 
Resp 8: We start the medication three, four months ago. After four months he is still not 
getting better. We did [not] understand. We did [not] understand between medication [TB 
and ARV treatments]. All the time he was taking the medication, it was not the right one. 
We have a card from Soweto Clinic. They give you a card. When they give medication to us, 
so tick tick tick tick [ticking off medication] everyday. So we coming here and they say to us 
no, it is not like that. This is for TB and this is for HIV. It is like so and so. Until this time 
today I understand. [care-giver] 
 
The individual who is on treatment or their caregivers may not be in a position to fully 
understand the instructions of the health professional. This may be due to language 
difficulties or people may struggle to understand the instructions due to the complex 
nature of combined treatment. Often those who have come for treatment may be too ill to 
be able to fully comprehend the treatment instructions that are given to them. ARV 
therapy may also be compromised if treatment for one condition is received at a local 
clinic (for example treatment for TB may be localised) and treatment for HIV is carried 
out at the regional hospital. This can be confusing for patients who may be assuming that 
they are getting all the medication from one site. This indicates that a two-level process 
may unfold in certain instances. On the one hand, a lack of knowledge on the part of the 
individual may contribute to the confusion created by multiple medical regimens. In this 
situation the PLWHA or their caregivers may benefit from added instruction and 
knowledge (Rosenstock et al., 1994). However, on the other hand, this situation can be 
avoided if the patient is treated at one centre only. This will avoid conflict and confusion 
that might arise from trying to adhere to different medical regimes from different 
hospitals or clinics, signifying a systemic level failure on adherence level.  
 
5.2.1.2 Side Effects 
 
Medication side effect symptoms are frequent in people treated with ARV and are one of 
the most important biological elements associated with non-adherence (Ammassari et al, 
2001; Murphy, 2003). Almost all the respondents reported that side effects contributed in 
a significant way to how they managed their regimen: 
Resp 2: People are going to tell you to use herbs [and] to stop taking ARVs, because ARVs 
there [is] a lot of side effects to them. So most of them fail to start or maybe some they are 
taking [ARVs] and then they default because of side effects. [dietician] 
Resp 3: I [am] taking tablets. I [am] feeling all right. After a year I was sore in my breast 
and stomach……. My breast were swelling. Dr M was telling me that my body was full of 
acid….and my feet was pain, painful. Sometimes I am feeling hot, sometimes I am feeling 
cold. [patient] 
All ARV medication is associated with adverse side effects ranging from mild to severe, 
and it is crucial for medical practitioners to manage these symptoms (Altice et al.; 
Murphy, 2003). Respondent 3 indicated she experienced pain throughout her body due to 
an increase in lactic acid. Side effects can be managed by using medication that counters 
side effects (Murphy, 2003). However, as has been seen in the discussion on the 
complexity of treatment, taking extra medication to counter the side effects may add to 
the pill burden for the PLWHA, placing the PLWHA under further pressure. This is 
supported by research where it was found that those who were put on mono-therapy 
instead of dual or triple therapy showed better adherence outcomes (Altice et al, 2001; 
Lesho & Gey, 2003) 
 In addition, using other drugs to counter the side effects of ARVs may not be enough as 
the subjectively held belief that the individual has around the experience of side effects 
may determine what action the individual will take (Rosenstock et al., 1994). Respondent 
2, a dietician, indicated that patients may search for alternate treatment because of their 
perception of the toxicity of ARV medication. Taking ARV treatment may reduce the 
threat of getting severely ill or dying. However, at the same time the action of taking the 
treatment itself can be seen as immediately upsetting, painful or even fatal. This personal 
evaluation of the biomedical considerations of being infected versus the toxicity of the 
ARV medication will then serve as a barrier of action and may lead to avoidance of that 
medication (Rosenstock et al., 1994). Additionally, any attempts at isolating and 
managing side effects as a biomedical issue is problematic as traditional and cultural 
beliefs cannot be isolated from the perceptions of ARV treatment. These belief systems 
intersect with the experience of side effects to determine the manner in which the 
individual will respond to the treatment.   
Furthermore, health-care providers reported that individuals on treatment often have an 
emotional response which results from the real powerful negative images of the side 
effects caused by ARV medication and may renege on their treatment or parts of the 
treatment regimen because of the fear of either the psychiatric or physical symptoms 
(Altice et al., 2001; Ammassarri et al., 2001; Stone, 2001).  In addition, PLWHA who are 
on treatment may stop taking or miss treatment because of an imagined perception of 
the impact of the medication as is shown by the following responses. Often these 
individuals will default on treatment due to the perception that the ARVs are causing the 
symptoms that they are experiencing. Some individuals may fear taking treatment 
because of a perception that taking ARVs may cause death. It has been found that in 
some cases death may occur soon after the person starts medication, however this may be 
due to the individual’s immunity level being compromised and illness having reached a 
stage where the medical intervention may have been too late (Frank, 2006).  
Resp 1: We listen to the patients. You will find that if the patient is complaining of sore feet 
or something that they “think” is related to ARVs, he’ll stop taking the medication 
properly. Very often you will find them complaining of something and the next time they 
are complaining and slowly the viral load goes up. [nurse] 
Resp 5: Someone else would say to them “When I was taking ARVs and I stopped them 
because [I] went crazy. I would wake up in the middle of the night and I would do funny 
things and stuff”. So when a person come here they already have in their minds, so it [is 
very difficult to change their mind state……..by the time they [the patient] comes here they 
[have] known of their friend or a neighbour who was taking ARVs and they die[s] because 
[even though] they were taking ARVs, so they will think that the ARVs killed them. 
[adherence counsellor] 
Despite extensive information being given to the individual on treatment, distorted 
perceptual responses to such information often continued to interfere with adherence. The 
medical view is that perception is based on the epistemology of absoluteness that is 
largely based on the element of knowledge (Rosenstock et al., 1994). However, 
Rosenstock et al. (1994) points out those perceptions can be real but there are also 
components of partiality that determine how a person may perceive their reality. It is 
because of this partiality in perceptual responses that challenging perceptions and 
changing behaviour around the toxicity of the ARV regimen can be a difficult task and 
may require extensive and close collaborative work on the part of a multidisciplinary 
team. Hence any policy around the management of side effects in a clinical setting will 
require input from an epistemological framework that will consider the manner in which 
the individual may be constructing their own reality around the experience of adverse 
symptoms related to ARV drugs (Gergon, 2001). 
Resp 5: Side effects are there but it [is] not everyone who experiences them and side effects 
are a short-term thing. There is always treatment for that. If they say something is not 
working, you find an alternative treatment for them. So to encourage them [the patients] to 
carry on coming and then talking with the practitioner or counsellors about the side effects. 
[adherence counsellor] 
 
Resp 1:  So I will notice that things [viral load] are climbing. We don’t have a policy in 
place but it is something that we are discussing….If we see it [viral load] climbing should we 
not do something like telephone counselling with that person? We see it climbing, we are a 
bit concerned, rather than waiting until it [is] [viral load] is really high. [nurse] 
 
The above responses by health-care providers indicate that building trust in the 
medication’s efficaciousness to not cause harm can be an important factor in changing 
people’s perceptions of the toxicity of the drugs so that adherence levels can be 
improved. This can be done by providing reassurance over medication (Hardon et al., 
2007). Often side effects will decrease or disappear over time and this valuable 
information must be communicated to the PLWHA (Nakiyamba et al., 2007). In addition, 
extensive information regarding the trade-off of being on treatment can assist in 
increasing the acceptance of ARVs in individuals who perceive the consequences of 
being on treatment as being worse than the progressive deterioration in health caused by 
HIV (Altice et al., 2001). It was also indicated by the medical practitioners that timely 
management of the symptoms adds to increased tolerance to side effects and improved 
adherence levels (Hardon et al., 2007). However, building trust in the medication’s 
efficaciousness by providing extensive information is not a straightforward task that will 
automatically lead to increased adherence. In resource-poor settings this is often difficult 
to achieve and people may have to negotiate managing side effects with a multitude of 
other realities.  
 
Furthermore, although knowledge about side effects is cited as an important aspect of 
adherence counselling (Hardon et al., 2007; Nakiyamba et al., 2006), how that knowledge 
about these side effects is imparted may serve as a barrier, as individuals may reject the 
medication because of the fear of the symptoms before they give themselves a chance to 
see if the medication works. Fishburn et al. (1994) believe that one must be particularly 
vigilant in identifying appropriate kinds of information that must be provided. This 
becomes evident in the following response by respondent 5 who is a counsellor to 
patients on ARV treatment. Finally, people’s perceptions towards the toxicity of the ARV 
drugs have also been influenced by the political factors which is a systemic level failure. 
The government’s role and the manner in which ARVs have been introduced have had a 
major impact on the fears and perceptions around the efficacy of treatment (Frank, 2006). 
Resp 5: When we do the talk [adherence groups] about side effects, we just generalise, 
because if you point out and say “This is D [ARV drug], you may experience hallucinations 
when you start”. They decide they going to take E [ARV drug] and leave D out. Only when 
you pick up that the viral load is not going down then they will tell you, “I was not taking 
the drug [D] because I was scared of it”….so they [will] take dual therapy [instead of the 
prescribed triple therapy]on their own, but they collect all the medication. [adherence 
counsellor] 
An important aspect to consider is that whilst some individuals may stop taking their 
medication in response to the experience and perceptions of severe side effects, there are 
also those who continue to take their medication despite experiencing severe toxic 
effects. This was reported by both patients as well as health-care providers and it is 
important to identify and understand these responses as further facilitators of ARV 
adherence. These were some of the responses. 
Resp 3: I was continuing to eating [taking] tablets because Doctor was saying to me do [not] 
stop. The time Doctor tell me stop, I stop…..this is because I want to live. [patient] 
Resp 7: They [patient] go to the doctor. They look for information. [treatment activist] 
Resp 5: So to encourage them [the patient] to carry[ing] on coming in and then talking with 
the counselor about side effects. [adherence counsellor] 
It would appear that those individuals who were able to manage the toxicity of treatment 
whilst they waited to talk to a health professional about the side effects showed a better 
level of adherence. In addition, where side effects have been discussed extensively 
through counselling, adherence levels have had a more positive outcome. This is 
supported by studies done by Altice, et el (2001), Hardon et al. (2007) and Nakiyamba et 
al. (2006). Individuals who can better accept the trade-offs between the benefits of the 
medication in relation to the limitations (for example, keeping the side effects in 
perspective, understanding that treatment is beneficial to health of self and for survival or 
the understanding that there are limited treatment options) were able to recognise that 
adherence to the medication was important. Respondent 3 articulated that it was her 
desire to live that allowed her to manage her severe side effect symptoms whilst she 
waited for medical help. 
 
It may also been found that those who have a high level of trust in the medical system 
may be better able to manage their side effects (Gordillo, 1999). In addition, allowing for 
the forgiveness of dosing that is delayed or missed is critical and it is important for health 
care providers to emphasise that if a treatment dose is missed it is always better to take a 
dose late than not at all (Hardon et al., 2007; Nakiyamba et al., 2006). This discussion is 
related to and intersects with the patient/practitioner relationship and a more 
comprehensive discussion on the complexity of practitioner and patient relationship is 
presented later under interpersonal level factors that impact on adherence levels. This 
show further that ARV adherence has to be seen from a biopsycosocial perspective.  
 
5.2.2 Psychological Factors 
 
5.2.2.1 Stress, Depression and Anxiety 
 
Emotional difficulties are common in those who are HIV positive. Individuals who have 
been diagnosed with HIV suffer from high rates of depression and are more vulnerable to 
anxiety (Kalichman et al., 2003; Simoni et al., 2000), and depression has been found to 
be a very common mediator of low adherence levels (Boarts et al., 2006; Kalichman et 
al., 2003; Simoni et al., 2000; Sledjeski et al., 2005). In addition, it has been found that 
the psychological stress that the PLWHA experiences leads to poor adherence levels 
(Bottonari et al., 2005). However, psychological issues in PLWHA remain under-
diagnosed even though they play a significant role in non-adherence to treatment. 
Furthermore, it has been found to be an area that is poorly researched (Gordillo et al., 
1999).   
 
This remains consistent in these findings, where almost all of the respondents including 
the patients indicated that the mental health of the PLWHA who is on treatment is an 
important area. However, despite an acknowledgement of this, many respondents in this 
research appeared to either diminish their engagement around this topic or acknowledged 
that it was an area that remained poorly understood. Whilst some of the respondents who 
were on treatment recognised that they are feeling constantly sad, helpless and hopeless, 
they did not always recognise their symptoms as psychological difficulties and are 
subsequently unable to get the correct assistance. In addition, it appeared that whilst 
many of the medical practitioners where well versed in psychiatric issues relating to non-
adherence, they did not have adequate experience in the psychological area and were 
therefore unable to engage with the PLWHA on psychological issues. It seemed that this 
was equally true of the counsellors. The following were some of the responses:   
 
Resp 1: We do think that there is a lot of depression in the patients taking ARVs… There is 
going to be further research on that issue [psychological issues]. We don’t know much about 
it at the moment. [nurse] 
 
Resp 7: They do [not] check such things (psychological aspects]. What they are focusing is 
that you start treatment and then forgetting to check the person like depression. [treatment 
activist] 
 
Resp 6: Depression, I think [it] is something that is there. Even now when I am on drugs, I 
still get depressed.  [treatment activist] 
 
According to Botonari et al. (2005), as the number of life stressors increased, adherence 
levels to ARV treatment decreases. However, it would seem that as a major life stressor 
was overcome, adherence levels seemed to increase again. Furthermore, previous 
research has shown that PLWHA may have experienced at least one traumatic event that 
was severe enough to meet the diagnosis of acute stress or posttraumatic stress disorder 
Gore-Felton et al., 2001; Gore-Felton & Koopman 2002; Kimmerling et al. 1999b). 
Although these stress disorders were not spoken about by the respondents in this 
research, it is important to note that co-morbid depressive symptoms may interact with 
traumatic symptoms to decrease adherence levels (Safren, Sledjeski et al., 2005). 
Nakayimba et al. (2006) argue that it is difficult to ascertain a causal effect between poor 
adherence levels and depression. This is because people who are depressed may be 
unable to take their medication as is required of them. However, on the other hand it may 
be that the PLWHA may get depressed when they struggle to take their medication for 
whatever other reasons. This is further corroborated by Schonnesson et al., (2004), where 
it was found that medical concerns around non-adherence may become a marker for 
depression.  
 
5.2.2.2 Other Psychological Symptoms 
 
Those who are on treatment will often face multiple psychological stressors. Constant 
intrusive thoughts around the illness and treatment may increase psychological distress 
for PLWHA. PLWHA may be in denial and unable to accept their status. Many face 
isolation. In addition fear and anger may increase anxiety in PLWHA further 
complicating their psychological functioning leading to problems in adherence levels as 
has been indicated as follows: 
 
 
Constant intrusive thoughts around treatment issues: 
 
Resp 6: You know, just the idea of taking treatment every single day, it gets hectic…..it does 
have an effect on you as a person. Just thinking you are not normal like everyone else. 
[treatment activist] 
 
Denial of being infected was reported to lead to poor adherence.  PLWHA who cannot 
accept their HIV status will often struggle with treatment as well: 
 
Resp 7: A person does [not] want to take the tablets but [they] can see “But I [am] sick. It 
[is] not an easy thing to convince a person of that, even to admit that he or she is [HIV] 
positive. [treatment activist] 
 
Resp 1: The patient is not necessarily ready [for treatment] if they have [not] accepted the 
fact that they [have] got HIV. [nurse] 
 
Fear around being ostracised or feelings of shame and guilt around being infected: 
 
Resp 1: He was hiding his medication [same patient that was adherent for a number of 
years]. He was taking his medication but he was hiding the fact that he was HIV 
positive…and the family was quite supportive. So, often it is very sad….Very often the 
family actually come in and say – but we could have helped them. We could have got you to 
give us somebody that would have made him want to come here. We could have done 
something for the patient. So very often it is the patient rather than the families who think 
that they should hide their status. [nurse] 
 
Fear around death and dying: 
 
Resp 6: Once you are diagnosed with any chronic condition you have a fear of death 
because death becomes a reality for you, because you are constantly looking death in the 
face every single day. [treatment activist] 
 
Resp 2: before… every time…. Night and day….and I don’t eat…I don’t sleep….I don’t 
watch my body…because my heart is telling me I am going to die. [patient] 
 
A sense of hopelessness and helplessness: 
   
Resp 7: They give up hope. We normally see that in squatter camps, the majority of them 
lose hope. If you [say] something about HIV/AIDS they will say, “Agh, what is it, we are all 
going to die.” [treatment activist] 
 
Resp 8: He was having stress. He did [not] want to talk. Sometimes he did [not] want to 
hear nothing. He was always wanting to be alone. [care-giver] 
Self-blame and anger at becoming infected with the virus: 
 
Resp 6: I was angry. It took me a long time to accept that it [is] not my fault that I got 
infected. After that I went through a period where I started healing gradually. But at the 
same time I faced stigma in a way I decided to disclose to a friend of mine just after I got 
tested. I told him in confidence and by the end of the week everybody who knows me knew 
that I am HIV positive. So it was anger. I was angry with myself. Angry with my ex-partner 
and also angry with my friend. Angry with the community. [treatment activist] 
 
Often PLWHA have to deal with anger that results from being infected and of the fear of 
the future (Shisana & Simbayi, 2002).  Fear of dying (Van Dyk, 1993) is also very 
prevalent in PLWHA. Respondents in this study indicated that these psychological 
factors remained ubiquitous in their lives and it also gets extended to issues around 
treatment. Even though many were aware that ARVs would give them the opportunity to 
live a long and healthy life, death remained a constant and intrusive companion for those 
on treatment. It seems that the anger and fear response may affect those who are both 
educated as well as those who are less educated in similar ways.  
 
In addition, the issue of disclosure is very intimately linked to psychological responses 
(Siegel & Schrimshaw, 2006). PLWHA show an intense fear around being stigmatised 
and discriminated against. The process of stigma is both psychological as well as social 
and continues to have an impact on those who are better educated as well on as those who 
are less educated, indicating that the level of education does not necessarily increase 
adherence levels.  
 
However, some patients and care-givers reported that despite having these intensely 
negative emotional responses, they were able to stay on medication. It would seem that 
those who were better at understanding and expressing their emotions were able to 
increase their adherence levels. This observation concurred with other studies (Frank, 
2006). The individual’s self-efficacy as a psychological resource may assist in increasing 
adherence to ARV treatment. According to Bandura (1994), those who are able to 
exercise personal control over their behaviour will show good health outcomes. 
Respondents who were able to believe in their own ability to manage their treatment and 
illness and to achieve some kind of self-directed behaviour responded in a much more 
favourable manner towards their medication. However, once again it must be noted that 
Bandura (1994) found that a psychological resource like self-efficacy is only one aspect, 
and environmental dynamics have to be taken into account to get a better understanding 
of treatment failures (Bandura, 1994).  
 
Furthermore, ARV treatment is a lifelong commitment and the manner in which the 
individual experiences and makes meaning of being on treatment thus becomes 
significant. How individuals comprehend, find meaning and manage their illness may 
lead to better coping capacity (Cederfall et al., 2002; Siegal & Schrimshaw, 2007). 
However, findings from this research has indicated that even those individuals who have 
accepted and made meaning out of the illness for themselves may need ongoing 
psychological support in order to manage their treatment regimen. Of particular concern, 
as discussed earlier, is the inability of many medical practitioners and adherence 
counsellors to provide the appropriate psychological assistance. This will be covered in 
more detail in the discussion of the counselling needs of those who are on treatment. 
 
5.2.2.3  Substance Abuse and Other Medical Conditions 
 
In addition to stress, depression and anxiety symptoms that the PLWHA may experience, 
other medical or psychological conditions may add to non-adherence indicating that some 
individuals may need additional and special care. Alcohol use and abuse came out as a 
theme that warrants some discussion. These are some of the responses of the counsellors  
Resp 5: Most of the people they are afraid to disclose that they are taking alcohol. It is only 
when they are defaulting and when we push that they talk. They will [not] disclose such 
information [alcohol intake] because they think we [are] not going to give them their 
treatment……We do find such cases that a person would say that on weekends because I 
drink and I was drunk I forgot my tablets. Or I took my tablets because I was drunk and I 
am not sure if I took the correct dose or what. [adherence counsellor] 
Resp 4: You find that they take the treatment and you find their acid is so high in their 
body and they are trying to do all of these sorts of tests only to find that it shows there is 
something else that they are taking [referring to alcohol use]. [adherence counsellor] 
 
 
It was with some trepidation that alcohol use was placed under individual level barriers 
and facilitators. Although alcohol use appears across all socio-economic classes, alcohol 
abuse is inextricably linked to South Africa’s historical past. Alcohol use and its 
interference with ARV treatment in resource-poor settings must take into account the 
systemic level factors like poverty, unemployment and lack of education.  
Psychologically, alcohol use may have an impact on the individual’s cognitive 
functioning, impacting on memory and thus a PLWHA may easily forget to either taking 
their medication in the correct doses or omit to take the medication completely (Frank, 
2000). Alcohol use is problematic as patients often do not immediately disclose the level 
of their alcohol intake for fear of not getting the much needed treatment as was reported 
by responded 5.   
 
In addition to alcohol use, a further theme that needs consideration is the impact of other 
medical conditions for example, epilepsy, on adherence levels. Respondent 5 and 10 
reported that conditions like epilepsy requires special attention as often people who are 
have these conditions are overlooked as the underlying assumption is that they are able to 
take care of all their medical needs.  
Resp 5: We have got people who have fits [epilepsy]. So a person would be okay for a few 
days and then the other days they no longer care. The family assume because they were 
okay last week, it [is] okay. They will be willing to take their treatment on their own and 
they [are] okay, but they still need support. [adherence counsellor] 
Resp 10: For almost two years I am giving him[referring to patient] his tablets, then I see 
maybe he is okay. He see the tablets, he knows the tablets. SO I do [not]know what changed. 
The doctor say something changed…but my brother, he is fitting [referring to epilepsy]..so I 
do[not] know. [care-giver] 
 
Respondent 10 articulated that it was difficult for her to take care of her brother who was 
on ARV treatment as her work often took her away from home. It was during these times 
that it was found that her brother could not manage his treatment on his own, despite a 
belief that he could 
 
 
 
5.2.3 Personal Factors 
 
PLWHA may miss treatment due to their own forgetfulness, being busy or being away 
from home (Conway, 2007).   
 
Resp 1: Often you have to give yourself physical reminders. So it may be a cell phone or an 
alarm or something. But it is so easy to forget and if you don’t have yourself organised and 
have your doses laid out or have a physical reminder to may be thinking -Well did I actually 
take it? I think I did. Yes, you know I always take at that time. I am sure I did take it. You 
could be taking double doses or skipping doses, it [is] very easy. [nurse] 
 
As taking ARVs is a long-term commitment, tailoring the regimen to suit the needs of the 
patients so that they are better able to incorporate their medication regimen into their 
lifestyle using strategies which include habit development and choosing a regimen that 
matches a particular lifestyle, may increase adherence levels (Conway, 2007). For 
individuals who manage to stay on their medication over a long period of time, the 
behaviour of consistently taking the medication at the same time may become a habit 
with little conscious effort. However, Fishbein et al. (1994) argues that habits may only 
form under stable conditions but may prove to be difficult in unstable environments. 
South Africa has a large mobile population and the constant movement between the rural 
and urban areas as well as between neighbouring countries can be disruptive in the 
formation of habits like taking medication at set times and thus the factor of population 
mobility may present an obstacle in maintaining a good adherence level. 
 
Patients and health-care providers both reported that using technology like alarms on 
cellular phones assisted greatly in managing the regimen. Electronic systems like A Little 
Reminder (ALR) have been known to improve adherence levels (Mannheimer et al., 
2006). However, once again this is not always appropriate and it may be that individuals 
would have difficulty in managing their treatment in public areas. The ringing of the 
alarm may make others aware of the person’s status leading to a fear of stigma and 
discrimination for the PLWHA.   
 
5.3 INTERPERSONAL & COMMUNITY LEVEL BARRIERS AND 
FACILITATORS TO ARV ADHERENCE 
 
5.3.1 Patient Practitioner Relationship 
 
Frank (2006) found that the relationship that the PLWHA has with the medical system is 
important as it contributes to the person’s perception of illness and medication. The 
health system is the first point of entry for diagnoses and treatment and often this is the 
first time that the PLWHA may come to receive information (Frank, 2006). It is argued 
that it is this interaction that will impact on the persons future decision-making processes 
around how they manage their illness (Frank, 2006). This concurs with other literature 
which shows that the manner in which the health care providers interact with patients and 
the time that is taken to understand the patient’s difficulties is important as it helps to 
develop trust in the physician and leads to PLWHA feeling satisfied with their health care 
providers (Leopold et al., 1996; Forest et al., 2002). As a result of such good 
relationships, patients may be more willing to seek out assistance when needed and 
leading to better adherence levels (Altice et al., 2002). The level of trust that the 
individual has in the medical system and the practitioners also overlaps with the 
experience of side affects and the level of adherence (Altice et al., 2001; Lesho & Gey, 
2003). Individuals who had more trust in the medical system and the practitioners were 
better able to talk about their symptoms and deal with the various side effects, thereby 
staying longer on the medication until they could access the appropriate help. The 
following responses show the perceived patient/practitioner relationship and its impact on 
ARV adherence. It would seem that often those who come for treatment will tend to look 
for those medical practitioners who they perceive as being helpful, open and trustworthy. 
Unsympathetic, hostile or unhelpful behaviour on the part of the medical staff will lead to 
unfavourable treatment outcomes as is very strongly illustrated by the following 
responses by health-care practitioners:   
 
 
 
Resp 1: I think that it [patient/practitioner relationship] is important. You [will] get 
patients who will come and tell you if your relationship is good. They [will] come and say – 
This is what is happening with me. Whereas if you do [not] have a good relationship they 
will hide things from you. [nurse] 
Resp 5: Some of the things we find out when we do re-adherence [counselling for those who 
default  treatment] is that maybe one of the staff members in the clinic said that if you are 
not taking your treatment and if you miss your appointment do [not] bother to come back. 
So they are afraid that if I [they] come back they [medical staff] will shout at me [patient]. 
[adherence counsellor] 
According to respondent 1 who is a medical practitioner it was important to build a 
relationship of trust with patients. This is imperative as often people may experience a 
host of side effects and this information will not be communicated to medical 
practitioners for various reasons. One reason that often came up in the interviews was 
that patients often did not reveal to medical practitioners that they were taking alternate 
medication with ARV treatment. In addition, patients often become intimidated by 
adverse behaviour by medical staff. Respondent 5 indicated that some patients would 
stop coming for refills because they may have become fearful of staff reactions.  
 
The physician is not a neutral entity in the health process but becomes a participant 
observer who, in the process of attending to the patient, is doing so through his own 
personal viewing system (Engel (1978) (as cited in Puustinen et al., 2003). The 
practitioner is both the initiator and the collaborator in the process of medical treatment 
and therefore, medical practitioners who are better able to understand the individual from 
different levels of reality including their own will be able to assist their patients in 
adhering to their regimen (Sixma & Spreeuwenberg, 1998).   
 
However, despite efforts by medical practitioners to understand the psychosocial reality 
of PLWHA, it was reported be respondent 1 who is a medical practitioner that the focus 
in the medical treatment of HIV/AIDS remains on the level of the individual patient with 
an intention to change the patient’s behaviour patterns rather than on the wider issues that 
may be impacting on such behaviour (Hillier, 2002). Adherence counselling in the 
clinical setting continues to centre around the individual’s attitude and behaviours 
towards their treatment. Re-adherence counselling is therefore focused on education that 
is aimed at changing individual behaviour. However, more attention needs to be paid to 
the interaction process between patients and medical staff. Too often the general 
practitioner’s role in the provision of health care overlooks the social and cultural issues 
that has an impact on attitudes and behaviours that lead to lowered adherence levels.   
 
Resp 1: It is interesting to see how they [doctors] have changed…They see the patient more 
as a person in a social environment whereas other units see the [patient] in front of 
them…because the adherence issue is so important they actually see the patient in a social 
setting.  I [have] noticed it over the years. Is something they develop, even before ARVs the 
doctors who were interested in HIV became very much a patient’s doctor. [nurse] 
 
Furthermore, even though there is a concerted effort on the part of both the practitioners 
and the patients to foster and develop relationships of trust, the medicalisation processes 
entrench medical social control (Hillier, 2002). One example can be found in the manner 
in which the discourse around medicine and alternate healing systems still includes 
language that constructs medical reality as superior. Part of the medicalisation process is 
that medical personnel, and more particularly medical doctors, are often constructed as 
more powerful and knowledgeable by the patients themselves (Hillier, 2002). Individuals 
may have a strong desire to please the practitioner and as a consequence may not give an 
accurate report of the reasons why they may be struggling to adhere to their treatment as 
indicated by medical practitioners in the quotes below. This power differential may be as 
a result of a belief that the doctor’s ability to define what is right and what is wrong does 
not match their own experiences. Patients may come into the system with the notion that 
they do not share the knowledge and skills of doctors and respond to this by surrendering 
themselves to the expert or professional (Hillier, 2002). However, it must also be noted 
that what may come across as pleasing behaviour may be a rejection of western 
understanding of their illness by patients. This may be because the treatment option may 
not fit into the person’s cultural and traditional understanding of their illness, further 
highlighting the responsibility that the medical practitioners have to better understand 
their patients’ cultural belief systems as this may assist in improving treatment adherence.   
 
Resp 5: They trust the doctors more then everyone else. They think that everything that is 
said by the doctor is okay. So some patients, you try and talk to them and they say “I do 
[not] want to talk to you. I want to talk to the doctor”. [adherence counsellor] 
Resp 1: One of the big thing is, [some] patients, they want to please, Whatever you say they 
will say “Yes” because they want to give you the answer that you want. Not necessarily the 
answer that is truthful. Like they don’t want to disappoint you…cultural issues play a part. 
[nurse] 
 
The above discussions on the patient and practitioner relationship are particularly 
pertinent in demonstrating the importance of deconstructing adherence levels with regard 
to ARVs. It is simplistic to reduce HIV treatment to biomedicine under the assumption 
that a trusting relationship with medical caregivers that includes competence, 
comprehensiveness, consistency of care and compassion (Laince et al., 1996; Kaplan & 
Rogers, 1993) may be sufficient in getting patients to adhere to their treatment. Whilst 
this is a very important aspect of care for those who are HIV-positive, the power 
relationship and dynamics between the two have to be considered as well. The 
powerlessness that the patient may feel in their relationship with the medical professional 
thus requires a critical examination. Medical practitioners need to understand their 
patients’ social and cultural realities so that PLWHA may be empowered to take control 
of their own reality through a process of conscientisation (Rappaport, 1981). 
 
5.3.2 Disclosure 
 
All of the respondents reported that disclosure of a person’s HIV status was a significant 
factor impacting on adherence to ARV medication. The following responses capture 
some of the complexity of disclosure for those who are on treatment. The participants 
reported that disclosure is not an easy task for PLWHA:  
 
Resp 1: They have been stable. Fantastic. On ARVs. Then suddenly they crashed, They 
stopped coming. They started being non-adherent and it seemed to be that it was something 
around disclosure, to the extent that one of them had to be admitted to a hospice. He was so 
sick…and that’s when he disclosed to the family. [nurse] 
Resp 4: Let’s take disclosure. For most people it [is] not easy. We think it [is] easy to 
disclose. Others disclose, others do [not] want to disclose. [adherence counsellor] 
Resp 5: They test when they [are] sick and they start treatment because they want to get 
well. As soon as they get well, it becomes a problem again because you find the issue of 
disclosure. [adherence counsellor] 
Resp 6: I [am] very open about my status, my friends know about my treatment but there 
are other sections, lets say I [am] at a party or any other social setting and at eight o’clock 
my alarm goes off and I know that I have to take the treatment. The kind of reaction that 
people give. Like ‘oh he is taking his pills now, which means he [is] HIV-positive’. It does 
have some kind of an effect on you. [activist] 
This finding is supported by the study conducted by Frank (2006) where it was found that 
the main reason disclosure was such a problem was because PLWHA feared the negative 
responses from others. Mass testing and disclosure has been a major drive of HIV-related 
campaigns. However, despite massive efforts to help people understand the benefits of 
disclosure, including the ability to increase adherence levels if the medication is not taken 
in secret and the accompanying support from their environment, people continue to suffer 
in silence. Lack of disclosure continues to form a large part of the isolatory nature of 
PLWHA due to a lack of support from others around them (Hardon et al., 2007, 
Kumarasamy et al., 2005, Nachega et al., 2006). As a result these individuals do not get 
adequate encouragement and support from others to take their medication. People who 
hide their status also have to keep the treatment that they are receiving hidden and this 
has various consequences on adherence, and taking medication in secret often leads to 
irregularity (Hardon et al., 2007, Kumarasamy et al., 2005, Nachega et al., 2006). This is 
confirmed by the following responses.  
 
Resp 1: Your patient should preferably be beyond that [referring to fearing stigma and 
discrimination] when they start ARVs. That is not easy though. The patients will tell you 
what you want to hear. [nurse] 
Resp 4: If you ask them if you [the patient] have a problem [relating to disclosure] he says 
“I do [no] have a person who [is] taking care of me. Nobody at home knows that I am ill. So 
if I [am] sick nobody knows that I am taking ARVs, and if I forget sometimes to take my 
ARVs, then I do [not] take them.” ……….It [is] easy to ask them “have you disclosed?” 
They say “yes”, but when it comes to treatment it [is] not easy because you can see that the 
patient is having a problem. Each and every time when he [is] sick, he is coming alone. 
[adherence counsellor] 
 
Disclosure is not a straightforward process and is very intimately linked to the processes 
of stigma and discrimination. In assessing how one may assist those who have difficulty 
with disclosure (so that adherence may improve) the individual’s perception of their 
environment and their perceived role in their environment becomes crucial (Bandura, 
1994). Hence, both the environmental factors that are external to the individual that stops 
them from disclosing their status, as well as the mental representations of the individuals 
( real or imagined views of themselves) (Baranowski et al., 2002) need to be taken into 
account. These concepts are intimately linked to the constructs of stigma and 
discrimination and are explained in more depth in the section below. 
 
5.3.3 Stigma and Discrimination 
 
Disclosure of a person’s HIV status is intimately linked to the construct of stigma and the 
consequences of stigmatising behaviour, i.e. discrimination (Deacon et al., 2005). 
PLWHA often struggle with disclosing their status because of an intense fear of being 
victimised (Deacon et al, 2005). HIV-related stigma is a well documented phenomenon 
and is arguable one of the most important factors impacting on the lives of PLWHA and  
it is a significant barrier to testing, care and quality of life in those who are HIV-positive 
(Aggleton et al., 2003; Deacon et al., 2005, Kelly et al., 2003; Niyonzima, 2003; Parker 
et al., 2002). Stigma is thus a significant factor that needs to be considered in the 
treatment of PLWHA since stigma and the resultant discrimination lowers adherence to 
ARV medication (Hardon et al., 2007; Kumarasamy, et al, 2005).  
 
Patients as well as health-care providers reported that HIV-related stigma and the 
resultant discrimination of those who are infected continues to play an important role in 
their lives. Stigma is a process of devaluation of the individual and aspects of this 
devaluation is related to the individual character that implies a religious, moral or ethical 
judgment Goffman (1963). Subsequent discriminating attitudes revolve around the 
perception that the PLWHA are to be blamed, punished, that they bring shame on the 
family and community or that they are deviant and responsible for contracting the disease 
in some way (Deacon et al., 2005). The response to those who are HIV-positive is one of 
disrespect and degradation and people are often isolated and victimised in very violent 
ways ( Deacon et al., 2005) as is shown in the following responses:  
 
Resp 1: We have seen discrimination many times. We would get a wife coming down from 
KwaZulu-Natal and chasing the girlfriend around with an axe because she thought the 
girlfriend had given HIV, patients being locked in their house, being fed through 
windows………We had one patient where they found out in a block of flats that the one 
couple had HIV. So they threw blood on the door. They did all sorts of funny things, stole 
their things and expected not to be held accountable for. Really strange things. [nurse] 
 
As a result of the widespread stigma attached to PLWHA, it stands to reason that 
PLWHA fear disclosing their status since they cannot be sure how others will respond to 
their news. There appears to be a persistent fear of being victimised or ostracised by 
family and community members as illustrated in the response below. This will often lead 
to people taking their treatment in secret as was indicated by respondent 4, or they may 
even stop taking ARV treatment completely as is articulated by respondent 5:  
Resp 4: He was staying with his mom. So his mom passed away…But when the mom passed 
away he had to go and stay with his grandmother and the grandmother did not know that 
her grandchild was taking ARVs. [S]he was afraid to tell her grandmother. She would [not] 
know how the grandmother would respond. So the child just kept quiet……… They say 
when you are HIV positive they think you are sleeping around. It may be that it is not easy 
for those women to explain to their husbands. Maybe they are from KwaZulu-Natal to they 
must vacate their place and go back there. [adherence counsellor] 
Resp 5: They are sick and they started treatment and now they have to go back to their 
families or partners. It [is] very difficult for them to disclose. Specially women because you 
find that they are dependent on their partners so if they tell them about ARVs it [is] like 
“You come with the issue of HIV in the house, you brought the HIV”. So it becomes difficult 
and in the end they end up defaulting the treatment. [adherence counsellor] 
Resp 1: The family would lose respect for him…you must be bad to get it. Very often with 
the older women as well…They feel they have done something wrong and they say “Ek is 
nie stout nie [I am not naughty”], but here I have got this thing. [nurse] 
 
The above responses show that the experience of stigma is both a psychological as well 
as a social process. PLWHA will often fear being rejected by others in their environment. 
They may also feel ashamed or guilty about contracting the illness through a 
psychological process of internalisation of how others have socially constructed them 
(Patel, 2005). This will hinder PLWHA from getting the appropriate treatment or in 
adhering to their medical regimen. However, the above responses also direct us to the 
social processes that are inherent in the analysis of stigma. PLWHA are often stigmatised 
for being part of a specific group that is defined negatively (Aggleton, et al, 2003). 
Racism and sexism are used as markers of differences in this process of othering people 
and constructing them as deviant (Aggleton, et al., 2003). It has been postulated that 
stigma is a process used by society to perpetuate and legitimise social inequalities, to 
legitimise social hierarchies and to reinforce pre-existing economic, educational and 
cultural disadvantages (Aggleton et al., 2003). As a result of this, certain race groups may 
be more affected by the stigmatising process. In addition, women are also more 
vulnerable to being blamed and ostracised for having contracted the illness. The 
combination of the psychological as well as social impact of stigma means that certain 
groups of people will thus be more vulnerable to non-adherence.  
 
Respondents reported that some patients expressed fear of a lack of confidentiality 
regarding treatment delivery. PLWHA feared that their status would be divulged to others 
in their communities and as a result of this fear there is the possibility that they will not 
return for medication refills. Or in some cases some individuals travelled long distances 
so that they could obtain treatment further away from home in an attempt to hide their 
status. This further complicated cost and put an extra financial burden on them.  
 
Resp 1: If somebody [staff member at the clinic] comes to me and says “My neighbour come 
to the clinic”. I say we actually need to sit down with the neighbour and tell them that you 
are bound [by confidentiality]. You are not allowed to tell anybody. The secrecy is 
important but it happens. We have had some discrimination issues where X has said 
something on the taxi………Ideally we get our patients to go to the closest clinic but some 
patients do [not] want to go to the closest clinic because they do [not] want their 
communities to find out that they [are] going to the clinic and they are scared that if they 
are waiting in queues the people are going to find out. [nurse] 
 
These responses by the medical practitioner show that there are significant real barriers to 
adherence levels in situations that have arisen as a result of stigmatising behaviour. This 
finding is supported by other research that has found confidentiality (Laniece et al., 2003; 
Nachega et al., 2006) and travelling long distances (Rief et al., 2006) as barriers to 
treatment adherence. However, in addition to the real experience of being stigmatised, a 
further significant theme that has to be considered is perceptual stigma. HIV-related 
stigma has become intensely entrenched and synonymous with the illness and PLWHA 
may default on treatment due to the fears associated with being positive. Often those who 
are on treatment will hide their medication from others with very tragic consequences as 
reported by respondent 1 and 4. In many instances the families of PLWHA have 
displayed very supportive attitudes and are surprised at the level of fear, shame and guilt 
that the person may have experienced. Perceived stigma is often more dangerous as it is 
the silent aspect of the stigma process (Patel, 2005). 
  
Resp 1: He was hiding his medication. He was taking his medication and he was hiding the 
fact that he has HIV. But you know the families come in and say, “but we could have helped 
him….we could have done something for the patient”. Very often it is the patient rather 
then the families who think they should hide their status. [nurse] 
Resp 4: She would [not] know how the grandmother would respond. So she kept 
quiet….The granny is so supportive and she was so worried how come she could [not] 
disclose to her, and how her mother [daughter] could keep this a secret all the time. How 
they do that alone. [adherence counsellor] 
One way that one can explain and understand aspects of perceptual stigma is through  
symbolic interactionism (Desmond, 1970). According to Mead (1934) the construction of 
the self is not a personal experience but arises out of social processes. These social 
processes interact on a symbolic level on self development and people come to take on 
the attitude and behaviours of others (Mead, 1934). In other words, the way that others 
behave may be taken on by PLWHA and this process of symbolic internalisation may 
become a frame of reference from which they acquire meaning of themselves. HIV-
related stigmatising behaviour of others can become a focal point of self-perception of  
constructing negative self-concepts about themselves and engaging in self-depreciating 
behaviours. The perception of how others may respond to them then becomes a part of 
the HIV-positive identity and a way of relating to the environment as was reported by the 
above respondents.  HIV-related stigma has become intensely synonymous with the 
illness that it is no longer necessary for the person to experience it on an individual level 
to fear it. Hence, both the real act of stigmatisation and discrimination as well as the 
internalised perception and resultant fear have a very substantial impact on adherence 
levels (Patel, 2005).  
 
Despite the severe impact of stigma and discrimination, particularly on aspects of 
disclosure and important theme that emerged is the development of a resistance identity 
by PLWHA towards this kind of victimisation. The following response by a patient sheds 
some light on the development of a resistance identity by PLWHA.  
 
Resp 3: If I [am] travelling, I [will] take this plastic, I [will] take these tablets, carry [them] 
in my bag and a little bottle of water. I [will] drink it. Do [not] worry, because HIV, maybe 
you have it too, maybe you too [are] positive. [patient] 
 
This patient articulated that it was more important for her to take her medication as 
people who may discriminate against her may also be HIV-positive. Assisting people 
challenge the responses of others  may lead to the PLWHA becoming more open about 
their status and their medication. The development of a resistance identity does not have 
to be limited to the individual but can be actively encouraged through the concept of 
community connectedness and empowerment (Rappaport, 1981).  
 
5.4 SYSTEMIC LEVEL BARRIERS AND FACILITATORS TO ARV 
ADHERENCE 
 
5.4.1 Poverty 
 
The impact of social inequalities on health is well researched and documented (Nettleton, 
2002) and poverty is an important consideration in ARV treatment. Although some 
research has indicated that poverty does not necessarily impact on adherence levels 
(Frank, 2006), other research has shown that people who live in impoverished 
circumstances find it more difficult to maintain their ARV regimen than those who have 
higher income levels (Nakiyamba et al., 2006). Participants in this study reported that 
unemployment, food needs and transport problems are some of the poverty-related 
difficulties they have experienced in trying to adhere to the treatment regimen. 
 
 
 
 
5.4.1.1. Unemployment 
 
The following quotes from the respondents highlight the huge challenges faced by 
PLWHA around unemployment. Individuals who are unemployed will have difficulties 
in meeting their food needs and in facing challenges of getting to and from health care 
facilities which are often not in the immediate vicinity.  
Resp 4: Most of them are saying that I [am] unemployed and I do [not] have work. 
[adherence counsellor] 
Resp 7: There is no one who can hire a person like maybe at the age of fifty. You are not 
even at the age of getting pension, but over fifty, you know, it is not easy to get a job. 
[treatment activist] 
 
Unemployment has been quoted as one of the biggest markers of poverty and is a critical 
factor that contributes to social problems in South Africa. The current unemployment rate 
in South Africa stands between 36 and 42% (Naledi, 2006). Unemployment in South 
Africa is heavily marked by race, gender and skills level (Naledi, 2006).  For those who 
are employed, earnings have fallen significantly over the past ten years and the 
population groups that have been most affected by this are those in the lowest income 
bracket, whose real earnings have almost halved (Naledi, 2006). The ravages of HIV 
have further complicated the issue of unemployment in the country. 
 
5.4.1.2 Hunger and Food Needs  
 
Nutritional and food needs are a critical component to those who are on ARVs. Proper 
nutrition is needed to strengthen the immune system and to slow down the progress of the 
illness (Castleman et al., 2003 Nakiyamba et al., 2006). Furthermore, proper nutrition is 
required to increase the efficacy of the ARV medication (Castleman et al., 2003). 
However, even though the South African constitution guarantees sufficient food for all its 
citizens as a basic human right, all the respondents indicated that meeting food needs is a 
major challenge many had to face   
 
Resp 4:  Our people, they do [not] eat. They are unemployed, nobody can afford food. So it 
becomes a problem because a person will say, “I can [not] take my medication if I have 
[not] eaten”.  Others are saying, “These pills are making me hungry more and more”. 
[adherence counsellor] 
Resp 5: Sometimes they do [not] have food at all at home, so they will [not] be taking their 
medication because they will be hungry. [adherence counsellor] 
From the above responses it becomes clear that it is difficult for PLWHA to take their 
ARV medication when they are hungry. PLWHA who are on treatment have reported that 
treatment increases their appetite and this puts a strain on already meagre resources. 
Some PLWHA may stop taking their treatment altogether because of a lack of food. In 
some instances patients may not adhere strictly to the treatment, often reducing intake of 
medication. This concurs with research which indicates that poverty-related lack of food 
complicates adherence levels (Nachega et al., 2006, Hardon et al., 2007). Although some 
research has indicated that socio-economic differences do not appear to have an impact 
on adherence levels, the findings of this research suggest differently. For the struggling 
classes it becomes a much more difficult task to meet their nutritional requirements. 
Often, in order for PLWHA to meet their required food needs they may have to find 
alternate ways of procuring funds. This is often an arduous and difficult task that reduces 
people to begging or borrowing funds. The following patient articulated the challenges 
that she has to face in meeting her food needs. 
 
Resp 3: I [am] telling friends give me five rand or ten rand to buy a cabbage or a beetroot 
or fruits. I am worried.  I [am] going to borrow money [from] a friend or neighbour. I [am] 
going somewhere. My husband if he [is] paid he [is] giving me some money. [patient] 
 
This concurs with findings where it has been found that some individuals may have to 
rely on other employed family members to provide the necessary financial support so that 
they can maintain their treatment regimen, including the provision of food (Nachega et 
al., 2006, Kumarasamy et al., 2005; Hardon et al., 2007). Borrowing funds from alternate 
sources may often place the individual in further debt and push them into further poverty. 
Nutritional supplementation, food donations via the Social Welfare Department and Non 
Governmental Organisations (NGOs) food programmes provide some relief for those 
taking treatment as is indicated by the following response. 
Resp 1: At one stage we researched e-pap. We managed to get donations for e-pap for our 
patients when they were really very, very sick and even without ARVs the pap lifted them 
up. [nurse] 
Resp 5: In other communities there are projects where people would engage themselves in 
like food gardening, they would go and help in a church somewhere where they would give 
them food parcels. [adherence counsellor] 
 
However, providing additional nutrition and food for the individual on treatment fails to 
take the complexity of poverty into account. The food that is provided through the 
government and donor systems does not sufficiently address the food needs of the person 
who is on treatment as the rations will often be used for the needs of the entire family. In 
many other instances these rations are also used to sustain extended family or community 
members. Those who are on treatment may compromise themselves so that others in the 
family system may gain access to the food as mentioned by respondent 4 who is an 
adherence counsellor.  
Resp 4: How do you deal with a person when they say, “I don’t have food”? How you going 
to deal with it because we give them e-pap. It [is] not for the whole month. The social 
workers try to give them food parcels but we don’t even know how many of them they in 
that house. Because most of the people, it [is] not only one, maybe it [is] eight or nine 
persons to a house. [adherence counsellor] 
5.4.1.3 Transport 
 
A further significant theme linked to poverty is transport costs. Travelling to and from 
ARV sites remains one of the most problematic and challenging issues for many PLWHA 
and it was a frequently discussed theme by both the patients or their care-givers as well as 
an often discussed factor that impinges on adherence levels by the medical care-
providers..   
 
Resp 3: I come once a month. When Dr M stopped my treatment I come once a week. 
Eleven rand to Diepsloot, Joburg six rand. Joburg to [HJ] hospital. Joburg to hospital is 
R32… and I am going to borrow [money]. Last year I am going to Rissik Street to want a 
grant. After two months was coming a letter to tell me [they] are not giving me the grant. 
[patient] 
 
Resp 4: In first time counselling [adherence counselling] we explain to our patient that it [is] 
not going to be a once-off visit. You ask them of their financial status…Most people who 
come this side it is double transport. It can cost R50, R60 just to come here from one of the 
townships. [adherence counsellor] 
Resp 5: Most of them are complaining about transport money. There is no one to give them 
money for transport to come to the hospital. [adherence counsellor] 
Resp 6: Many people in our country, they can only access their treatment from the public 
sector and usually this is the provincial or regional hospitals, which are very far for them. 
As you know we have a high rate of unemployment and poverty, many people actually can 
[not] afford to have the money to get into the taxi every single month and to go and get their 
treatment. [treatment activist] 
  
Like nutritional and food needs, transport was another factor that forced people to resort 
to drastic measures to meet the need (Kumarasamy, 2005). This is not only a critical issue 
for individuals who live in rural areas (Hardon et al., 2007) where HIV treatment points 
are difficult to access. The high level of unemployment and the increasing cost of 
transport place an added financial burden on those needing to access treatment. It may 
also possibly remain a major reason why some individuals may not be able to come to the 
health facility for re-fills of their medication (Hardon et al., 2007). Increasing localised 
roll- out sites may be one way that the health system can be organised to manage 
problems such as the difficulty that PLWHA face in getting to regional hospitals. 
However, this cannot be managed in isolation and aspects like the severe implications of 
stigma and discrimination need to be taken into account.  
 
While short-term solutions are important, Van der Vliet (1996) believes that to limit HIV-
related strategies to social and economic contexts would be to deprive people control 
over their lives. It becomes imperative to engage with systemic level conditions like 
poverty as an empowering exercise (Rappaort, 1981). This would require an engagement 
with the communities at a level that would allow for active participation to take place.  
Hence, poverty-related issues that impact on ARV treatment indicate that free treatment 
in itself is not sufficient (Kumarasamy, 2005), and systemic level solutions have to be 
found around issues like meeting people’s food and transport needs.   
 
 
5.4.2.4 Social Grants  
 
A significant theme linked to poverty that was frequently discussed by the all the 
respondents was the issue of the government social grant. The above discussions 
demonstrate that the link between HIV and poverty is not limited to the rate of HIV 
infection (Barnett & Whiteside, 2002;  Kalichman Et al, 2003; Kalichman, 2005, 
Shishana & Simbayi, 2002) but extends to ARV treatment where various factors like 
unemployment, lack of food and high travel costs impact on adherence levels. The 
government social grant is one of the ways that poverty is being addressed. Research has 
found that social grants significantly assist towards the alleviation of poverty and it is are 
often the only financial resources available to PLWHA and their families (Booysens, 
2004)  as is indicated by the following response.  
 
Resp 1: If they [the patients] take all their ARVs and they get better, then they do [not] 
qualify for the grant. And often the grant is not only feeding them but it [is] supporting the 
whole family. [nurse] 
 
Resp 2: Last year, I [am] going to Rissik [street] to [get] a grant. After two months was 
coming the letter to tell me the reason which they do[not] give me a grant.  
 
Having access to the grant is a significant concern for many PLWHA as has been found 
in other research (Hardon et al., 2006; Kumarasamy et al., 2005) and it has become a very 
significant theme that needs further investigation as many individuals make use of the 
grant as a way to control and manage their socio-economic situation with serious 
implications for adherence levels. PLWHA usually qualify for the grant in the initial 
phases of the illness when they are too ill to work. However, once ARV treatment 
restores the PLWHA to health, they are deregistered from the grant system.  
 
Health-care workers (as is indicated by the above response by respondent 1) reported that 
patients may be motivated to default on their treatment because they want to qualify for a 
grant. In some instances patients would go through great lengths to avoid taking 
treatment so that they may be able to access the grant. Respondent 7 an activist, 
articulated that often patients may manage their treatment in a manner that keeps them 
just ill enough to access the grant. Both the respondents noted that PLWHA would often 
face a great deal of physical pain and suffering in an attempt to manage their CD4 count 
in this manner. It was indicated that even when patients are given  information on the 
damage that this does to their bodies and to their immune systems, the desperation 
created by poverty is so great that people will be motivated to remain ill. The social grant 
has to be evaluated against the conditions of poverty levels experienced by PLWHA, as 
often this is the only income available to the person and it becomes their only means of 
survival, with serious consequences to ARV treatment adherence 
.  
Resp 1: He [the patient] did not qualify for a grant. He was stage 1 and he was angry with 
us because he was not getting his grant. He actually went to the newspapers and then he got 
opinions from people who said he should be on treatment but he is actually a big problem 
because I do [not] think he [is] going to be compliant either because his motivation is not 
right either. His motivation is that he can [not] pay his flat rent. We started to work him up 
for ARVs because his count had come down and he said to me, “What about the grant?”. 
His motivation is purely and simply the grant. [nurse] 
 
Resp 7: People tend to not adhere because their is this social grant. If somebody is taking 
the medication then the doctor makes a note that this person qualifies to get a grant. Then 
when you start taking the ARVs then your CD4 count goes up and you get well. Then you fit 
to work, and this person thinks they [social services] will cut my grant, then how am I going 
to live without that. So they tell themselves As long as I live I [will drink them [ARVs] and 
sometimes I will [not] drink them [ARVs]. The doctor is saying you are not good and the 
money is not cutting off…….Instead of taking their medication they staying with pain. But 
there is medication here that can help you and it [is] for free. The problem is the grant You 
take your medication today, you do [not] take your medication tomorrow, it does resistance 
in your body and by the time you start another [treatment] then it does [not] work and 
people they have passed away. [treatment activist] 
 
In resource-poor settings free treatment is clearly not enough and social grants have 
become an important factor. However, despite the much needed relief that the social 
grant provides it also creates a paradoxical situation for many. According to the Health 
Belief Model, it would be logical and rational for those who are on treatment to respond 
to their illness by taking care of their health and not willingly risk putting themselves in 
any kind of danger (Rosenstock et al., 1994). According to this theory, given the serious 
consequence of not taking ARV treatment, PLWHA will make every attempt to take the 
medication exactly as prescribed. It would appear that the negative aspects of suffering 
and even facing death would be seen as strong motivating factor to get well. 
 
However, Lupton (1999) argues that the manner in which the individual identifies risk is 
never an objective factor. Thus, the way in which the PLWHA construct their illness and 
the reality of their existence is constructed, deconstructed and reconstructed through their 
various experiences (Gergen, 2001). In order to assess the dynamics that are created 
around the social grant, it is imperative to understand that for those who are struggling 
with their day-to-day existence it may make more sense to negotiate their daily poverty-
related difficulties rather than focus on the illness. Even though individuals may have the 
required information and knowledge about the consequences of non-adherence, for some 
individuals the option of immediate poverty relief is more important than facing pain and 
eventual death some time in the future.  Therefore, in order to understand the process that 
is unfolding, one needs to look through the eyes of those who are trying to exist in and 
through poverty (Gergen, 2001).  
 
5.4.2 The Health Care System  
 
The South African health care system is overburdened with reports by the Human 
Research Council of South Africa (Ncayiya, 2004) suggesting that the country’s supply 
of health care workers is on the decrease. This, together with the manner in which the 
health care system is organised can have an impact on PLWHA who are on treatment 
(Hardon et al., 2007). The following responses by HIV/AIDS activists strongly indicated 
the impact that the health care system has on adherence levels.  
 
Resp 6: We are also not seeing any political leadership from our political leaders. As far as 
our health services are concerned here in South Africa it is a shambles. Health professionals 
are leaving for other countries. Hospitals are there but the services are not good. If you go 
to some of our hospitals you can [not] believe that this is actually where you treat people. So 
health is not our governments priority, which is something totally opposite to what our 
constitution says, that everybody has a right to access quality healthcare. Some times when 
you go to a hospital you end up having to spend the whole day there, sometimes you get 
turned away, you do [not] get any services and the human resource factor is really one of 
the things the government is not doing anything about. Other hospitals they experience 
stop-outs, you find that a certain drug is not there...sitting in the queues in the clinic or 
hospital waiting to be served and even the doctors, there are not enough doctors in [on] the  
site. Sometimes you might be experiencing side-effects which you are told once you start 
experiencing such and such [side-effects] you have to see a doctor. You have to consult and 
you can [not] afford to go to a private practitioner. [treatment activist] 
 
Resp 7: There are long queues in the clinics and slowness and some of the hospitals cut of 
the queue and say we are taking 60 people, you are too late. [treatment activist] 
 
Medical facilities are often under resourced and the lack of staff leads to an increased 
workload, leading to burnout, absenteeism and low staff moral (Hardon et al., 2007).  
This can lead to decreased quality of care for the PLWHA. This, coupled with difficult 
administrative procedures, means that that people on treatment often have to wait in long 
queues to be seen (Hardon et al, 2007. The time that the individual spends at the health 
care facility often leads to frustration for the person and which can impact negatively on 
adherence levels as been reported by the patients in this study. Those who are employed 
lose at least one working day when they go to the clinic or hospital. The extra time that is 
needed for routine check-ups and getting medication refills places an additional burden 
on those who have not disclosed their status to others and on those who may not have 
adequate support from those around them. Requests are often made for three to four 
prescription refills, however, paradoxically, one month refills are needed to monitor 
adherence levels and extended time periods may only serve to impose constraints on the 
monitoring of  adherence levels in PLWHA. Furthermore, whilst side effects may be 
understood as an individual level problem that has been managed primarily through 
educative means firmly entrenched in a biomedical worldview, systemic level difficulties 
add to this burden. As has been indicated by respondent 6, it is often a frustrating task for 
individuals to negotiate the health system and it may be more useful and beneficial for 
PLWHA if alternative ways can be found to manage their illness.  
 
5.4.3 Political Contributors  
 
The South African government was slow to respond to the HIV crisis and remained 
complacent around acknowledging the full impact of the illness. Early political responses 
to the HIV pandemic were caught up in a quagmire of controversy and confusing 
messages (Barnett & Whiteside, 2002). The political leadership’s early attitude towards 
the pandemic centred around preventative programme implementation. In addition, the 
government questioned whether HIV actually even existed and if it indeed was the cause 
of AIDS (Barnett & Whiteside, 2002). The lack of political commitment and willingness 
to mobilise adequate resources led to the subsequent ARV roll-out being a long and 
drawn-out process (Schneider, 1996). However, these early responses by the political 
leadership not only impacted on the ability of people to access ARV treatment but it has 
also impacted on issues around adherence to treatment.  The following are some of the 
responses by HIV/AIDS activists that capture the attitude and stance of the political 
leadership in this country and the role that the government has played in contributing to 
the systemic difficulties around adherence to ARV treatment. These include the 
perpetuation of stigma and the stand that the Health Ministry has taken over the toxicity 
and benefits of ARV treatment. 
 
Perception of Government Response 
 
Resp 6: Our government is not prioritising the lives of the people of our country. Like if you 
are investing in the lives of people in our country, it [is] like investing in the economy. If you 
have access to treatment, you can live a healthy, a long and productive life. [treatment 
activist] 
 
Resp 7: Government, the thing is [they] are slow. They do hear what people are asking but 
they are slowly to reply. Like prevention from mother to child, it [is] not implemented in all 
hospitals and certain hospitals you will find that you can already find that you stay far from 
there. [treatment activist] 
 
Stigma 
 
Resp 6: I can say our government played a great role in perpetuating stigma. Our president 
is quoted as having said that he [has] never seen someone with AIDS. So there is mixed 
messages it also helps to perpetuate the situation that we find ourselves in. People can [not] 
accept that HIV is there. [treatment activist] 
 
Nutrition versus ARV treatment 
 
Resp 6: The Minister of Health, she [is] always talking about nutrition, saying nutrition can 
help you not go to the stages of AIDS, always highlighting the negatives of taking drugs. She 
is always talking about garlic and lemon and all that. [treatment activist] 
 
The government’s role and the manner in which ARVs have been introduced in the 
country has generated much fear that has impacted on people’s perceptions of HIV as 
well as the efficacy of treatment (Frank, 2006). In this regard Frank (2006) believes that 
people’s perception of the efficacy of the drug will determine how well they adhere to the 
treatment.  This argument may be particularly pertinent in this situation and may throw 
some light on how PLWHA deal with their perceptions around the toxicity of ARV 
medication and the experience of side effects. It may be that some individuals may stop 
taking the medication without consulting appropriate medical staff in favour of garlic, 
african potato, lemon and beetroot which are very rigorously promoted by the Health 
Department. In addition, the conflicting messages also appear to impact on adherence 
levels as patients turn increasingly to alternative and traditional healing systems as a way 
of managing their perceptions of ARV treatment (Frank, 2006).   In addition, Frank 
(2006) also points out that people who come from the poorer socio-economic levels may 
adhere more closely to the government’s directives due to their loyalty to the 
government. However, one would need to take into account that the government is in a 
position of authority and power and thus information coming from these political 
structures would be more trusted by those needing medical attention.  
 
In addition to the early responses that have pointed to a distorted consciousness around 
the perception of ARV treatment, a further political failure that has been reported is the 
lack of adequate drug supplies and the procurement of improved treatment. 
 
Resp 6: When our government started to roll out ARVs, they never anticipated that many 
people would take drugs. So there is never enough supply of ARVs. More and more people 
know there is treatment available and the demand far outweighs the supply…Other 
hospitals experience stop-outs. You find that a certain drug is not there. You have to take 
your drugs in combination and once you do [not] take your medication in combination it 
can cause problems. Like you may develop resistance. Other people end up not taking the 
whole course of their medication because a certain drug is not available……I do [not] think 
that the government is doing enough in terms of procuring tenders from [drug] suppliers. 
Because even the drugs that we are using are the same that was introduced in 1994. We 
have [not] had an improvement in as far as treatment is concerned. Whereas in other 
countries they have even better [treatment] choices then ours and their choices are better 
than ours in that they have less side effects. [treatment activist] 
 
It would seem that often the problem of drug shortages at the ARV roll-out sites are 
linked to administrative problems where demand for treatment outweighs the clinics’ 
anticipated need for treatment. This oversight on the part of the medical health system 
has very serious consequences for those who are on treatment. In addition, respondent 6 
also indicated that much of the treatment used in the public health system has serious side 
effects. The more recent ARV medication has reduced toxicity, but these are not 
available in public hospitals. This shows a lack of political commitment and a failure on 
the part of the Health Department to PLWHA and it is a direct infringement of basic 
human rights that demand adequate medical care for all.  
 
5.4.4 Traditional and Other Belief Systems  
 
All the respondents emphasised the importance of educating those who are HIV-positive. 
Knowledge about the virus itself and the treatment is a critical step towards empowering 
patients to take care of themselves. Educating people around the importance of taking the 
medication exactly as is prescribed, toxicity of the medication, the benefits of treatment, 
better nutrition, maintaining a positive attitudes and developing support systems are 
imperative determinants in increasing adherence levels (Stemson et al., 2005).  
 
Resp 1: We have started the Wellness Centre in 2000. We are saying to them [patients] this 
is HIV. This is what it does to your immune system. These are the bad effects on your 
immune system. These are the good things for your immune system. Looking at diet. 
Looking at disclosure. Even before they [the patient] goes to adherence [counselling], they 
go to the Wellness Centre. [nurse] 
 
Resp 6: By turning to people and educating them I [have] realised that with education, you 
give someone enough education on drugs; they will change their minds before treatment. So 
we can teach people by speaking in their own language, trying to simplify things, they tend 
to get an understanding and see why the benefits far outweighs the negatives and more and 
more people actually do want to go on ARVs. [treatment activist] 
 
Resp 3: [in response to benefit of adherence counselling] they tell me if I take my 
medication, after a time the viral load is up. If I am staying two days, one week, one month 
without medication, the sick is coming back. The time is coming maybe I [am] going to 
die...[so] every time I am remembering to take my medication, eating. [patient] 
 
Models of individual health behaviour are useful in developing interventions that use 
knowledge as a way of getting people to understand their susceptibility to getting very ill 
and dying if ARV treatment is not taken exactly as has been prescribed. Benefits and 
barriers can be explained to the individual, added control (Rosenstock et al., 1994) and 
mastery over their illness can be evaluated with the patient (Fishbein et al., 1994). 
However, educating people around HIV and its treatment in a top-down process remains 
problematic and cultural practises have to be taken into account. Lupton (1999) puts 
forward the compelling argument that giving people knowledge around their illness is not 
enough, but knowledge has to be managed through the reproduction of meaning that the 
individual constructs through their social interactions. The different socio-cultural 
matrices and competing views have to be taken into account when analysing what it 
means for the PLWHA to be on ARV treatment. For many South Africans, traditional 
healing systems are an established form of health care in their communities (Pretorius, 
1996). It has been estimated that between 60 to 80% of the South African population 
makes use of traditional healing systems (Pretorius, 1996). Many South Africans also 
make use of both the traditional healing systems as well as western medicine (Pretorius, 
1996). However, there appears to be a dichotomy and schism between the two healing 
systems that has become a barrier for people adhering to ARV treatment (Owen Smith et 
al., 2007; Wong at al. 2006). Health care providers as is indicated by respondent 1 in the 
quote below reported that often patients are conflicted around the two treatment systems. 
Patients may often favour traditional healing and this will impact on ARV treatment 
adherence. Respondent 5 reported that many patients would seek out both treatments but 
would often hide the fact that they are also on taking traditional treatment.     
 
Resp 1: Sometimes the family will tell them [patients], “You [have] been to the clinic, you 
[have] got them [ARVs] but first do the traditional medicine. First you must be stronger 
because the ARVs have side effects, because they are so toxic. You must get stronger first. 
So take some other medication and boost your immune system first….The family does not 
believe in ARVs and believe that they should take traditional medicines…we do [no]t advise 
our patients to take traditional medicine together with ARVs because of possible 
interactions. [nurse] 
Resp 5: They [are] afraid to disclose [traditional treatment] because when you do education 
you say it is important that you do [not eat [take] ARVs with other things [traditional 
medication], and then because they still believe that maybe whatever that I [am going to be 
doing is going to “cure” HIV. So they think, “If I mix the two it might cure the HIV”. So 
they do not disclose such things until they see it becomes a problem. It makes them sick. 
That is when they will say, “I was also taking this”. [adherence counsellor] 
The toxicity of ARV medication is particularly problematic (Owen Smith et al., 2007) 
and this together with the mixed messages that have been sent from the South African 
political structures(Barnett & Whiteside, 2002) have had a major influence on PLWHA 
who appear to be relying increasingly on alternative healing systems (Frank, 2006). 
PLWHA may hide alternative medication from medical practitioners in the mistaken 
belief that taking the two together may be more beneficial. PLWHA who are using other 
treatments may be significantly more likely to miss doses of ARV, suggesting that they 
are using these as an alternative to ARV treatment rather then complementing treatment 
(Owen-Smith et al., 2007, Wong et al., 2006), often with serious consequences for the 
PLWHA,  as is suggested by the following statement.  
 
Resp 1: They are so sick, they were desperate, they were trying anything, without having 
necessarily going through all of the issues [ARVs vs. traditional medicine]. Then a year, two 
years later when they [are] really feeling well, then they start thinking, well maybe they can 
just go back to traditional medication……The main thing is that if they [are] going to stop 
taking ARVs then they must stop taking ARVs. One time, not partially take them because 
they half believe in the. They must stop taking them, try their traditional medicine so we 
can take a viral load and see whether the ARVs are working at this stage. If they start 
taking them less and less then we have a problem when viral load resistance starts. [nurse] 
 
The two systems of traditional healing and western medicine are set up as a dichotomy 
and it has been argued that in this dualism, traditional indigenous knowledge has been 
treated with disdain and arrogance by a western worldview (Muller & Steyn, 1996). It is 
further postulated by Muller and Steyn (1996) that medical pluralism can exist side by 
side. Understanding and incorporating the value of traditional medicine and alternative 
healing systems into the biomedical model appears to be imperative in the management 
of PLWHA who are on ARVs. It is a futile exercise to exclude these alternate ways of 
being and there is a benefit to be derived by being more inclusive. A combination of the 
two healing systems can help PLWHA to improve their adherence levels. The following 
responses indicate the benefits of working with alternate healing systems: 
 
Resp 1: I think it is useful to work with them [referring to working with traditional healers]. 
Because especially with patients who are more with the traditional healing and the 
ancestors [belief]. If they are told by the traditional healer that, “This treatment is okay, go 
and get this treatment”. We educating the traditional healers and they do refer patients 
in… they are referring for HIV testing, and they will tell the patient, “you must finish this 
course of medicine before you start on ARVs”. [nurse] 
 
Resp 7: With HIV you experience a lot of things, you can get peripheral sores, etc. so you 
can go for treatment, the western treatment. I think if we can train traditional healers, to 
make them understand, here I can help you, now I can [not] help you. I [am] working with 
doctor, I can transfer you to doctor... Working with traditional healers, you [are] not telling 
people we [are] against what you are doing...there [is] one woman in our location. She [is] a 
sangoma, when you go to her she tell that person she is working with a doctor. She is doing 
good work. She [the sangoma][will] tell you, “You can come back to me, come show me 
your tablets so that I can see which medication from me will go together with this one 
[ARVs]. So I believe that she has got an understanding. [Treatment activist] 
 
 
However, a major issue that arises from the responses and from literature (Muller & 
Steyn, 1996) is the feasibility of such a partnership. The new health care system in South 
Africa is based on the principle of primary health care that allows for PLWHA to have 
their needs met at a local level where communities can participate and be more in control 
of their health needs. There is an opportunity for a partnership to develop between 
western and traditional healing in the health system (Pretorius, 1996). As has been 
argued, (Pretorius, 1996) one of the main constraints to such a partnership is one of 
cultural systemic differences. Around HIV/AIDS in particular there is much debate 
(Pretorius, 1996) of unhealthy and dangerous practices by traditional healers that can lead 
to PLWHA suffering unduly and dying as a consequence (Rissik, 1996).  
 
In addition, it is often feared that a status quo may be created by the professionalisation 
of traditional healers in that it will give the government an excuse not to provide adequate 
health care facilities to under resourced areas (Muller & Steyn, 1996). Certainly one can 
argue that the government’s conflicting messages around ARV treatment and their focus 
on nutrition and immune boosters seems to point to the fact that they may be back 
stepping from political responsibilities with regard to PLWHA. Yet, it is important to 
note that traditional healers are physically, socially and culturally more available and 
accessible to masses of people (Muller & Steyn, 1996). It might be a dangerous practise 
to exclude different forms of healing systems and initiatives must be put in place within 
the health care system as well as from outside the public health care system to include 
traditional systems.  
 
Furthermore, although there is much focus on traditional belief systems, organised 
religious systems play an equally important function in people’s lives. The following 
statements reflect the importance of religious beliefs in terms of adherence levels 
regarding ARV treatment. 
Resp 5: Some people would say [that] at my church they have services for, they pray for 
people who are HIV-positive and after they pray they [will] be cured from HIV. So they 
come here and they want HIV tests every now and then, and when it [they] continues to be 
HIV-positive they become depressed and they want to stop treatment because they lose faith 
in everything. There is this one lady, she always comes and she would look for a person who 
she has never seen before. She would pretend to be a new patient and do HIV- test until we 
noticed. I called her and she came in and we spoke about it. She said that she believes that 
the prayer service that they have at the church, they [are] going to help her cure HIV. So 
she was thinking if she takes the medication it would be like she does not believe in God. So 
she stopped the medication and only believed in prayer. [adherence counsellor] 
This concurs with Frank’s (2006) findings in which she argued that people are often 
desperate and will turn to religious practices to find a cure for their illness. Furthermore, 
many South Africans have a dual belief system that incorporates traditional healing 
systems and organised monotheistic religious beliefs like Christianity. Although it is 
understood that religion may impact on adherence levels, very little research has been 
found in this respect with regard to the PLWHA point of view. However, Respondent 5 
articulated that it was important to understand and to work with individuals in their 
respective systems of belief. This can lead to an acceptance of ARV treatment that will 
increase adherence levels as PLWHA. The statement by Respondent 5 highlights the 
argument by Airhihenbuwa (1995) that culture can be used as an ally in the 
deconstruction of health issues. Even if great sensitivity is shown towards alternate belief 
systems, it would seem to be a pointless and meaningless exercise to change people’s 
belief systems to fit in with western medical ways of thinking (Airhihenbuwa. 1995). 
This would only serve to strengthen the arrogance of traditional western medicine whilst 
creating a further stoic resistance to ARV treatment by PLWHA. Tapping into the 
strengths and attributes that are helpful in promoting better adherence may prove to be a 
more successful way of engaging with different religious beliefs (Airhehenbuwa, 1995).  
 
Gramsci (1971) argues that social structures like religion can be seen as a hegemony 
based on persuasion and consent. According to Gramsci (1971), religious leaders as 
functionaries of the hegemony use systems of religious ideological knowledge to 
legitimise and maintain power. One way of challenging this power around certain 
convictions may be from the religious system itself. This argument is poignantly brought 
to life by the following response: 
Resp 5: I spoke to her about curing and healing and God loves everyone so if there was a 
cure He would bring it to everyone else, not only to one person. So because doctors are also 
created by God, people who are making the medication are also created by God. So it s one 
way that God is giving support by making people create treatment. At first she was 
reluctant but I had an ongoing conversation until she realised that it was important for her 
to take the medication and still continue praying. You must believe in your ARVs. 
Everything comes with belief. If you believe that prayer is healing, you must believe that 
ARVs are going to keep the virus away and you will live healthy like everyone else. 
[adherence counsellor] 
 
Respondent 5 reported that one way that she managed religious issues during counselling 
with her patients was not to create a dichotomy between religious beliefs and traditional 
western medication. However, she draws on religious beliefs through a process of 
dialogue or an ongoing conversation where she parallels healing through ARV treatment 
as part of a religious belief. Apart from being inclusive of the religious belief, this way of 
engaging is also tantamount to a challenge on the power of religious leaders who 
promotes religious believe over ARV medication 
 
5.5 INTERVENTION LEVEL BARRIERS AND FACILITATORS TO 
TREATMENT 
 
5.5.1 Counselling 
 
PLWHA often experience a disproportional amount of emotional difficulty in relation to 
their diagnosis as they struggle to cope with the demands of the situation as well as the 
limited resources that may be available to them (Kalichman et al., 2003; Simoni et al., 
2000). These emotional difficulties extend to the treatment regimen and the research 
indicates that the level of adherence to ARV treatment may depend on the person’s 
ability to adapt to and manage their illness (Cederfall et al., 2002; Siegel & Schrimshaw, 
2007). Counselling plays a vital role in the provision of care and support for those who 
are HIV-positive. The following response by a patient illustrates how crucial counselling 
is in assisting those who are diagnosed as HIV-positive:  
 
Resp 3: I [am] feeling my heart is so painful because my heart was telling me to die. The 
time…come to hospital and I get counselling. I [am] feeling alright. Because my heart is 
telling me I [am still here a long long time. [patient] 
 
Significantly, the care and support that the PLWHA receives in understanding and 
managing their illness has to be extended to ARV treatment. Although medical 
practitioners are more involved in the treatment and management of the illness, 
counsellors often spend a greater time in covering HIV-related issues in more detail 
(Safren et al., 2005). Counsellors are also in a better position to try and understand the 
person’s background information in order to help them manage their adherence levels 
better (see respondent 4 below). Respondent 5 also reported that counsellors would often 
spend more time discussing perceptions around stigma, issues around disclosure, fears 
around dying, complexity of treatment and effects of the toxicity of the medication in 
more detail. This is supported by other research where it has been found that counsellors 
spend more time with those who are on treatment (Safren et al, 2005).  
Resp 4: I go back to their history. Is he married, having children, is he employed, is he 
working, going to church. I find out these things. I find out their history when they start 
ARVs. What were some of the difficulties when he started. So if you find out these things 
you can pick up the problems...because once he starts telling you his stories then he starts 
opening up and the problems…what makes him not take the ARVs. [adherence counsellor] 
Resp 5: You [will] find that in a counselling session, re-adherence session, the person will 
mention the issues with disclosure, their fears around death, the side effects and things like 
that. Once they see the doctor and they do [not] see the counsellor, so they do [no]t get that 
support. It [is] best if, let’s say every time they come for their appointments, you sit down 
with them and find out, “How are you now doing with the issue that you are afraid of, the 
side effects, are you dealing with the issue of disclosure?”. [adherence counsellor] 
Counsellors can assist PLWHA with cognitive coping strategies that help the individual 
to adjust to their stressful life situation (Sarafino, 2002). In other words, those who are on 
ARV treatment may be able to increase their adherence levels as their coping abilities 
increase (Sarafino, 2002; Siegel & Schrimshaw, 2007). One way that cognitive coping 
can be increased in PLWHA is through the provision of information and education 
around the illness as well as the treatment of HIV (Rosenstock et al., 1994).  Knowledge 
around the biomedical components of ARV medication can help the person to understand 
what is happening in their bodies. Information can assist the PLWHA to look out for 
certain symptoms and side effects, get the correct assistance from the practitioners  and 
manage their nutritional need. Educative endeavours around treatment may also help to 
reduce confusing biological messages and perceptions around treatment, thereby  
allowing for  more empowered and informed choices around the management of the 
illness.   
 
Evidence suggests that individual level models of health behaviour which use education 
and the dissemination of information as a way of targeting certain  health belief variables 
can improve adherence levels (Janz et al, 2002). In situations where those who are on 
treatment have a larger degree of control of their behaviour and environment, distorted 
beliefs around treatment can be identified and changed (Fishbein et al., 1994). In 
addition, the HBM which is based on the premise that those who have a better 
understanding of their health issues will perform better than those who are less 
knowledgeable (Rosenstock et al, 1994), offers a way of identifying and changing certain 
distorted beliefs around ARV treatment.  Counselling at the individual level may also 
help in assisting patients to develop a sense of increased self-efficacy that will help 
patients to question their health and see the point of changing certain behaviours to 
increase adherence (Bandura, 1994). For example, if people are given information that 
gives them an increased sense of mastery over managing their relationship with the 
practitioner, they will be able to better manage any adverse side effects and they will be 
able to negotiate this relationship in a more constructive way.  
 
There is therefore a twofold process with regard to adherence counselling. On the one 
hand it serves a very important function in the provision of emotional and psychological 
support. On the other hand, counselling also serves an educative purpose that allows the 
person to become more informed about the important issues around ARV treatment and 
adherence.  However, a significant theme that requires discussion is the many challenges 
that the counsellors experiences as well as the shortfall of counsellors in the public health 
system that prevents people from accessing appropriate levels of care and support. The 
following are some of the responses that demonstrate  the difficulties experienced by 
counsellors who work in the public health system: 
Resp 4: Most of the time you feel hopeless. If the social service gives them money they come 
back next time but sometimes social service will [not] because they keep records. [adherence 
counsellor] 
Resp 5: Sometimes you feel so discouraged. Like after giving all the information using 
education and trying to get all the support for the person it still happens. You really get 
discouraged. You [are] really not sure whether you [are] winning the situation or you [are] 
just going backwards. [adherence counsellor] 
Resp 7: It [is] hurting sometimes. It [is] no good because you come across a lot of people and 
their problems and it ends up affecting you…how can we help that person. [treatment 
activist] 
 
In resource-poor setting, training and using lay counsellors takes the burden off the 
medical system (Hardon et al., 2007. Counselling also for the PLWHA to gain the much 
needed information as well as support with their treatment (Hardon et al., 2007). In the 
South African health facilities, many counsellors may be volunteers recruited through 
NGO services. They have to face large volumes of people wanting to access their 
services. As a result counsellors struggle with low motivation and work fatigue that may 
leave them with a sense of hopelessness and helplessness. Other problems include staff 
shortages and the lack of adequate facilities at the ARV roll-out site that would be 
conducive to meeting the counselling needs of the person as is articulated in the 
following response: 
Resp 5: On our side, counselling side, the problem comes with the issue of the counselling 
rooms. Because these are the only counselling rooms we have. So there is a lot of people 
standing outside, you feel pressures that you give all your time to one person and people end 
up waiting. So counsellors end up giving less time for counselling [per patient]. It really 
impacts very badly because you do [not] give yourself enough time to attend to all the issues 
that the person might want to discuss with the counsellor because you are rushing for the 
queue outside. Also when you start taking ARVs it [is] always a rush. There [is] a line of 
people who want to see the same counsellor. So it [is] more about getting there, being told 
you have to take this treatment for life, This is the kind of treatment you will be taking. The 
possible side effects that you will get. There is no psychological support. [adherence 
counsellor] 
 
It would seem that only a small number of ARV users may be able to make use of the 
counselling service at each visit even though monitoring adherence requires regular 
contact and support and a need for ongoing counselling. Quality of care becomes severely 
compromised. This is supported by other research (Hardon et al., 2007). A further major 
difficulty experienced in the counselling situation is that counsellors are often trained in 
dealing with the biomedical aspects of treatment and adherence. The focus on adherence 
counselling is on the educative component around managing the benefits of ARV 
treatment, managing side effects and the complexity of the treatment and talking to 
patients about the benefits of developing good practitioner relationships. In addition, 
social aspects like the importance of disclosure, stigma and discrimination are discussed 
in adherence counselling. However, whilst counsellors understand the impact that these 
issues have on adherence levels, this information is imparted in a top-down manner rather 
than in a way that will allow the PLWHA to engage with the issues on a more personal 
level. Furthermore, counsellors do not receive adequate training in identifying and 
integrating psychological issues, and as a consequence patients often do not get the 
psychological help that is much needed and which may be contributing to low adherence 
levels. Therefore, while the educative component to adherence counselling may be 
adequate, there are two important components that appear to be missing that may increase 
adherence levels. The first is the inadequate psychological assistance. More importantly, 
the educative component of ARV adherence does not necessarily take the person’s needs 
and own solutions into account. 
 
5.5.2 Social Support and Support Groups 
 
In addition to counselling for PLWHA, support networks and social support outside of 
the counselling situation are critical important in assisting those who are HIV-positive 
deal with their emotional and social challenges, and they can be a very powerful force 
that can be a rich source of empowerment for those living with HIV/AIDS (Heaney & 
Israel, 2002; Walch et al., 2006). Respondents three and four articulated the importance 
of social support with regard to treatment and adherence. Being open about their status 
and knowing that they are accepted by others allows for a space where individuals may 
be able to express their feelings. This reduces the shame attached to being HIV-positive 
allowing the person to be more open about their treatment. In addition, those who are on 
treatment can often find very valuable and powerful support from other people who are 
on treatment as has been indicated by respondent 1. In a clinical environment where 
people have to often wait for long hours for their medical check-ups and treatment refills 
the sharing of common experiences often develops a sense of camaraderie between 
people who are on ARV treatment. These informal support networks become very useful 
in assisting people to understand each other and manage their treatment. 
 
Resp 3: [in response to what makes taking the treatment easier] If I [am] going out, talking 
with my friends, my sister, my husband. My friends, tell me they like me. My sister tells me 
she likes me. My husband tells me I love you. I [am] feeling all right… If I cry my friends is 
here. [patient] 
Resp 4: She would [not] know how the grandmother would respond. So she kept quiet...The 
granny is so supportive …and the child is so happy because [s]he is coping again. [S]he is 
going back to school. And the grandmother each and every time she is bringing him to the 
clinic...[referring to further example] [S]he was staying with his [sic] mom…the mom use to 
remind her [to] take the treatment], she used to take her to the clinic. The mom use to do 
everything with the patient. [adherence counsellor] 
Resp 1: They [will] talk to them [other patients] and they [will] say, “Don’t worry, as long 
as she takes the treatment, as long as keeps her appointments, she will get well”. So there is 
that support. Very often they come the same day each month so they become little cliques 
and they are a support system for each other. [nurse]  
 
These findings are supported by Heaney and Israel (2002) where it has been found that 
social support and networks have a very significant influence on health outcomes. Studies 
have indicated that people who are on ARV treatment and who receive adequate 
emotional support and the correct affirmations (Siegel & Schrimshaw, 2007) are better 
able to adhere to their medication regimens. Support systems can also help reduce the 
impact of stigma and discrimination (Kumarasamy et al., 2005) that the person may fear 
thus allowing for a more open attitude towards taking medication in public. In addition to 
the emotional support, social support networks are also a site of educational interventions 
where people can be assisted with information that can lead to increased adherence. In 
resource-poor settings where counselling is problematic and fraught with difficulties, 
social support networks can serve to assist those who are struggling with various issues 
around the illness and its treatment to find a space that can reduce the emotional burden 
like fear, anger and guilt (Kalichman, et al., 2003; Simoni et al., 2000). Finally support 
networks can be a powerful place for empowerment and mobilisation (Rappaport, 1981) 
for PLWHA and this will be discussed more fully under the community level intervention 
section.   
 
In addition, home-based care-giving and support is an area that has been found to provide 
much needed assistance to PLWHA (Gupta & Santos da Silva, 2006) and this can be 
extended to include assistance around ARV treatment. Family members like siblings and 
children have been found to be useful as facilitators to ARV adherence (Hardon et al., 
2007) . Both respondents 8 and 10 reported that they played a vital role in facilitating 
treatment adherence for their family members who were ill and could not manage to take 
their medication without assistance. This is supported by research done by Hardon et al. 
(2007) who found that children can be an important source of support when it comes to 
collecting medication for their parents or in contributing towards their food needs. 
Furthermore, they can also play a role in assisting those family members who are too ill 
to understand treatment instructions or who are too weak to be able to take their 
medication without assistance. However, taking care of PLWHA places a huge 
responsibility on family members and it is thus not only the infected people who are in 
need of support. Those who are affected by the illness need appropriate support structures 
as was reported by respondent 8. People who are primary caregivers to PLWHA are also 
in need of appropriate levels of care and support. 
 
Resp 8: I run a business with my father, so we will be together, so I [am] going to give him 
the medication. When I am go[ing] [on business trip], I will go with this medication…The 
way we are close, me and my father. When I say to him “eat this” [referring to ARVs] he is 
going to eat this. He will [not] say no. I will try my level best to give him the 
medication….We [have] got one of our cousins, he [is] helping me maar[but] I know 
sometimes he [will] be far. Because Baba [ referring to father] even he has things coming to 
him [and] it [is] going to hit me, ya wabona [ you understand]. If there are support groups 
there I can take further steps, but I do [not] have support groups like this, what can I do but 
I do [not] mind to go there. [care-giver] 
 
 
Despite the many benefits of social networks and support groups, family and community 
members may prove to be a hindrance to PLWHA who are on treatment and this has the 
potential in reducing adherence levels (Nakiyamba et al., 2006; Wagner, 2002). Finding 
the appropriate support even for those who have disclosed their status to other family and 
community members can be an arduous and difficult task. Often people in the immediate 
environment may be preoccupied with other commitments as was reported by respondent 
5.  Furthermore, as has been discussed extensively under culture and traditional beliefs, 
members of the family or wider community may have differing and often conflicting 
belief systems around ARV treatment. Respondent 1 highlighted the duality that may 
arise in such situations where the person who is on treatment may not want to take ARV 
treatment due to alternate belief systems but may be forced to do so by the family. 
Alternatively, it may be that the family may put pressure on the person to seek alternative 
cures and this may clash with the treatment regimen.  
Resp 5: Even when they [patients] disclose to their family it [is] very difficult for them [the 
family] to monitor the people [patient] that is being treated for HIV because maybe they 
[the family member] have to go to work and there [is] no person who can say, “I am going 
to stay at home and make sure they are taking their treatment”. [[adherence counsellor] 
Resp 1: Family problems sometimes. Either the patient does [not] believe that in their ARVs 
but they are coming because the family is pushing them or the family does [not] believe in 
ARVs and believes that they should take traditional medicine or immune boosters before 
they go on ARVs. [nurse] 
Resp 4: Sometimes it [is] just the family. How family talks make you stop taking the ARVs 
because most of the time people do [not] understand why people have to take these tablets. 
Especially when it comes to HIV. [adherence counsellor] 
In addition, for groups to be sustainable as a support system they need to be convenient to 
access as is reported by respondent 5. A problem that arises in this respect is that due to 
the perceptions around stigma and discrimination, PLWHA may continue to fear being 
victimised or ostracised by their communities and are therefore reluctant to access these 
facilities.  
Resp 5: We had support groups but the problem was that most of the people who come here 
are from townships, Soweto, Alexandra, Witkoppen. So we would rather refer them to 
support groups near their place instead of coming here always. They may not have 
transport money and we do [not] have money to give them for transport………Some of 
them [patients], they do come and report back that I am going to a support group and it [is] 
very beneficial. But some of them feel that “no”. “I felt that because my neighbour is also 
going there or I felt that the support group is near where I stay. So people are going to see 
me coming there and it becomes a problem. [adherence counsellor] 
From the information that was provided by the participants it would seem that treatment 
intervention is primarily provided through treatment and adherence counselling. In 
addition, social support level intervention is available to people who are on treatment, 
however, they are largely in informal settings. Both counselling and social support 
networks as methods of interventions have huge benefits in increasing people’s 
adherence levels. However, as interventions they also serve as significant barriers to 
ARV treatment as has been argued in the above two sections. These intervention 
modalities also remain severely limited. It would seem that this is particularly so in 
addressing systemic level issues that impact on ARV adherence, however, the 
interventions are also severely limited in addressing individual and interpersonal level 
issues. Visnergarwala and colleagues (2006), in their study of ARV adherence, proposes 
the de-institutionalising the approach to ARV adherence. It is recommended by 
Vinesgarwala et al. (2006) is an area that requires further investigation.  
 
Significantly, none of respondents made any reference to organisational and community 
level intervention that proposes a model in which people can take control over their lives 
and their environment to ensure better health outcomes through empowerment, a critical 
consciousness and social action (Rappaport, 1981). However, one respondent made 
reference to notions of empowerment. Respondent 6 who is a treatment activist reported 
that empowering people was a crucial element in addressing systemic level barriers to 
adherence like poverty that leads to decreased adherence levels. Although this was only 
reported by one respondent the information has none the less been included so that this 
crucial area may at least be identified for further research purposes. There is a possibility 
that this topic was not engaged with by more of the participants not because it is of little 
significance but it may be that it has not reached a point of critical consciousness yet. 
Initially this section was constructed under the sub-theme of community level 
intervention but methodological restrictions imposed on data received from just one 
participant has led to the placement of this argument as an extension under the sub-theme 
of social intervention.  
 
As a activist, Respondent 6 believed that those who are HIV-positive may be empowered 
through the development of skills that would allow them to take better charge of their 
environment and their lives. The same respondent also expressed that it was important for 
people to stop seeing themselves as victims of their circumstances. 
 
Resp 6: If we can empower our people as a community. Empowering the people to learn, to 
start doing things for themselves. Like having their own food gardens, like finding ways of 
making money, opening your own small business even though it [may] not be a formal 
business. Find something to sell in order for you to have money...If you empower someone 
you give them skills and the ability to do things for themselves. To think for themselves 
instead of having to depend on the government or having to depend on other people in 
order to make sure your quality of life impoverished…..Especially with HIV, once they are 
diagnosed, people will like start wanting to access disability grants. So, we need to come out 
of that mindset. Being HIV-positive does not mean that you cannot do things for yourself; 
you can still do things for yourself. [treatment activist] 
 
The notion of empowerment can be seen on two levels. Firstly, at the level of the 
individual those who are on treatment can be empowered to take charge of their 
wellbeing. This may increase the ability to engage with their illness with increased 
confidence as well as increased self-esteem (Perkins & Zimmerman, 1995). Individual 
level empowerment may assist those who are on ARV treatment to better understand and 
negotiate the relationship between them and the health care professional, be more active 
rather than passive in negotiating medication and side effects, take charge of their 
psychological wellbeing, deal with stigma and discrimination and seek out the 
appropriate support networks (Perkins & Zimmerman, 1995). Respondent 6 expressed the 
need for a sense of empowerment: 
 
 
Resp 6: We do [not] have to always be putting the blame on other people. On the external 
factors. On the services you get from the health facility or the service you get from the 
health workers or even what the government is doing. At the end of the day, the only person 
who will determine how you adhere to your treatment, how you deal with your 
psychological issues is you, yourself. If you within yourself because we all have the power to 
overcome. [treatment activist] 
 
However, this kind of response once again limits intervention to individual psychological 
reactions.  Empowering individual should also include self-determination with an 
emphasis on collective initiatives that will enable groups of people to take charge of their 
lives (Perkins & Zimmerman, 1995).  Hence it is argued that macro-level policy changes 
need to be implemented in order to address the systemic level barriers and facilitators to 
ARV adherence (Frank, 2006). The argument that is proposed is that any macro-level 
systemic changes can only happen if PLWHA gain an awareness of the cultural as well as 
socio-political factors (Freier as cited in Hope & Timmel, 2003) that impact deeply on 
their ability to manage their illness and treatment thereof. It is crucial for the 
communities on the whole to be able to identify, mobilise and address social and public 
health issues through active participation (Freier as cited in Hope & Timmel, 2003) and a 
critical awareness of the various contexts that impinge on their ability to maintain 
adequate ARV adherence levels. People and communities can become vehicles of power 
(Foucault, 1998) and move away from being mere passive objects and bystanders in their 
experience of being HIV-positive and the treatment. The response that follows captures 
most poignantly this gap in addressing the needs of those who on ARV treatment:  
 
Resp 6: You never see these projects happening [referring to community empowerment 
projects]. In most cases it is more about talking instead of actually doing. Like it [is] no 
action. We really do [not] have a policy around that. [treatment activist] 
 
This study concurs with Frank (2006) where it was reported that HIV-adherence requires 
a micro as well as a macro level understanding. By dividing the themes into individual, 
interpersonal and systemic level factors, this study has also added meso level factors. 
Individual level factors like treatment complexity and side effects would require a 
continued intervention that is based on education and training as a way of containing and 
managing these difficulties. Similarly, psychological difficulties experienced by PLWHA 
would require counselling as well as psychological services that are individual in nature. 
Meso level factors like the patient/practitioner relationship, disclosure and stigma would 
benefit from continued social network and support group interventions 
 
Of greatest concern and a major factor that requires some discussion is that many of the 
difficulties faced by PLWHA on ARV treatment may initially appear to be located at the 
individual level; where it is spoken by patients as well as some health-care providers as if 
these are the aspects that PLWHA may have power over and difficulties can be changed 
through ARV adherence counselling or through the support group assistance.  However, 
as one begins to deconstruct some of the narratives from both the patients as well as the 
health care provider’s perspectives it becomes more clear that many issues are systemic 
in nature. This is supported by Franks (2006) study where it was reported that micro level 
issues are impacted by macro level factors and these are difficult to separate.  
 
Furthermore, whilst many of the healthcare-providers understood that the challenges 
faced by the patients are systemic in nature, many expressed frustration and exasperation 
at not being able to engage with or assist their patients adequately with these difficulties. 
Whilst this is also true of medical health in general in South Africa, these systemic 
problems become even more difficult for those who are HIV- positive as they have to 
deal with added complications like the experience of stigma and discrimination or 
political driven mixed messages around HIV-treatment. It is with this in mind that 
community empowerment, activism and concientisation is highlighted as a critical area of 
mass mobilisation and social change that require further investigation that may assist and 
benefit future policy drives that will assist PLWHA.  
 
 
5.6 CONCLUSION 
 
This chapter has presented the results and the discussions obtained from the study. The 
chapter has been thematically organised to answer the research aims and questions. The 
major topics covered have been individual level, interpersonal level, systemic level and 
intervention level barriers and facilitators to ARV adherence levels. 
 
 
 
 
 
 
 
 
 
CHAPTER SIX 
 
CONCLUSION 
 
6.1 SUMMARY AND CONCLUSION OF STUDY 
 
HIV/AIDS is a global pandemic with statistics showing that South Africa remains one of 
the countries with the highest prevalence rates (UNAIDS, 2007). Advances in ART have 
meant that while HIV remains an incurable illness, it has been turned into a chronic 
condition (Avert, 2008b; Barnett & Whiteside, 2002). However, the South African 
government has been slow in responding to the provision of adequate treatment to 
PLWHA, and access to ART remains problematic (Department of Health, 2000). A 
further issue that remains a challenge is the difficulty experienced with the level of 
adherence to ART (Department of Health, 2000). It is possible for those who are HIV-
positive to live stable and productive lives for as long as they continue to take ARV 
treatment exactly as has been prescribed to them by the medical practitioners. However, a 
95% adherence level is necessary for the treatment to be of optimal benefit (Low-Beer et 
al., 2002; Shutner et al., 2007). 
 
Adhering to ART is complex and requires more than a mere conforming to a set of 
medical standards and instructions. This study has made use of the biopsychosocial 
model in an attempt to bring medical theory and clinical work in line with the many 
psychosocial realties faced by PLWHA who are on treatment (Engel, 1978 as cited in 
Puustinen et al., 2003). The aim of this study was to explore the various biological, 
psychological and social factors that impact on adherence levels and as a consequence 
lead to increased HIV-related morbidity and mortality rates. In order to gain a deep and 
rich understanding of this topic, the qualitative method of research was deemed to be the 
most appropriate for this study. The sample was drawn from a variety of situations, 
including medical practitioners, counsellors, HIV activists as well as those who are 
currently on ARV treatment. The vast amount of data that was generated through the 
semi-structured interviews was thematically organised to reflect the biological, 
psychological and social factors that impact on ARV treatment.  
 
Four main clusters of information emerged. These are individual, interpersonal and 
community, systemic and intervention levels of barriers and facilitators to ARV 
adherence. On the first level, treatment factors like the complexity of treatment and the 
toxicity of the medical regimen appeared to be impacted by the individual level factors 
like the ability to understand and manage the illness and medical regimen.  In addition, 
psychological factors were also conceptualised as an individual level theme. On the other 
hand, the patient/practitioner relationship, issues around disclosure, stigma and traditional 
healing/belief systems are more related to interpersonal barriers and facilitators in ARV 
adherence. Significantly, a further theme that emerged was around those barriers and 
facilitators that are systemic in nature. These included poverty-related issues like 
transport and food needs, problems within the health care system and political 
contributors 
 
However, despite this categorisation, the main findings in this study suggest that none of 
the factors identified and discussed by the participants as having some kind of impact on 
adherence levels, be they positive or negative, can be seen in isolation. There is thus in 
actual fact a web of interlinked reasons why those who are on ARV treatment may 
struggle to take their medication exactly as prescribed. Thus, for example, while 
complexity of treatment and side effects may be biological in nature, a more favourable 
and committed response by the Health Department in the procurement of newer treatment 
options would reduce these factors significantly, making it easier for PLWHA to adhere 
to a less complicated and less toxic medication regimen. A further example is that while 
stigma and discrimination operate on an interpersonal and community level, the 
government’s role around the perceptions of HIV and ARV treatment continues to 
contribute to the perpetuation of stigma. Furthermore, aspects like food needs and 
transport issues are traditionally seen as individual level factors but they are also poverty-
related systemic level failures that stop people from accessing and adhering to ART. Of 
particular significance is that systemic level factors remain particular pertinent, as has 
been consistently found in this research, and appear to have a pervasive impact on both 
the individual level and interpersonal level factors. 
 
In addition, although most of the findings in this study support the findings of other 
research conducted in this field, there is also significant additional information that has 
come to light. Complexity and toxicity of treatment, the patient/practitioner relationship, 
stigma and discrimination, the role of traditional belief systems, transport and food needs 
all remain primary issues for those on ARV treatment. However, a new important theme 
that has emerged is that of the social grant. The social grant has become a major concern 
for many PLWHA and has been identified as an area that is complicating ARV treatment. 
  
Furthermore, in the course of exploring the various biopsychosocial factors at these three 
levels, a particularly pertinent fourth theme started to emerge. This is the manner in 
which ARV treatment intervention comes to impinge on ARV adherence levels. Lay 
counselling and informal support systems are the predominant methods of intervention. It 
is critical to our understanding to note that the traditional intervention methods that have 
been constructed to assist people in understanding their illness and the treatment are 
based on looking at individual behaviour from a point of view that takes into account the 
person’s knowledge, attitudes, behavioural intention and behavioural practices (Fishbein 
et al., 1994; Rosenstock et al., 1994). Traditionally, gaps in the above factors are then 
targeted for change.  
 
However, if we take into account the many systemic level factors that are woven into 
people’s daily experiences around HIV, then it becomes obvious why we need to 
understand how PLWHA construct and deconstruct their contextual matrices that give 
meaning to being HIV-positive and as a consequence what it means to be on treatment 
(Gergen, 2001; Lupton, 1999). Thus, for example, the paradoxical nature of social grants 
has to be deconstructed through an epistemological framework that takes this into 
account. In this research paper it is therefore argued that it is essential to provide 
individual level intervention, like counselling, or interpersonal level intervention, like 
social support, to those who are on ARV treatment in order to improve adherence levels. 
However, at the same time it is also crucially important to empower PLWHA through 
concientisation and activism.  
 
6.2 LIMITATION OF THE STUDY 
 
Being a qualitative research study, this research has been limited by the restricted sample 
size. As a consequence, one limitation is the inability to provide generalisible data. The 
views and opinions are therefore a reflection of a specific group of participants. This 
affects the external validity of the study (Greenstein, 2003). However, as the main 
purpose of this study has been to gain an in-depth understanding that will add to the 
existing body of knowledge and generate future research in this area, the criteria of 
credibility, transferability, dependability and conformability were adhered to in order to 
ensure soundness of the study (Rosenthal & Rosnow, 1991). 
 
A further limitation to be taken into account is the voluntary basis of participation. This 
means that the volunteers could have provided information that was socially desirable or 
that was not in accordance with their true experience (Rosenthal & Rosnow, 1991). It 
may therefore be possible that the information presented may be biased and not 
completely reflective of the group (Rosenthal & Rosnow, 1991). 
 
In addition, some participants had difficulty in verbalising and expressing their thoughts 
and feelings. This may have been due to a difficulty with the medium of language used in 
the interviews. There were instances when it seemed that some participants did not 
understand the questions asked and there is the possibility that by rephrasing the 
questions some leading questions might have been asked. 
 
A significant strength of the sample was that some of the participants included people 
who had defaulted on their treatment and were at the clinic for re-adherence counselling. 
This allowed for the participants to be more open and forthcoming about some of the 
issues that had impacted on their adherence levels. However, despite assurances of 
complete confidentiality by the researcher, there is also a possibility that participants may 
have been hesitant to be completely honest about their experiences as they might have 
been afraid that such information might impact on their chances of going back on ARV 
treatment. 
 
6.3 RECOMMENDATIONS 
 
6.3.1 Recommendations regarding adherence to treatment 
 
Biomedical 
 
As the clinical setting is the first place of contact for those who require ARV treatment, it 
is the first point of discussion under recommendations. 
 
The patient/practitioner relationship is an important one. In this study, practitioners 
displayed a warm and open attitude towards their patients. Many of the practitioners have 
also become activists and have dedicated their time in lobbying for treatment for their 
patients. This kind of activism needs to be continued so that better treatment options may 
be procured and offered to patients. 
 
Many patients continue to see medical doctors as having expert knowledge and insight 
into their problems. A challenge for practitioners is to remain engaged around these 
issues with their patients. Working in a multidisciplinary team can help the medical 
practitioners to assist their patients with both psychological and social difficulties. 
 
 
 
 
 
 
 
 
Psychological 
 
Patients who enter the system for treatment are often first referred to counsellors who will 
deal with adherence issues. Most counsellors are trained in the biomedical understanding 
of HIV and ARV treatment. Knowledge around the illness and aspects like complexity of 
treatment and side effects are communicated very proficiently. However, counsellors are 
not trained to engage with psychological issues. As PLWHA suffer from a 
disproportional amount of emotional difficulties, this area needs to be researched and 
adequate psychological care and service need to be offered to the patients. 
 
The role of community psychology needs some exploration as this modality of 
intervention will focus on the extended notion of community empowerment through 
collective initiatives. In this way, PLWHA may become more engaged with the systemic 
level challenges.  
 
Socio-cultural 
 
The traditional healing systems are an established form of health care in the South 
African society. Understanding and incorporating these systems into the western medical 
modality is thus necessary and will allow for medical pluralism and inclusivity. 
 
Stigma continues to be a huge predictor of lowered adherence levels. Continued support 
around this issue is necessary.  
 
Social support networks are a valuable source of empowerment for PLWHA. Support 
structures can help to reduce emotional difficulties like shame and guilt that the patient 
may be experiencing. These networks are also platforms where the PLWHA may obtain 
information regarding their treatment. The combined emotional and practical support can 
assist in increased in adherence. 
 
Continued activism from multiple forums (medical practitioners, counsellors, social 
workers, HIV activists and PLWHA) must continue to take on and challenge systemic 
level barriers to ARV adherence.  
 
Political 
 
The stance taken by the political leadership and the role of the government continues to 
add to the many systemic level difficulties experienced by PLWHA who are on 
treatment. A greater commitment is required by our political structures. It is 
recommended that the Department of Health make a greater effort to commit to: 
 
• Work towards eliminating the many mixed messages that are communicated to 
the public, particularly around the toxicity of treatment and the benefits of ARV 
treatment.  
• This will also assist in eliminating the perpetuation of systemic level stigma 
around HIV. 
• To engage traditional healing systems and to allow for medical pluralism in the 
treatment of PLWHA. 
• Make provision for better psychological services in the clinical setting 
• Continue working towards increasing ARV sites that will make access to 
treatment easier for PLWHA. 
• Make greater efforts to procure newer drugs that will decrease the complexity as 
well as the many side effects currently experienced by PLWHA who are taking 
older drug regimens. 
 
 
 
 
 
 
 
6.3.2 Recommendation for future research 
 
Based on the results of this study, it is recommended that future research be conducted in 
the area of the effectiveness of ARV adherence counselling. The shortfalls in ARV 
counselling and gaps in theoretical knowledge around this area need further investigation. 
 
The government social grant has been identified as an element that is increasingly 
complicating ARV treatment adherence, and thus this area requires further research. 
 
Finally, there are many predictors that impacts on ARV adherence levels and much 
research has been done to uncover these variables. However, there is a lacuna in a 
theoretical understanding around how these factors come to interact with health believes 
and behaviours. This research has made a tentative attempt at bringing together the 
various biopsychosocial factors that contribute to varying adherence levels to ARV 
treatment together with some theoretical understanding using various health models. 
However, future research is needed in uncovering aspects like how PLWHA 
conceptualise and construct themselves, the manner in which risk is understood and 
power differentials that impacts on how PLWHA constructs their illness and how this 
may impact on future treatment.  
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Appendix 4 
 
PERMISSION TO CONDUCT RESEARCH – DEPT OF HEALTH/HEAD OF HIV 
UNIT 
 
Dear Sir/Madam 
 
My name is Rabia Patel and I am currently registered for the Masters degree in 
Community and Counselling Psychology at the University of Witwatersrand, 
Johannesburg. As part of my degree I am required to undertake a research project. My 
research would be looking at and understanding possible barriers and facilitators to ART 
adherence. I would hereby like to request permission to be able to conduct my research at 
the Helen Joseph and/or the Johannesburg Hospital.  
  
Adherence to antiretroviral medication is essential for the successful treatment and 
sustained viral control in individuals who are HIV-positive. However, adherence to 
medication can be a complex interaction of emotional, cognitive, behavioural, social and 
medical factors. The focus of my research is to better understand the biomedical, 
psychological and social barriers as well as facilitators to antiretroviral therapy (ART). It 
is envisaged that this research will possibly be able to add some value to both theoretical 
as well as practical aspects in the overall outcome of adherence to ART. 
 
In undertaking this research, I will make an attempt to understand the viewpoint of 
medical practitioners as well as patients on ART. My intention is to conduct semi 
structured, in-depth interviews in order to get a qualitative understanding of their 
experiences of the barriers and facilitators to adherence to ART. Furthermore, I will need 
to interview a minimum of six medical practitioners (3 medical doctors and 3 nurses) and 
five patients. It is envisaged that the interviews will last for approximately an hour. I 
will tape the interviews and take some notes during the interviews. This will help me to 
gather the required information. All information I receive will be confidential. The 
audiotapes will be destroyed as soon as they have been transcribed. No identifying details 
will be included on any transcribed material or in the research report. 
 
I include herewith my research proposal for further information. Either my supervisor or I 
can be reached at the numbers provided below for any further questions. 
 
Thanking You 
 
Rabia Patel                                                                                       Malose Langa 
(Researcher)                                                                                     (Research Supervisor) 
(011) 615-1771                                                                                 (011) 717-4536 
0824498386 
 
 
Appendix 5 
 
 
Participants Information Sheet 
               
 
 
Hello, 
 
My name is Rabia Patel, and I am conducting research for the purposes of obtaining a Masters in 
Community and Counselling psychology at the University of the Witwatersrand.  The focus of my 
research is to better understand what makes it easier or more difficult to take antiretroviral medication. 
It is hoped that this research will be able to assist in improving the overall outcome of adherence to 
ART. 
 
We would like to invite you to participate in this study. Participation in this research will entail being 
interviewed by me, at a time and place that is convenient for you. The interview will last for 
approximately one hour. With your permission this interview will be recorded in order to ensure 
accuracy. Participation is voluntary, and no person will be advantaged or disadvantaged in any way for 
choosing to participate or not participate in the study. All of your responses will be kept confidential, 
and no information that could identify you would be included in the research report. The interview 
material (tapes and transcripts) will not be seen or heard by any person in this organisation at any time, 
and will only be processed by myself. You may refuse to answer any questions you would prefer not to, 
and you may choose to withdraw from the study at any point without any negative consequence to you 
or the treatment that you receive. 
 
In the event of stress occurring as a result of participation in this study, you will be provided with details 
of available psychological services at the hospital. If you choose to participate in the study please fill in 
your details on the form below and place it in the sealed box that is provided. You may find this box in 
the reception area of the hospital where you are receiving the treatment. I will empty the box at regular 
intervals, and will contact you within two weeks in order to discuss your participation.  
 
In taking part in this research I hope to bring awareness of the needs of HIV- positive people who are on 
antiretroviral treatment and to help equip health professionals to make the appropriate responses in 
dealing with non-adherence to treatment. It is also hoped that this research will contribute both to a 
larger body of knowledge on adherence to ARV. If you have any questions I can be reached at the 
following telephone numbers. 
 
Thanking You 
 
Rabia Patel                                                                                       Malose Langa 
(Researcher)                                                                                     (Research Supervisor) 
 
 
 
 
 
 
(011) 615-1771 
0824498386 
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CONSENT FORM - PARTICIPANT 
  
 
 
 
 
I _____________________________________ consent to being interviewed by  Rabia 
Patel for her study on HIV/AIDS – Living with Chronic Medication: Barriers and 
Facilitators to Antiretroviral Therapy Adherence. I understand that: 
  
- Participation in this interview is voluntary. 
- That I may refuse to answer any questions I would prefer not to. 
- I may withdraw from the study at any time. 
- No information that may identify me will be included in the research report, and 
my responses will remain confidential.  
 
 
Signed ________________ 
 
 
 
 
 
 
 
CONSENT FORM – AUDIOTAPE 
 
 
 
 
 
I _____________________________________ consent to my interview with Rabia Patel 
for her study on HIV/AIDS – Living with Chronic Medication: Barriers and Facilitators 
to Antiretroviral Therapy Adherence being tape-recorded. I understand that: 
  
- The tapes and transcripts will not be seen or heard by any person in this 
organisation at any time, and will only be processed by the researcher. 
- All tape recordings will be destroyed after the research is complete.  
- No identifying information will be used in the transcripts or the research report. 
 
 
Signed _____________________ 
 
 
Appendix 7 
 
PERMISSION TO CONDUCT RESEARCH – TAC/AIDS CONSORTIUM 
 
 
Dear Sir/Madam 
 
My name is Rabia Patel and I am currently completing my Masters degree in Community 
and Counselling Psychology at the University of Witwatersrand, Johannesburg. As part 
of my degree I am required to undertake a research project. My research would be 
looking at and understanding possible barriers and facilitators to ART adherence. I would 
hereby like to request permission to be able to conduct my research at your organisation.  
 
Adherence to antiretroviral medication is essential for the successful treatment and 
sustained viral control in individuals who are HIV-positive. However, adherence to 
medication can be a complex interaction of emotional, cognitive, behavioural, social and 
medical factors. The focus of my research is to better understand the biomedical, 
psychological and social barriers as well as facilitators to antiretroviral therapy (ART). It 
is envisaged that this research will possibly be able to add some value to both theoretical 
as well as practical aspects in the overall outcome of adherence to ART. 
  
In undertaking this research, I will make an attempt to understand the viewpoint of 
HIV/AIDS activist. My intention is to conduct in-depth interviews in order to get a 
qualitative understanding of their experiences of the barriers and facilitators to adherence 
to ART. Furthermore, I will need to interview a minimum of 3 members from your 
organisation. It is envisaged that the interviews will last for approximately an hour. I 
will tape the interviews and take some notes during the interviews. This will help me to 
gather the required information. All information I receive will be confidential. The 
audiotapes will be destroyed as soon as they have been transcribed. No identifying details 
will be included on any transcribed material or in the research report. 
 
I include herewith my research proposal for further information. Either my supervisor or I 
can be reached at the numbers provided below for any further questions. 
 
Thanking You 
 
Rabia Patel                                                                                       Malose Langa 
(Researcher)                                                                                     (Research Supervisor) 
(011) 615-1771                                                                                 (011) 717-4536 
0824498386 
 
 
 
 
Appendix 08 
 
Interview Schedule – Participants on ART 
 
Introduction 
How long have you been on treatment? 
What treatment are you on? 
What are your experiences of receiving the treatment at the hospital? 
What do you think makes it difficult for you to take your medication? 
What are some of the things that makes it easier for you to stay on your medication? 
What can be done to help you with the difficulties that you may be experiencing in taking 
your treatment? 
Is there anything more you would like to add? 
 
Please note that the above are the core questions. These questions are meant to get 
the participant to share the possible barriers and facilitators to adherence to ARV’s. 
As this study wishes to capture the experiences of the participants and build up to a 
theoretical formulation, the original interview schedule was meant to be a thematic 
guide to ensure that important areas that may be impacting on adherence is noted 
when conducting the interviews.  
 
1) What makes the treatment difficult? 
Draw out Biomedical Factors 
• How complicated is the treatment 
• How is this experienced 
• Are they experiencing any side effects 
• How do they deal with this 
• How expensive is it to get the treatment 
• Is the hospital facilities difficult to access 
• How is their experience of the medical personnel 
2) What are some of the things that makes treatment easier? 
• Did they receive any pre treatment counselling  
• Are they receiving any counselling presently 
• What type of counselling are they receiving 
3) Do the way you feel have an impact on your treatment? 
Draw out  psychological factors 
• Explore pre medication psychological factors 
• How did they experience being HIV-positive 
• Depression 
• Stress 
• Coping styles 
• Self esteem 
• Anger 
• Fear 
• Guilt 
• Blame 
• Was any of this was explored before the start of treatment (via counselling or 
medical practitioners) 
• Post medication psychological factors 
• Has any of this changed 
• Positive responses (look for support etc) 
• Negative Responses (withdrawal, self blame etc) 
 
4) Draw out social factors 
• Financial situation 
• Material support 
• Does the way others behave towards you impact on your treatment 
• Is it easy or difficult to take the medication around others 
• Stigma 
• What kind of social support are you getting? 
• How do the above two impact on adherence 
  
Closing Interview 
5)What are some of your concerns? 
6)What can be done to make the process of taking medication easier for you? 
7)Is there anything more you would like to add? 
 
Interview Schedule – Others 
Medical Personnel 
 
1) Can you tell me about the ARV treatment plan? 
2) How do you determine who qualifies for the programme? 
3)Adherence is vital in ARV treatment plan. Can you define adherence? 
4)What are some of the problems that impact on adherence to treatment? 
5)How is this managed? 
6)What are some of the aspects that lead to increased adherence? 
7)What can be done to improve adherence to ART? 
 
HIV/AIDS Activist/Counsellors 
 
1)Adherence is cited as one of the major aspect that impacts on effective viral load 
treatment on those who are HIV- positive. Can you tell me what is understood by 
adherence? 
2)How does differ from the concept of compliance? 
3)What are some of the biomedical factors that have an impact on adherence? 
4)What in your experience are the psychological factors that impact on adherence? 
5)How do these impact on adherence to ART? 
6)Can you tell me how socio-economic factors impact on adherence to ART? 
7)What other factors in your opinion makes it difficult for patients to adhere to 
medication? 
8)What can be done to improve adherence? 
